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Mycotoxins are a series of secondary metabolites produced by various mould species 
growing on plant-based products either in the field or during storage. Hitherto, 
approximately 300−400 mycotoxins have been discovered, among which, about 30 
are considered as the most important dietary risk factor, higher than synthetic 
contaminants, plant toxins, food additives or pesticide residues. They have been 
categorized into different groups on the basis of their different origins, mainly 
including aflatoxins (AFs), ochratoxins, trichothecenes, fumonisins, zearalenone 
(ZEN) and its derivatives, and others. They can contaminate various food and 
feedstuffs, including cereal crops, vegetables, fruits and botanical. Due to the 
widespread occurrence and high toxicity, mycotoxin research has become more and 
more important around the world. 
The main goal of the present PhD-dissertation is to provide in-depth research to 
further unravel the health risks related to frequently occurring mycotoxins. Several 
objectives have been set and are described in details here. 
The first objective is to develop a reliable analytical platform as a support tool for 
the whole research, including: (1) to develop rapid targeted liquid chromatography 
tandem mass spectrometry (LC-MS/MS) methods for simultaneous determination of 
frequently occurring mycotoxins (Chapter 2), which could be used for exposure 
assessment (Chapter 4) and secondary metabolites identification (Chapter 2); (2) to 
develop sensitive and sample-saving LC-MS/MS methods for the in vivo kinetics 
study of selected mycotoxins in different biomatrices (Chapter 3); (3) to develop an 
untargeted analytical strategy combining different techniques, i.e., liquid 
chromatography time of flight mass spectrometry (LC-TOF), LC-MS/MS, 
LC-orbitrap, LC-ion trap and nuclear magnetic resonance (NMR), for identification of 
new metabolites produced by toxigenic fungi (Chapter 2) and the mycotoxin 
metabolites in toxicokinetic studies (Chapter 3). 
 Among the frequently observed mycotoxins, AFs and ochratoxins are related to 
Aspergillus species, while trichothecenes, fumonisins and ZEN are all produced by 
Fusarium fungi, emphasizing the importance of these two fungal genera. Therefore, 
the second objective is to investigate the metabolic profiles and the toxin-producing 
abilities of Aspergillus and Fusarium species, thereby laying down the basis for a 
thorough assessment of the adverse effects caused by these fungi. 
The third objective is to provide in vivo toxicokinetics data for selected 
Aspergillus and Fusarium mycotoxins. Among the naturally and frequently occurring 
Introduction and Objectives 
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mycotoxins produced by Aspergillus and Fusarium fungi, aflatoxin B1 (AFB1), T-2 
toxin (T-2) and ochratoxin A (OTA) are included. Since low elimination and high 
accumulation effects of OTA are observed, the metabolism was further investigated to 
address the remaining uncertainties regarding OTA biotransformation 
(glucuronidation and targeted tissues) in rat.  
As an important Aspergillus mycotoxin, OTA has been widely found in wine, 
sultanas and dried apricots destined for export from Turkey to the European Union, as 
well as in dates and dried fruits in Tunisia and Spain. However, up to now, no studies 
are avaible to clearly identify the risks of OTA in the human diet in China. Since the 
dietary habits in China are completely different from those in most other countries, 
and in addition the country encompasses a large geographic area and different 
environmental conditions, i.e., temperature and humidity, the fourth objective is to 
quantitatively perform a risk assessment for OTA to humans in China.  
Deoxynivalenol (DON) and its derivatives, 3-acetyldeoxynivalenol (3-ADON) and 
15-acetyldeoxynivalenol (15-ADON), important mycotoxins produced by Fusarium 
species, have been found in cereal-based products in Belgium, northern Iran, Japan, 
Denmark, Pakistan, and also in China. Humans can be simultaneously exposed to 
DON, 3-ADON and 15-ADON, but health risk assessments are usually performed on 
individual mycotoxins, which may underestimate the total risk. Therefore, the fifth 
objective is to make the first attempt using concentration addition (CA) concepts to 
quantitatively assess the potential risks to Shanghai residents associated with the 
dietary intake of co-occurring mycotoxins. 
The complete research is presented in 4 chapters. All the essential information of the 
research work gathered from the different chapters was used to form the general 
conclusions and future perspectives in Chapter 5 and Chapter 6. A schematic illustration 
of the research carried out in this PhD-dissertation is shown in Fig. I. 
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Figure I Schematic illustration of the research carried out in this 
PhD-dissertation 
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1.1 GENERAL INFORMATION ON MYCOTOXINS 
 
The word “mycotoxin” originates from the Greek “Mykes” and Latin “Toxicum”, 
representing a series of secondary metabolites produced by various mould species 
growing on plant-based products either in the field or during storage 1,2. Mycotoxin 
production is mainly considered to be dependent on the surrounding intrinsic and 
extrinsic environments. Since mycotoxins can weaken the receiving host, they might 
be used by the fungus as a strategy to adapt the environment for further fungal 
proliferation 3,4. Mycotoxicosis is the term used for poisoning associated with 
exposures to mycotoxins, and is adopted because of the mysterious Turkey X-disease 
in 1962 in the United Kingdom, which was linked to a peanut meal contaminated with 
secondary metabolites of Aspergillus (A.) flavus (i.e. aflatoxins, AFs). Mycotoxins 
were thereafter stated to be a major public health concern, and more and more 
attention has been paid on mycotoxinresearch around the world. Hitherto, 
approximately 300−400 mycotoxins have been found; they are evaluated as the most 
important dietary risk factor, higher than synthetic contaminants, plant toxins, food 
additives or pesticide residues. The most frequently found mycotoxins have been 
categorized into different groups on the basis of their different origins, mainly 
including AFs, ochratoxins, trichothecenes, fumonisins and zearalenone and its 
derivatives. The chemical structures of frequently occurring mycotoxins in food and 
feed are shown in Fig. 1.1. These mycotoxins have the potential for both acute and 
chronic health effects via ingestion, skin contact and inhalation. They can enter the 
blood stream and lymphatic system inhibiting protein synthesis, damaging 
macrophage systems and inhibiting particle clearance of the lung 5,6. 
 
1.1.1 Aflatoxins 
 
AFs, a family of structurally related mycotoxins, are produced as secondary 
metabolites by the spoilage fungi of the Aspergillus genus, particularly A. flavus and A. 
parasiticus7. The term “aflatoxin” is derived from three words: (i) the “a” that 
represents the Aspergillus genus; (ii) the “fla” that represents the species flavus; and 
(iii) the “toxin” that means poison. Among the 18 different types of identified AFs, the 
most important members are aflatoxin B1 (AFB1), aflatoxin B2 (AFB2), aflatoxin G1 
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18 
(AFG1) and aflatoxin G2 (AFG2). In addition to these four major types of AFs, two 
others, aflatoxin M1 (AFM1) and aflatoxin M2 (AFM2), can be formed in animals or 
humans after ingestion of AFB1 and AFB2 8. Approximately 0.3-6.2% of AFB1 in 
animal feed is transformed into AFM1 in milk 9,10. AFs have been reported to 
contaminate food and feedstuffs in the tropics and semi-tropics where high 
temperature and humidity are optimal for the growth of moulds and production of 
toxins. A variety of important foodstuffs are susceptible to AFs contamination, such as 
cereals, botanicals, nuts, dried fruits and spices 11-16.  
Among the major AFs of concern, AFB1 is the most frequent metabolite in 
contaminated samples and is classified by the International Agency for Research on 
Cancer (IARC) in group I as human carcinogen, of which, the carcinogenic 
mechanism is achieved by affecting the pericellular membrane, interfering the 
inductive style of specific enzymes and inhibiting the synthesis of RNA 17. AFB2, 
AFG1 and AFG2 are also classified in group I as human carcinogens. Although the 
toxicity of AFM1 and AFM2 is lower than AFB1, they are known for their 
hepatotoxic and carcinogenic effects. Due to the negative effects on animal and 
human health, strict regulations have been established for AFs in food and feed by 
different countries. Maximum levels of AFB1 and total AFs (the sum of AFB1, AFB2, 
AFG1 and AFG2) are the parameters currently employed to limit AFs in many foods 
18. In more than 75 countries, maximum levels for AFB1 and total AFs in food are 5 
and 10 μg/kg, respectively. In China, the maximum levels for AFB1 are 5-20 μg/kg in 
different foods 75,76. In the European Union, more strict maximum levels have been 
set as 2 and 4 μg/kg for AFB1 and total AFs, respectively 19-21. To ensure milk safety, 
the US Food and Drug Administration (FDA) and the European Commission (EC) 
have also established maximum levels for AFM1. The FDA (1996) has set a 
maximum level of 500 ng/L for AFM1 in milk, while the EC set a limit of 0.05 μg/kg 
in milk and 0.025 μg/kg in baby food 9,19 (Table 1.1). 
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Figure 1.1 Chemical structures of frequently occurring mycotoxins 
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1.1.2 Ochratoxins 
 
Ochratoxins, mainly including ochratoxin A (OTA) and ochratoxin B (OTB), are 
secondary metabolites produced by several species of fungi, notably A. ochraceus, A. 
melleus, A. alliaceus, A. petrakii, A. ostianus, A. sclerotiorum, A. sulphureus, A. 
auricomus and A. albertenses, as well as Penicillium verrucosum 22,23. Between the 
two ochratoxins of concern, OTA, related to both urothelial urinary tract tumors and 
Balkan endemic nephropathy, is the more frequently present metabolite in 
contaminated samples 24. IARC has classified OTA in group 2B as a possible 
carcinogenic compound to humans. Although the toxicity of OTB is lower than OTA, 
it is known for its nephrotoxicity and renal carcinogenic effects 25.  
Ochratoxins occur in a large variety of foods, i.e. cereals, beans, spices, dried fruits, 
grapes, cocoa and traditional Chinese medicines, and because of a carry-over effect, in 
milk, blood, liver, kidney and poultry meat from animals fed with contaminated feed, 
posing high potential health risks to animals and humans 26-29. Based on the animal 
studies and epidemiological studies on humans, the provisional tolerable daily intakes 
(PTDIs) of OTA established by EFSA and JECFA are approximately 17 and 14 ng/kg 
b.w./day, respectively, while a much lower value of 5 ng/kg b.w./day is proposed by 
the Scientific Committee for Food (SCF) 30. The EC has set maximum limits for OTA 
at 5 μg/kg in raw cereals, 3 μg/kg in all products derived from cereals and 10 μg/kg in 
raisins, respectively 19,31, while in China, the maximum limits for OTA in different 
foods are in the range 2-10 μg/kg (Table 1.1). 
 
1.1.3 Trichothecenes 
 
Trichothecenes, with molecular weights ranging between 200 and 500 Da, represent a 
group of secondary metabolites produced by toxigenic Fusarium species, especially F. 
graminearum, F. sporotrichioides, F. poae and F. equiseti 32-34. The trichothecenes 
family includes more than 200 toxins with a sesquiterpenoid structure with or without 
a macrocyclic ester or an ester–ether bridge between C-15 and C-4 35. A common 12, 
13-epoxytrichothecene group responsible for its cytotoxicity and a 9, 10 double bond 
with various side chain substitutions are contained in this type of mycotoxins. This 
family of related polycyclic sesquiterpenoids is divided into four types (A–D) 
according to their characteristic functional groups. HT-2 toxin (HT-2), T-2 toxin (T-2), 
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diacetoxyscirpenol (DAS) and neosolaniol (NEO) are naturally occurring type A 
trichothecenes. Deoxynivalenol (DON), 3-acetyldeoxynivalneol (3-ADON), 
15-ADON, nivalenol (NIV) and fusarenon X (Fus X) belong to type B trichothecenes. 
In contrast to type A trichothecenes, type B trichothecenes possess a C-8 keto-group. 
The number and position of the hydroxyl and acetyl-ester groups can influence the 
relative toxicity within eukaryotic cells. Type C trichothecenes are characterized by a 
second epoxide group, while type D trichothecenes are macrocyclic compounds. 
Among the four groups, type A and type B trichothecenes are widespread 
contaminants 36. These two types trichothecenes can contaminate a variety of cereal 
grains including wheat, oats, barley, maize, rice and traditional Chinese medicines, 
especially in cold climate regions or during wet storage conditions 37-40. 
Acute and chronic ingestion of type B trichothecenes by humans and animals can 
elicit a variety of toxic effects, i.e. feed refusal, weight loss and vomiting, while 
ingestion of type A trichothecenes can lead to immunosuppressive and cytotoxic 
effects, due to their inhibitory effects on DNA, RNA and protein synthesis, and 
effects on cell division and membrane function 6,41-44. JECFA has evaluated the risk of 
trichothecenes and established the PTDI of DON at 1000 μg/kg b.w./day45, and the 
SCF has set the PTDI for the sum of T-2 and HT-2 as 60 μg/kg b.w./day31. In the 
European Union, the maximum contents are 1250 μg/kg for DON and 50-1000 μg/kg 
for the sum of T-2 and HT-2, respectively, in most of the unprocessed cereals. In 
China, the maximum limit for DON is set at 1000 μg/kg while still no regulation has 
been established for T-2 and HT-2 (Table 1.1).  
 
1.1.4 Fumonisins 
 
Fumonisins are a family of secondary metabolites, whose structures have been 
elucidated in 1988. They are produced by several fungal species like F. verticillioides 
and F. proliferatum 46, which are regarded as maize pathogens causing root/stem/ear 
diseases. These compounds are diesters of propane-1,2,3- tricarboxylic acid and either 
2-acetylamino-12,16-dimethyl-3,5,10,14,15-pentahydroxycosane (A-series 
fumonisins), 2-amino-12,16-dimethyl-3,5,10,14,15-pentahydroxycosane (B-series 
fumonisins, FBs) or 1-amino-11,15-dimethyl-2,4,9,13,14-pentahydroxynonadecane 
(C-series fumonisins) with related homologues differing in the absence or presence of 
hydroxyl groups at positions C-5 and C-10 of the C-20 aminopentol backbone. 
Chapter 1 Introduction 
 
22 
Among the main groups, FBs are the most abundant analogs with fumonisin B1 (FB1), 
fumonisin B2 (FB2) and fumonisin B3 (FB3) appearing to be of major importance 
47,48. It has been reported that more than half of maize and maize-based products are 
contaminated with FBs 49-51. Contamination levels of FBs vary depending on the 
climatic conditions prevailing in the region in which the maize is cultivated, 
transported and stored 30,52. FB1/FB2 (around 3:1) and FB1/FB3 (about 12:1) ratios 
were observed in fumonisin-contaminated maize samples 51. 
Special attention has been paid to FBs because of their potential adverse effects in 
animals and humans 5,53. The consumption of FB-contaminated food and feedstuff has 
been associated with severe disorders in animals, i.e. esophageal and hepatic cancer in 
rats and pulmonary edema in pigs, and with the development of hyperendemic levels 
of human esophageal cancer 54. Investigations have also shown an association with 
primary liver cancer in Henan Province in China 55. FB1 has been classified as a 
possible carcinogen for humans (Group 2B) by IARC. Regarding the potential risks, 
the SCF suggested a TDI of 2000 μg/kg b.w./day for FB1, FB2 and FB3, alone or in 
combination 48. To reduce the intake of FBs, the EC has set a maximum level of 800 
μg/kg for maize-based breakfast cereals and snacks, 1000 μg/kg for maize and 
maize-based foods intended for direct human consumption and 200 μg/kg for 
processed maize-based foods and baby foods for infants and young children 47,48. No 
maximum limits have been established for these mycotoxins in China (Table 1.1) 
 
1.1.5 Zearalenone and its derivatives 
 
Zearalenone (ZEN) and its derivatives, α- and β-zearalenol (α- and β-ZEL) are a 
group of phenolic compounds produced mainly by Fusarium moulds 56,57. They are 
most frequently detected in maize but they can also contaminate other cereals (wheat) 
and plant products (traditional Chinese medicines) 58. ZEN production is favored by 
low temperatures and high humidity. It may co-occur with DON in grains such as 
wheat, barley, oats and maize and with fumonisins in maize 59,60. Acute and chronic 
intoxication of ZEN, α- and β-ZEL in animals can elicit a variety of toxic effects, i.e. 
enlargement of mammary glands and uterus, infertility, vaginal prolapse and atrophy 
of testicles and ovaries 61. α-Zearalanol (α-ZAL) is a resorcyclic acid lactone and 
might arise from the metabolism of α-ZEL or ZEN. It is used to improve the feed 
conversion efficiency and to promote growth rates in livestock production in some 
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non-EU countries 62,63. However, long-term investigations with rats, dogs and 
monkeys indicate that α-ZAL is a weak estrogen effecting predominantly changes in 
mammary glands and organs of the reproductive system 64. The major metabolites of 
α-ZAL are zearalanone (ZAN) and β-zearalanol (β-ZAL), which also have 
endocrine-related biological activity though they are less biologically active than 
α-ZAL. Because of the potential health effects of ZEN and its derivatives in domestic 
animals (particularly swine), maximum limits for ZEN, ranging from 20 μg/kg to 
1000 μg/kg in unprocessed foods, have been established in many countries (Table 1.1) 
33. In the US, the maximum residue levels (MRLs) for α-ZAL in uncooked edible 
cattle tissues are set at 0.15 mg/kg in muscle, 0.3 mg/kg in liver, 0.45 mg/kg in kidney 
and 0.6 mg/kg in fat. In Australia, MRLs for α-ZAL are 0.005 mg/kg in cattle meat 
and 0.02 mg/kg in the edible offal of cattle 63,65.  
 
1.1.6 Other mycotoxins 
 
Besides the five types of mycotoxins mentioned above, several other mycotoxins can 
frequently contaminate cereal crops and pose potential health risks to humans and 
animals due to their toxic effects.  
Sterigmatocystin (STC), a fungal secondary metabolite produced by many 
Aspergillus species such as A. chevalieri, A. versicolor, A. ruber, A. amstelodami, A. 
aureolatus, A. quadrilineatus and A. sydowi, can frequently co-contaminate different 
cereal crops with AFs. It has been classified into group 2B by IARC as a potential 
carcinogen, mutagen and teratogen 66,67. 
Citrinin (CTN) can be produced by Penicillium citrinum, P. expansum, P. 
verrucosum, A. terreus, and Monascus ruber. It can contaminate maize, wheat, rye, 
barley, oats, and rice, frequently in combination with OTA. CTN possesses antibiotic 
properties against gram positive bacteria, but it cannot be used as a drug due to its 
nephrotoxicity. The major target organs of CTN are kidney, liver and bone marrow. 
Eventhough CTN is one of the first isolated mycotoxins, the data on the mechanism 
of its toxicity are still controversial and most have been obtained in vitro 68,69. 
Patulin (PAT), a toxic chemical contaminant, is produced by several mould species, 
especially Penicillium, Aspergillus, Paecilomyces and Byssochlamys. It is the most 
frequently found mycotoxin in apples and apple-derived products such as juice, cider, 
compotes and other food intended for young children. Exposure to this mycotoxin is 
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always associated with immunological, neurological and gastrointestinal outcomes. 
Since 2003, the maximum limits of PAT have been set as 50 μg/L for fruit juices and 
derived products, 25 μg/L for solid apple products and 10 μg/L for juices and foods 
destined for babies and young infants by the EC 14,70 (Table 1.1). 
Gliotoxin (GT) is the prototype of a class of epidithiodioxopiperazines (ETPs) that 
can be produced by several fungal species, e.g., Eurotium chevalieri, A. fumigatus, 
Gliocladium fimbriatum and also some Trichoderma and Penicillium species. It can 
modulate the immune response and induce apoptosis in different cell types. The 
toxicity has been attributed to the unusual intramolecular disulfide bridge 71. 
Recently, modified mycotoxins, especially the glucoside and sulfate conjugates of 
the free mycotoxins (i.e., ZEN, DON, T-2 and HT-2), have been observed 72. These 
modified mycotoxins can be generated by plant metabolism or food processing 
coexisting with their free mycotoxins, and reportedly, more than 30% of the 
mycotoxins-contaminated crops also contain their related derivatives 72. Consumer 
health risks may result from hydrolysis of the modified mycotoxins into their toxic 
free forms during mammalian digestion. 
Research on several other mycotoxins, including fusaric acid, mycophenolic acid 
(MPA) and cyclopiazonic acid (CPA) has also emerged 73. The toxicity data on 
secondary metabolites produced by Aspergillus fungi are summarized in Table 1.2. 
 
1.1.7 Regulations set by the European Commission and China 
 
As described above, a large amount of mycotoxins has been found in a variety of 
foods and feeds, i.e., cereals and derived products, fruit and derived products, dried 
fruit and derived products, the major ones of which include AFs, ochratoxins, FBs, 
ZEN, DON, T-2 and HT-2. As the toxins can be accumulated in animal tissues or 
excreted in milk, it is possible to find contaminated animal-derived food products of 
pork, chicken, eggs and dairy products. Due to their high toxicity and widespread 
occurrence, different regulated standards have been established by the EC and also in 
China 19-21, 74-76. The maximum limits of the main mycotoxins set by the EC and 
China are shown in Table 1.1. For different food commodities, compared to the 
European Union, it can be observed that maximum limits are most of the time higher 
in China for AFs and DON, but more strict for ZEN. In addition, there are still no 
regulations for FBs, T-2 and HT-2 in China. 
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Table 1.1 Maximum limits of different mycotoxins in food set by the European Commission and China. 
Mycotoxins Food Commodity 
European 
Commission 
(μg/kg) 
China 
(μg/kg) 
Aflatoxin 
B1/ Sum of 
aflatoxin 
B1, 
aflatoxin 
B2, 
aflatoxin G1 
and 
aflatoxin 
G2/ 
Aflatoxin 
M1 
Groundnuts (peanuts) and other oilseeds, to be subjected to sorting, or 
other physical treatment, before human consumption or use as an 
ingredient in food stuffs, with the exception of: 
-groundnuts (peanuts) and other oilseeds for crushing for refined 
vegetable oil production 
8/15/- 20/-/- 
κ Almonds, pistachios and apricot kernels, to be subjected to sorting, or 
other physical treatment, before human consumption or use as an 
ingredient in food stuffs 
12/15/- -/-/- 
λ Hazelnuts and Brazil nuts, to be subjected to sorting, or other physical 
treatment, before human consumption or use as an ingredient in food 
stuffs 
8/15/- -/-/- 
Tree nuts, other than the tree nuts listed in κ and λ, to be subjected to 
sorting, or other physical treatment, before human consumption or use as 
an ingredient in food stuffs 
5/10/- -/-/- 
Groundnuts (peanuts) and other oilseeds and processed produces thereof, 
intended for direct human consumption or use as an ingredient in food 
stuffs with the exception of (1) crude vegetable oils destined for refining 
and (2) refined vegetable oils. 
2/4/- 5/-/- 
ν Almonds, pistachios and apricot kernels, intended for direct human 
consumption or use as an ingredient in food stuffs 
8/10/- 5/-/- 
ξ Hazelnuts and Brazil nuts, intended for direct human consumption or use 
as an ingredient in food stuffs 
5/10/- 5/-/- 
Tree nuts, other than the tree nuts listed in ν and ξ and processed products 
thereof, intended for direct human consumption or use as an ingredient in 
food stuffs 
2/4/- 5/-/- 
Dried fruit to be subjected to sorting, or other physical treatment, before 
human consumption or use as an ingredient in food stuffs  
5/10/- 5/-/- 
Dried fruit and processed products thereof, intended for direct human 
consumption or use an ingredient in food stuffs 
2/4/- 5/-/- 
All cereals and all products derived from cereals, including cereal 
products, with the exception of food stuffs listed in *, & and @ 
2/4/- 20/-/- 
* Maize and rice to be subjected to sorting, or other physical treatment, 
before human consumption or use as an ingredient in food stuffs 
5/10/- 20/-/- 
Raw milk, heat-treated milk and milk for the manufacture of milk-based 
products 
-/-/0.05 -/-/0.5 
Following species of spices:  
Capsicum spp. (dried fruits thereof, whole or ground, including chillies, 
chilli powder, cayenne and paprika) 
Piper spp. (fruits thereof, including white and black pepper) 
Myristicafragrans (nutmeg)  
Zingiber offcinale (ginger)  
Curcuma longa (turmeric)  
Mixtures of species containing one or more of the above-mentioned spices 
5/10/- -/-/- 
& Processed cereal-based foods and baby foods for infants and young 
children 
0.1/-/- 0.5/-/- 
Infant formulae and follow-on formulae, including infant milk and 
follow-on milk 
-/-/0.025 -/-/0.5 
@ Dietary foods for special medical purposes intended specifically for 
infants 
0.1/-/0.025 0.5/-/0.5 
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Table 1.1 Maximum limits of different mycotoxins in food set by the European Commission and China. 
Mycotoxins Food Commodity 
European 
Commission 
(μg/kg) 
China 
(μg/kg) 
Ochratoxin 
A 
Unprocessed cereals/raw cereal grains 5 5 
All products derived from unprocessed cereals, including processed cereal 
products and cereals intended for direct human consumption with 
exception of foods for infants and young children and foods for special 
dietary purposes 
3 5 
Grape juice (and as ingredients in other beverages) and related products 
(concentrated grape juice, grape nectar, grape must intended for human 
consumption) 
2 2 
Dried vine fruit (currants, raisins, sultanas) 10 - 
Wine, fruit wine, aromatized wine, aromatized wine-based drinks and 
aromatized wine-product cocktails 
2 2 
Roasted coffee beans and ground roasted coffee excluding soluble coffee 5 5 
Soluble coffee (instant coffee) 10 10 
Baby foods and processed cereal-based foods for infants and young 
children 
0.5 - 
Dietary foods for special medicinal purposes intended for infants 0.5 - 
Deoxynivale
nol 
Unprocessed cereals other than durum wheat, oats and maize  1250 1000 
Unprocessed durum wheat and oats  1750 1000 
Unprocessed maize  1750 1000 
Cereals intended for direct human consumption, cereal flour (including 
maize flour, maize meal and maize grits), bran as end product marketed 
for direct human consumption and germ, with the exception of foodstuffs 
listed in π 
750 1000 
Pasta (dry)  750 - 
Bread (including small bakery wares), pastries, biscuits, cereal snacks and 
breakfast cereals  
500 1000 
π Processed cereal-based foods and baby foods for infants and young 
children  
200 1000 
Zearalenone 
Unprocessed cereals other than maize 100 60 
Unprocessed maize 200 60 
Cereals intended for direct human consumption, cereal flour, bran as end 
product marketed for direct human consumption and germ, with the 
exception of foodstuffs listed in ρ, σ and τ 
75 60 
ρ Maize intended for direct human consumption, maize flour, maize meal, 
maize grits, maize germ and refined maize oil  
200 60 
Bread (including small bakery wares), pastries, biscuits, cereal snacks and 
breakfast cereals, excluding maize snacks and maize based breakfast 
cereals  
50 - 
Maize snacks and maize based breakfast cereals  50 - 
σ Processed cereal-based foods (excluding processed maize-based foods) 
and baby foods for infants and young children  
20 60 
τ Processed maize-based foods for infants and young children  20 - 
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Table 1.1 Maximum limits of different mycotoxins in food set by the European Commission and China. 
Mycotoxins Food Commodity 
European 
Commission 
(μg/kg) 
China 
(μg/kg) 
Sum of T-2 
toxin and 
HT-2 toxin 
Barley (including malt) and maize  200 - 
Oats (not shelled)  1000 - 
Wheat, rye and other cereals  
Oats                                   
100 
200 
- 
Maize  100 - 
Other cereals  50 - 
Oats bran and oats flakes  200 - 
Bran of cereals with the exception of oats bran and oats flakes, and 
milling products of maize  
100 - 
Other milling products of cereals  50 - 
Breakfast cereals with the inclusion of formed cereal flakes  75 - 
Bread (with the inclusion of small bakery products), pastry, cookies, 
cereal snacks and pasta  
25 - 
Processed cereal-based foods for infants and young children  15 - 
B-series 
Fumonisins 
(Sum of B1 
and B2) 
Unprocessed maize, with the exception of unprocessed maize intended to 
be processed by wet milling 
4000 - 
Maize intended for direct human consumption, maize-based foods for 
direct human consumption, with the exception of foodstuffs listed in υ and 
φ 
1000 - 
υ Maize-based breakfast cereals and maize-based snacks 800 - 
φ Processed maize-based foods and baby foods for infant and young 
children. 
200 - 
Milling fractions of maize with particle size> 500 micron falling within 
CN code 110313 or 11032040 and other maize milling products with 
particle size > 500 micron not used for direct human consumption falling 
within CN code 19041010. 
1400 - 
Milling fractions of maize with particle size ≤ 500 micron falling within 
CN code 110220 and other maize milling products with particle size ≤ 
500 micron not used for direct human consumption falling within CN 
code 19041010. 
2000 - 
Patulin 
Fruit juices, concentrated fruit juices as reconstituted and fruit nectars 50 50 
Spirit drinks, cider and other fermented drinks derived from apples or 
containing apple juice 
50 50 
Solid apple products, including apple compote, apple puree intended for 
direct consumption with the exception of the foodstuffs listed in ψandω 
25 50 
ψ Apple juice and solid apple products, including apple compote and apple 
puree, for infants and young children and labeled and sold as such. 
10 50 
Baby foods other than processed cereal-based foods for infants ω and 
young children. 
10 - 
- means limit has not been established and the detection in China follows the regulations set by EU in this case. 
Current maximum limits for different mycotoxins set by European Commission (EC) according to references 19-21,74. 
Current maximum limits for different mycotoxins set in China according to the reference 75,76. 
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1.2 IDENTIFICATION AND QUANTIFICATION OF 
SECONDARY METABOLITES PRODUCED BY 
ASPERGILLUS AND FUSARIUM FUNGI 
 
As described in Chapter 1.1, the five typical classes of mycotoxins are mainly 
produced by Aspergillus and Fusarium fungi. AFs and ochratoxins are related to 
Aspergillus species, while trichothecenes, FBs and ZEN are all produced by Fusarium 
fungi, emphasizing the importance of these two genera. It is necessary to investigate 
the metabolic profile of these fungi to fully understand their harmful effects so as to 
enable efficient prevention and control.   
 
1.2.1 Metabolic study of Aspergillus fungi 
 
1.2.1.1 General information on Aspergillus fungi 
 
The genus Aspergillus, a group of asexual filamentous fungi, are frequently found in 
cereals and other plant based food such as wheat, maize, rice and peanut, as well as in 
air, water, soil and indoor air environments. The growth of Aspergillus is unfavorable 
for food and feed industries because of possible production of mycotoxins including 
AFs, CPA, ochratoxins and kojic acid. These mycotoxins are mainly produced by A. 
flavus, A. niger, A. parasiticus, A. pseudotamarii, A. toxicarius, A. bombycis, A. 
parvisclerotigenus, A. minisclerotigenes, A. ochraceus and A. arachidicola. In 
addition, the fungi can also produce spores that cause diseases, i.e., allergies and 
asthma, to animals and humans. In a recent study, A. flavus was found to be the 
predominant etiological agent among patients with fungal rhinosinusitis and 
endophthalmitis in Gulf countries, India and Sudan 77. It has been proved that A. 
flavus spores can kill animals in a way that is comparable to A. fumigatus spores, 
based on an observation using immunosuppressed mice 78. High temperature, high 
moisture and poor food storage conditions encourage growth of most of the toxigenic 
moulds, as well as the development of mycotoxins.  
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1.2.1.2 Secondary metabolites produced by Aspergillus fungi 
 
A diverse range of mainly polyketide-derived secondary metabolites along with 
non-ribosomal peptides and a number of compounds of mixed biosynthetic origin 
have been reported to be produced by Aspergillus fungi 78 (Table 1.2).  
 
Table 1.2 Secondary metabolites produced by Aspergillus fungi. 
Secondary metabolites Producers Toxic effects 
Aflatoxin B1 A. flavus 69,78,79 
Hepatotoxicity, 
Carcinogenesis 
All have been classified in group I 
by IARC as human carcinogens 
Aflatoxin B2 A. flavus 69,78,79 
Aflatoxin G1 A. arachidicola and A. parasiticus 78 
Aflatoxin G2 A. arachidicola and A. parasiticus 78 
Aflatoxin M1 
A. flavus and A. parasiticus 
(In vivo transferred from AFB1) 10,80,81 
Aflatoxin M2 
A. flavus and A. parasiticus 
(In vivo transferred from AFB2) 80 
Ochratoxin A A. niger and A. alutaceus 80 
Nephrotoxicity 
Teratogenesis 
Carcinogenesis 
It has been classified by IARC in 
group 2B as a possible 
carcinogenic compound to 
humans 
Fumonisin B2 and 
Fumonisin B4 
A. niger 82,83 
Esophageal and hepatic cancer in 
rats and pulmonary edema in pigs, 
and with the development of 
hyperendemic levels of human 
esophageal cancer 
FBs have been classified in group 
2B as a possible carcinogenic 
compound to humans 
Citrinin A. terreus 68 
Nephrotoxicity and other chronic 
effects 
Cyclopiazonic acid A. flavus and A. parvisclerotigenus 78 
Muscle necrosis, intestinal 
hemorrhage and edema oral 
lesions 
Naptho-γ-pyrones A. niger 84 
Antibacterial, antifungal, 
antitumoral and cytotoxic effects 
Bicoumarins A. niger84 Non-toxic 
Malformins A. niger 84 
Toxic after intraperitoneal 
injection and non-toxic by oral 
administration 
Asperazine A. niger 84 Non-toxic 
Aflatrem, pseurotin, kojic 
acid, two related pyrazines, 
aflavinines, paxillines, 
paspalinines, aspersitin, 
metabolites related to 
pigment and melanin 
formation, asparasone A as 
well as three related 
anthraquinone compounds  
A. flavus 79 
Non-toxic or low toxic level (very 
little is known about the toxicity 
of these compounds) 
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The most important and well known metabolites are AFs including AFB1, AFB2, 
AFG1, AFG2, AFM1 and AFM2 (See Chapter 1.1.1). AFB1 and AFB2 can be 
produced by A. flavus, which is an opportunistic pathogen of crops, while AFG1 and 
AFG2 are produced by A. parasiticus and A. arachidicola. AFM1 and AFM2 are 
normally considered to be the in vivo metabolites converted from AFB1 and AFB2. 
However, in several publications, AFM1 and AFM2 were reported to be produced by  
A. flavus and A. parasiticus and could be found in cereals 17,78.  
Other toxicologically important Aspergillus metabolites include OTA, FBs, CTN 
and CPA. OTA and its precursors (ochratoxins B, β, and α) are the most significant 
mycotoxins produced within A. niger and A. alutaceus 85. FBs are a group of 
polyketide-derived mycotoxins, which were first discovered in 1988 from F. 
verticillioides 86. Recently, putative homologues to the F. verticillioides fumonisin 
gene cluster were discovered in two different A. niger genomes 82,83 resulting in FB2 
production in A. niger. Besides FB2, FB4 can also be produced by A. niger in lower 
amounts, about 10–25% of the amount of FB2. A survey indicated that FBs were 
produced by approximately 75% of all A. niger strains in grapes and raisins, and 76% 
in coffee, and therefore, FBs are considered to be much more common metabolites 
produced by A. niger than OTA (6–10%) 87. CIT, an important mycotoxin, is 
produced by A. terreus 68. CPA, which is produced by A. flavus and A. 
parvisclerotigenus, can lead to a variety of human diseases, i.e., muscle necrosis, 
intestinal hemorrhage and edema oral lesions 78. 
Another abundant family of Aspergillus secondary metabolites are the 
naptho-γ-pyrones (NGP) produced by the A. niger group and comprising of a series of 
aurasperones, fonsecinones and nigerones, as well as monomers such as flavasperone 
and rubrofusarin B (Table 1.2) 84. Investigations of the biological effects of several 
NGPs showed the antibacterial, antifungal, antitumoral and cytotoxic effects 88,89. 
However, until now, there are no data on the bioavailability of these compounds, and 
thus, they currently can not be considered as mycotoxins. The bicoumarins, which are 
considered non-toxic, represent another prominent family of secondary metabolites 
produced by A. niger. Malformins, also produced by A. niger, have been shown to be 
toxic after intraperitoneal injection while non-toxic after oral administration. 
Asperazine, a non-toxic complex diketopiperazine dimer, was first isolated from a 
marine-derived A. tubingensis (reported as A. niger) 84.  
Apart from the above described metabolites, some other compounds have also been 
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reported to be produced by Aspergillus fungi, including aflatrem, pseurotin, kojic acid, 
two related pyrazines, aflavinines, paxillines, paspalinines, aspersitin, metabolites 
related to pigment and melanin formation, as well as asparasone A and three related 
anthraquinone compounds recently found in our lab 79. 
 
1.2.2 Metabolic study of Fusarium fungi 
 
1.2.2.1 General information on Fusarium fungi 
 
Fusarium species are saprophytic moulds universally found in the environment 34. 
They were described for the first time by Link more than 200 years ago and they 
currently contain over 20 species. Fusarium species infect various crops including 
soft and durum wheat, barley, oats, rice, maize, potato, asparagus, mango, grasses, 
and other food and feed cereals. Collectively, Fusarium diseases include wilts, blights, 
rots, and cankers of many horticultural, ornamental, field and forest crops in both 
agricultural and natural ecosystems 4. In addition to this, Fusarium species can also 
cause infection in animals and humans. The infection starts with direct contact of 
materials contaminated with Fusarium conidia or inhalation of Fusarium conidia. 
Then, the conidia germinate and form filaments that invade the surrounding tissue. On 
the other hand, some toxic secondary metabolites including trichothecenes, FBs, ZEN 
and its derivatives, can be produced by Fusarium species, posing potential health risks 
to humans due to their toxicity and widespread occurrence in different crops, i.e., 
maize, wheat, rice and beans, around the world 59,69. Nine to sixteen different 
Fusarium species were detected in maize kernels and stalks, among which, F. 
graminearum, F. verticillioides and F. proliferatum were the most prevalent species in 
kernels whereas in stalks, they were F. equiseti, F. proliferatum and F. verticillioides90. 
Because of widespread occurrence and toxic effects in plants, animals and humans, 
the genome of the Fusarium fungi has been investigated. Until now, there are already 
five completely sequenced Fusarium genomes (F. graminearum, F. 
pseudograminearum, F. oxysporum f. sp. lycopersici, F. ‘solani’ f. sp. pisi and F. 
verticillioides), which also have mostly completed genetic and physical maps 
available 91. Environmental conditions seriously influence the growth of different 
Fusarium species. For example, F. graminearum is mainly found in cooler areas (< 
15 °C) and F. asiaticum in warmer regions (> 15 °C) 92. 
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1.2.2.2 Secondary metabolites produced by Fusarium fungi 
 
Various secondary metabolites, normally low-molecular-weight molecules, have been 
reported to be produced by Fusarium fungi. Prior to completion of the first Fusarium 
genome sequence, a total of 40 structurally distinct families of secondary metabolites 
were reported to be produced by the genus as a whole, meanwhile, some families, 
such as FBs and trichothecenes, consist of tens of different analogs. These compounds 
are diverse in structure and biological activity, for example, non-toxic pigments, toxic 
compounds to plants and/or animals, plant growth regulators and pathogens like 
enniatins and trichothecenes. Most of the secondary metabolites produced by 
Fusarium species are synthesized via the activities of non-ribosomal peptide 
synthetases (NRPSs), polyketide synthases (PKSs), or terpene synthases (TSs) to form 
more complex biologically active compounds: non-ribosomal peptides, polyketides, 
or terpenes.  
Among the different secondary metabolites, mycotoxins that adversely affect 
human or animal health found in postharvest crops such as cereal grains or forages 
have been paid more and more attention during the last decade. These mycotoxins can 
be produced by saprophytic fungi during crop storage or by endophytic fungi during 
plant growth. Fusarium toxins are normally produced in cereals under high moisture 
conditions at or near harvest time. The frequently occurring mycotoxins and related 
mycotoxigenic Fusarium fungi are shown in Table 1.3.  
Fumonisins, including fumonisins A1, A2, B1, B2, B3 and B4, are all 
cancer-promoting metabolites produced by F. proliferatum and F. verticillioides that 
have a long-chain hydrocarbon unit 46,93. Moniliformin (MON), highly toxic resulting 
in rapid death in chicks and rats, can be produced by at least 30 Fusarium species, but 
mainly by F. proliferatum. MON is usually found on maize kernels and can be 
transferred to next generation crops. It can survive for years in the soil 94,95. ZEN and 
its derivatives are a group of phytoestrogenic compounds produced by several 
Fusarium species (F. culmorum, F. equiseti, F. graminearum and F. verticillioides) 34. 
T-2 and HT-2, belonging to type-A trichothecenes, are secondary metabolites of F. 
langsethiae, and also F. sporotrichioides. DAS, another toxic type-A trichothecene, is 
produced by F. poae, F. semitectum, F. moniliforme, F. sporotrichioides, F. 
acuminatum, F. culmorum, F. crookwellense, F. venenatum, F. sambucinum, F. 
graminearum, F. equiseti, F. solani, F. roseum, F. tricinctum, F. avenaceum, F. 
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langsethiae, F. compactum and F. clamydosporum. DON, the most important type-B 
trichothecene can be produced by F. graminearum, F. culmorum, F. crookwellense, F. 
sporotrichioides, F. poae, F. tricinctum, and F. acuminatum. In practice, the 
co-occurrence of DON and ZEN, or additional mycotoxins in contaminated cereals 
poses even higher risks to animals and human beings.  
Fusarium species are different on cereals in different countries, resulting in various 
patterns of mycotoxin production. Environmental conditions, plant species and 
storage methods, i.e., physical (i.e., moisture, relative humidity, temperature, and 
mechanical damage), chemical (i.e., carbon dioxide, oxygen, composition of substrate, 
insecticides and fungicides), and biological factors (i.e., plant variety, stress, insects, 
spore load, etc.), can seriously influence the production of mycotoxins. 3-ADON, 
15-ADON and NIV are used for grouping chemotypes of different Fusarium fungi in 
different countries. In Japan, 15-ADON and 3-ADON were frequently found in the 
northern part with a temperature of less than 15 oC, which is favorable for F. 
graminearum growing, while NIV was observed in the warmer south (≥15 oC) 
produced by F. asiaticum 92,96. In China, F. graminearum isolates were exclusively of 
the 15-ADON type, while F. asiaticum was considered to be a NIV or 3-ADON 
producer 97. In Italy, France, England and Wales, 15-ADON was predominantly 
produced by F. graminearum, which also produced 3-ADON in Finland and Russia 31. 
In South America, 15-ADON-type F. graminearum strains were associated with 
wheat and NIV-type F. meridionale was common on maize, while on rice NIV-type F. 
asiaticum frequently occurred 31.  
Table 1.3 Frequently occurring mycotoxins and related mycotoxigenic Fusarium fungi. 
Mycotoxins Fusarium species 
B-series fumonisins  F. proliferatum and F. verticillioides47,91 
Moniliformin More than 30 Fusarium species, mainly F. proliferatum 92,93 
Zearalenone and its derivatives F. culmorum, F. equiseti, F. graminearum and F. verticillioides 34 
T-2 toxin and HT-2 toxin F. langsethiae and F. sporotrichioides 69 
Diacetoxyscirpenol 
F. poae, F. semitectum, F. moniliforme, F. sporotrichioides, F. 
acuminatum, F. culmorum, F. crookwellense, F. venenatum, F. 
sambucinum, F. graminearum, F. equiseti, F. solani, F. roseum, F. 
tricinctum, F. avenaceum, F. langsethiae, F. compactum and F. 
clamydosporum 69 
Deoxynivalenol 
F. graminearum, F. culmorum, F. crookwellense, F. 
sporotrichioides, F. poae, F. tricinctum and F. acuminatum 69,90,95 
3-Acetyldeoxynivalenol F. graminearum, F. asiaticum69,90,94,95 
15-Acetyldeoxynivalenol F. graminearum69,90,94,95 
Nivalenol F. asiaticum, F. Meridionale 69,90,94,95 
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1.2.3 Analytical methods for identification and quantification of the secondary 
metabolites in various food and feed samples 
 
Because of the diversity of their chemical structures and their presence in trace 
amounts, along with the complex matrices, identificaton and quantification of 
Aspergillus and Fusarium secondary metabolites present a major analytical challenge. 
 
1.2.3.1 Sample pretreatment approaches 
 
Since the secondary metabolites are small and polar compounds, they are usually 
extracted with polar solvents or mixtures of several polar solvents, i.e., methanol, 
acetonitrile and water. The proportion of the solvents in the extraction mixture is 
dependent on the physical and chemical characteristics of the targets and the selected 
analytical systems. In order to improve the extraction efficiency, as well as to remove 
the impurities, some additives, for example formic acid, acetic acid, sodium chloride 
and magnesium sulfate, are added 1,73. Frequently used extraction mixtures include 
acetonitrile/water/acetic acid (79/20/1) 95 and acetonitrile/water (84/16, v/v) 98. 
Different extraction approaches have been applied for the extraction of various 
mycotoxins, including ultrasonication, homogenization and mechanically shaking 
99,100. Accelerated solvent extraction (ASE) was utilized to achieve satisfactory 
extraction recoveries for multiple mycotoxins 73. 
Following the extraction, raw extracts are usually subjected to a further purification 
step to remove interferences. Different purification methods have been developed 
based on liquid-liquid separation (LLS) 101,102, SPE 103,104, immunoaffinity column 
(IAC) 105,106, and single-step clean-up cartridges (Mycosep@) 98. LLS utilizes two 
immiscible liquid phases to separate the target analyte and interferences into different 
phases. LLS is simple with high recovery values but time- and solvent-consuming. 
SPE and IAC require a sequence of three to four steps: preconditioning, sample 
loading, washing the impurities and eluting the analytes of interest from the cartridges. 
SPE and IAC are being increasingly used due to their high enrichment factor, efficient 
elimination of interferences, rapid phase separation, shorter time, and less solvent 
consumption. However, the commercial cartridges are too expensive to be used for 
high throughput screening purpose. When Mycosep® columns are used for 
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purification, the targeted analytes pass through the cartridges and the impurities are 
adsorbed, which offers advantages of speed, sensitivity, simplicity, solvent efficiency 
and in some cases increased recovery. In recent years, two novel clean-up methods, 
molecularly imprinted polymers and immuno-ultrafiltration (IUF), have been tested 
and gradually attract more and more attention due to their effective purification 
effects 107.  
One should bear in mind that a thorough purification is necessary for targeted 
analysis to remove the impurities from the samples so as to ensure a reliable and 
accurate analysis, while for the untargeted analysis, little purification is performed 
and raw extracts can be directly injected into the instrument for the identification of 
the secondary metabolites. 
 
1.2.3.2 Detection methods 
 
For the detection of Aspergillus and Fusarium secondary metabolites, a variety of 
analytical methods have been developed for rapid high-throughput screening, accurate 
quantification of targeted mycotoxins and identification of untargeted analytes. 
Thin layer chromatography (TLC) is one of the oldest analytical methods for the 
detection of mycotoxins. Poor separation, low accuracy and sensitivity limit the 
application of TLC 108,109. Enzyme-linked immunosorbent assay (ELISA), based on 
the specific binding of immunoglobulin antibodies with their specific antigens, is a 
fast and sensitive method for rapid analysis of targeted analytes. It does not need extra 
cleanup or enrichment steps, and has been applied as a screening tool for different 
mycotoxins. Although ELISA methods are widely used because of the simple sample 
preparation and low cost, most of them have the disadvantages of cross-reactivity and 
false positive results, requiring that positive samples should be re-analyzed by other 
quantification methods 110-112. 
Analytical methods based on gas chromatography (GC) and liquid chromatography 
(LC) have been established for accurate quantification. Although GC is sensitive and 
reliable, the tedious derivatization step limits its application 56,113. Therefore, LC 
combined with different detectors is the best approach for the accurate quantification 
of mycotoxins 114,115.  
LC is a dynamic separation technique, partitioning mixtures on the basis of their 
differences in affinity between the mobile phase and stationary phase. Considering the 
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particle size of the packing material, several types of columns are currently used in 
LC 116,117. The conventional particle size for LC columns is 5 μm, while in recent 
years sub-2 μm particle size columns have emerged, resulting in increased speed, 
better chromatographic resolution and improved sensitivity, selectivity and specificity 
98,118. Different detectors, such as ultraviolet (UV) detection and fluorescence 
detection (FD) have been combined with LC to detect the presence of secondary 
metabolites produced by Aspergillus and Fusarium fungi. In recent years, the 
availability of atmospheric pressure ionization sources, i.e. atmospheric pressure 
chemical ionization and electrospray ionization, have significantly improved the 
possibilities of employing liquid chromatography-mass spectrometry (LC-MS) in 
mycotoxin analysis. LC-MS has become the technique of choice for mycotoxin 
analysis due to its high sensitivity, simple sample preparation and its compatibility 
with almost the whole range of compound polarities, as well as the ability to provide 
structural information for further identification 119. No other technique in the area of 
instrumental analysis has developed so rapidly as LC-MS during the past 10 years. 
For accurate quantification of the targeted analytes, multiple reaction monitoring 
(MRM) methods are frequently developed. The retention time and the area ratio 
between the quantification transition and the qualification transition should be 
considered for identification. 
Identification of less studied or novel compounds promotes further developments in 
science and, as a consequence, gives rise to new analytical methods. The difficulties 
arising from untargeted analysis are that no prior information on the compounds to be 
detected has been obtained, and therefore, sophisticated instrumental performance and 
several data processing steps are necessary 120. Full scan by high resolution mass 
spectrometry is the first step for the identification of compounds. To ensure accuracy 
and precision, references such as purine (m/z 121.050873 in positive electrospray 
ionization mode, ESI+) or HP-0921 (m/z 922.009798 in ESI+) are sprayed throughout 
the analytical run, so that the software could perform a correction of the exact mass of 
the analytes over time. The accurate mass of the analyte is calculated not only on the 
basis of the [M+H]+/ [M-H]- ions, but also by considering the adduct ions, i.e., 
[M+Na]+, [M+K]+ or [M+NH4]+/ [M+CH3COO]- or [M+HCOO]-. The isotopic 
pattern of the precursor ions is also checked taking into account a peak spacing 
tolerance of 2.5 mDa 121. The possible elemental compositions can be deduced from 
the obtained accurate mass. Then, based on previous knowledge, such as type and 
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number of atoms, several impossible formulas are further ruled out. After 
confirmation of the elemental compositions, a database search can be performed to 
explore whether the unknown compounds were ever investigated. Fragmentation data 
using MS/MS and/or MSn analysis by ion trap are necessary for further identification 
of the compounds. In the most complicated case, NMR is inevitable for structure 
elucidation 79. 
Overall, a great variety of analytical methods have been established for detection of 
Aspergillus and Fusarium secondary metabolites, especially for mycotoxins. However, 
until now, literature on the untargeted analysis is still scarce.  
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1.3 IN VIVO KINETICS AND METABOLISM OF SELECTED 
ASPERGILLUS AND FUSARIUM MYCOTOXINS 
 
As discussed in the previous chapters, the most typical and frequently occurring 
mycotoxins are produced by Aspergillus and Fusarium fungi. It is important to further 
investigate the in vivo kinetics and metabolism of these mycotoxins for revealing their 
toxicological mechanisms. In this PhD thesis, focus has been put on AFB1, T-2 and 
OTA. 
 
1.3.1 Analytical methods for in vivo kinetics and metabolism study of AFB1, T-2 
and OTA 
 
During the last decade, various analytical methods have been employed to 
quantitatively analyze AFB1, T-2, OTA and their metabolites in biological fluids, 
different organ tissues and faeces. These mainly include TLC, GC coupled with mass 
spectrometry (GC-MS), high-performance liquid chromatography (HPLC) combined 
with different detectors and radioactivity 114,122-132. Radioactivity is very sensitive, but 
is not suitable for kinetic analysis due to interferences of the extensive metabolites in 
vivo. TLC and HPLC coupled to UV or FD could reach an acceptable sensitivity in 
premise of a tedious derivatization process due to the weak chromophore of AFB1 
and T-2. GC-MS has provided high sensitivity for T-2, however for the other two 
mycotoxins, the tedious derivatization process is also necessary. Currently, 
LC-MS/MS seems to be one of the most frequently used approach for quantitative 
analysis of multiple mycotoxins in vivo due to its high sensitivity and selectivity. 
With respect to the qualitative analysis of mycotoxins and their metabolites, 
radioactivity and NMR have been established 133,134. For these methods, metabolites 
should be purified from the biomatrices, making the procedures tedious and expensive. 
Recently, high resolution mass spectrometry (HRMS) such as orbitrap technology or 
time of flight mass spectrometry (TOF) has been proposed as a powerful approach for 
identification of unknown compounds 135. This method can be used for the qualitative 
analysis of the metabolites without any purification step or commercial standard, and 
therefore, is one of the most promising approaches for metabolism study of 
mycotoxins. 
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1.3.2 In vivo kinetics of AFB1 
 
The term “kinetics” is derived from “toxicokinetics” to describe mathematically the 
time-concentration relationships in absorption, distribution, metabolism and excretion 
of harmful substances to reveal their toxic actions in animals. In male 
Sprague-Dawley rat, the kinetics of intratracheally and orally administered 
[3H]-AFB1 were studied. After administration of a single dose of AFB1 (600 µg/kg), 
faeces, urine and blood samples were collected at different intervals for the two 
different administration ways. The plasma half-life times (t1/2s) were 87.7 and 91.8 h 
for the intratracheal and oral groups, respectively. Similar urinary and faecal excretion 
profiles were obtained i.e. by day 23, urinary excretion of label accounted for 16.4% 
and 15.0% of the dose in the intratracheal and oral groups, and faecal excretion for 
56.0% and 54.6%, respectively 136. After intratracheal administration, the results 
showed that the blood concentration-time profiles best approximated a 
two-compartment open model with first-order absorption. The first-order absorption 
rate constant was 0.083 per min and the first-order elimination rate constant was 
0.00928 per h 137. The kinetics of AFB1 in monkey, rat, and mouse were 
comparatively analyzed by Zachary et al 138 after intravenous administration. In 
plasma, the time-concentration curves showed that AFB1 could quickly be distributed 
and after 1 h, the concentration was only 12%, 11% and 3% of the administered 
dosefor monkey, rat and mouse, respectively. Meanwhile, monkey being relatively 
sensitive to the acute effects but resistant to the carcinogenic effects of AFB1, showed 
the largest volume of distribution and body clearance of AFB1 but the lowest 
first-order rate constant for elimination. The mouse, a species relatively resistant to 
both the acute and carcinogenic effects, exhibited the fastest elimination of AFB1 and 
the lowest volume of distribution. In the rat, an extremely sensitive species to the 
carcinogenic effect of AFB1, the plasma biological half life was similar to that of the 
monkey, but body clearance was much lower. The yeast cell wall (YCW) of 
Saccharomyces cerevisiae was used to decrease the absorption of AFB1 in vivo. The 
results showed that co-administration of YCW with AFB1 decreased the extent, but 
not the rate of its absorption. Concurrently, radioactivity in faeces increased by up to 
55% compared with controls, while the excretion in urine decreased (p < 0.05) 139 
(Table 1.4). 
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Table 1.4 Comparative kinetics data for aflatoxin B1, T-2 toxin and ochratoxin A in different animal species. 
Mycotoxins Animals (Tissues) Administration ways Kinetics data 
Aflatoxin B1 
Rats 
Intratracheal 138,139 
Plasma half-life (t1/2)=87.7 h; Urinary excretion 
16.4% and faecal excretion 56.0%; two-compartment 
open model: the first-order absorption rate constant 
was 0.083 per min and the first-order elimination rate 
constant was 0.00928 per h 
Oral 136 
Plasma half-lives (t1/2)=91.8 h; Urinary excretion 
15.0% and faecal excretion 54.6% of the dose 
Intravenous 138 
Aflatoxin B1 could quickly be distributed and after 1 
h, the concentration was only 11% of the dose 
Monkey Intravenous 138 
Aflatoxin B1 could quickly be distributed and after 1 
h, the concentration was only 12% of the dose 
Mouse Intravenous 138 
Aflatoxin B1 could quickly be distributed and after 1 
h, the concentration was only 3% of the dose 
T-2 toxin 
Rat Oral 122,130,131 Mainly excreted in the faeces 
Rat liver 
Isolated perfused rat 
liver experiment 140 
93% of the delivered T-2 toxin was metabolized by 
the liver; no obvious accumulation effects 
Mouse Oral 141 
80% was excreted in the faeces and the remaining 
20% was excreted in the urine; no obvious 
accumulation effects 
Dog Intravenous 142-144 
Half-life (t1/2)=5±2 min; Clearance= 0.11±0.26 
L/min/kg; Volume of distribution =0.9±0.6 L/kg 
Swine Intraaortal 145 
Half-life (t1/2)=14 min; Volume of distribution =0.37 
L/kg 
Chicken Oral 131 
80% of the orally administered T-2 toxin was rapidly 
biotransformed to polar metabolites and eliminated 
in excreta within 48 h 
Ochratoxin A 
Rat 
Oral 146,147 
Rapid absorption phase of 18 min; 
bioavailability=67.3%; after absorption phase, the 
unbound fraction=0.02%; Maximum plasma 
concentration was reached within 1-3 h but this 
persisted for 4 days before decline. Half-life (t1/2)= 
58-120+ h; The OTA excretion route is mainly 
through bile 
Intravenous 146,147 
The unbound fraction=0.02%; the OTA excretion 
route is mainly through bile 
Humans 
Oral 147 
After absorption phase, the unbound fraction=0.02%; 
the OTA excretion route is mainly through kidney 
Intravenous 147 
The unbound fraction=0.02%; the OTA excretion 
route is mainly through kidney 
Monkey 
Oral 147 
After absorption phase, the unbound fraction=0.08%; 
the OTA excretion route is mainly through kidney 
Intravenous 147 
The unbound fraction=0.08%; the OTA excretion 
route is mainly through kidney 
Pig 
Oral 147 After absorption phase, the unbound fraction=0.1% 
Intravenous 147 The unbound fraction=0.1% 
Mouse 
Oral 147 After absorption phase, the unbound fraction=0.1% 
Intravenous 147 The unbound fraction=0.1% 
Fish 
Oral 147 After absorption phase, the unbound fraction=22% 
Intravenous 147 The unbound fraction=22% 
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1.3.3 In vivo kinetics of T-2 
 
In order to fully reveal the toxicology of T-2, in vivo kinetics of this mycotoxin in 
different animals were thoroughly investigated. Following oral administration (1 
mg/kg) of tritiated T-2 to rats, the results showed that T-2 was mainly excreted in the 
faeces, which might be due to the enterohepatic circulation 129,130. An isolated 
perfused rat liver (IPL) experiment of T-2 indicated that 93% of the delivered T-2 was 
metabolized by the liver (IPL) 140. Similar to rat, the results of the oral administration 
of tritiated T-2 (1 mg/kg) to mice showed that 80% of the total radioactivity was 
excreted in the faeces and the remaining 20% was excreted in the urine 141. Both in rat 
and mice, no obvious accumulation effects were observed in specific organ. With 
regards to dogs, after intravenous injection of T-2, the following kinetic parameters 
were obtained: a half life of 5±2 min; a clearance of 0.11±0.26 L/min/kg; and a 
volume of distribution of 0.9±0.6 L/kg. The high (metabolic) clearance of T-2 and 
HT-2 suggests that they have a high liver extraction ratio or multisite metabolism 
142-144. Swine is also a very important animal to reveal the toxicity of T-2. After 
intraaortal (IA) administration of T-2 to swine, the results showed that the t1/2 is 14 
min and the volume of distribution is 0.37 L/kg. Comparing different concentrations 
of T-2 (0.3 and 0.6 mg/kg) for the IA administration, no significant differences were 
observed for the clearance rate (92 and 84 mL/min/kg) 145. In monkey, a high level of 
radioactivity was found in the urine 1 day following dosing, proving high amounts of 
urinary metabolites, of which 30% to 50% was in the form of glucuronide conjugates 
138,141. In chicken, 80% of the orally administered T-2 was rapidly biotransformed to 
polar metabolites and eliminated in excreta within 48 h 131 (Table 1.4). 
 
1.3.4 In vivo kinetics of OTA 
 
OTA is rapidly absorbed after oral ingestion in different animals. In rat, a rapid 
absorption phase was observed (18 min) mainly through the gastrointestinal tract, the 
stomach and the proximal jejunum 146. The passive absorption might be due to the 
high binding affinity of OTA to plasma proteins. In studies comparing the oral and 
intravenous administrations, the bioavailabilities for OTA were 67.3% and 100%, 
respectively 146,147. With regard to gender, the males tended to reach lower plasma 
concentrations than females for a same administered dose. However 96 h after oral 
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administration, a higher OTA faecal excretion in males than in females was observed, 
which indicated a possible less efficient gastrointestinal absorption in males 148,149. 
The absorption of OTA was also influenced by the age of rats: younger rats (10 weeks 
old) reached higher OTA concentrations than older rats (15 weeks old) in plasma 149. 
The absorption extents were different for different animal species: 66% for pig, 56% 
for rat and rabbit and 40% for chicken. 
After absorption, OTA could bind to serum albumin or other small proteins, which 
facilitates its passive absorption in the non-ionized form and partly explains its long 
half-life in the body. The unbound fraction is as low as 0.02% in humans and rats, 
0.08% in monkeys, 0.1% in pigs and mouse and 22% in fish after oral or intravenous 
administration of OTA (50 ng/kg bw/day) 147. Stojkovic et al. indicated that in human 
and porcine serum, OTA binds more specifically to small proteins (molecular mass 
around 20 KDa) than to albumin 150. Due to the fact that such small proteins can 
easily pass through the glomerular membrane, this binding could be relevant to the 
OTA predominant nephrotoxic effect on mammals. Different animal species showed 
different distribution rates for OTA. After oral administration of OTA to 240 rats, a 
maximum plasma concentration was reached within 3 h but this persisted for 4 days 
before decline. After 28 days, OTA could also be detected in plasma with the t1/2of 
181.8 h 151. After oral administration of OTA to Sprague-Dawley male rats, the 
maximum plasma concentration was reached within 1 h, and the t1/2 was 58-103 h 
146,152. For Wistar male rats, the t1/2 was more than 120 h, which is longer than 
Sprague-Dawley male rats 147. Interestingly, the t1/2 after oral ingestion was reported 
to be shorter than after intravenous injection, which is a reflection of the first pass 
effect with primary biliary and subsequent faecal excretion. With regard to tissue 
distribution, the t1/2s of OTA in tissues were shorter than that in plasma, which might 
be attributed to the binding affinities of OTA with albumin in plasma. For pig, chicken, 
rat and goat, the accumulation of OTA was as follows: kidney > liver > muscle > fat 
or kidney > muscle > liver > fat. OTA could also cross the blood brain barrier and be 
detected in the brains in the mouse 153,154. Surprisingly, in the plasma of fetus, the 
concentration of OTA was even higher than in the plasma of mother, which meant that 
OTA could be transferred through placenta from mother to fetus 155.  
Faecal, milk, biliary and renal excretions play important roles in plasma clearance 
of OTA 156. In rat the OTA excretion route is mainly through bile while in humans and 
non-human primates the primary route of excretion is via the kidney 153. The 
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contribution of each route of excretion depends on various factors including the route 
of administration, the dose, the degree of serum macromolecular binding and 
differences in degree of enterohepatic circulation 157,158 (Table 1.4). 
 
1.3.5 Metabolism of AFB1 
 
Biotransformation and mechanisms of AFB mutagenesis and carcinogenesis are well 
known. As shown in Fig. 1.2, AFB1 is a ‘‘pro-carcinogen” and should be transferred 
to exo-AFB1-8, 9-epoxide (AFBO) in vivo to elicit the carcinogenic (and toxic) 
activity 159. AFBO has been recognized as the toxic metabolite transformed from 
AFB1. It is highly reactive, and can be transformed to dihydrodial AFB1 under 
neutral or acidic conditions, then it is transferred to monoalcohol and dialcohol 
catalyzed by acetaldehyde reductase 160. AFBO can also bind covalently to cellular 
macromolecules to form long-lived lysine adducts with serum albumin and 
promutagenic adducts with DNA 161,162. 
AFB1 could also transform to aflatoxin P1 (AFP1), aflatoxin Q1 (AFQ1) and 
aflatoxin L (AFL). The toxicity of these metabolites is significantly lower than that of 
AFB1, and thus their formation is considered to be a detoxification pathway 137,159. 
AFM1 keeps some carcinogenic potential and is another important oxidized 
metabolite of AFB1, which is frequently detected in different milk products 159,163. 
Cytochrome P450s (CYP450) have been proved to play an important role in oxidation 
reaction. Major CYP450 enzymes involved are CYP1A and CYP3A4, catalyzing the 
formation of different metabolites including AFM1, AFBO and AFQ1 159.  
 
 
 
Figure 1.2 Metabolic pathways of aflatoxin B1 (compiled from references 137,159-163) 
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1.3.6 Metabolism of T-2 
 
From in vivo experiments with different animal species, it can be concluded that T-2 
does not accumulate in the bodies of animals. The major metabolic pathway is 
concerned with hydrolysis, hydroxylation, de-epoxidation, and conjugation 164, as 
given in Fig. 1.3. 
T-2 can be transformed to 3’-OH-T-2 and HT-2 metabolites by hydroxylation and 
hydrolysis 164,165. A major part of HT-2 is then hydroxylated at C’-3 position of 
isovaleroyl ester to form 3’-OH-HT-2, which is considered as an activation pathway 
occurring in mice, rats, guinea pigs, swine, cows, and chickens 166. Another part of 
HT-2 is further hydrolyzed to yield the T-2 triol and then to the T-2 tetraol, which is 
primarily excreted in urine considered to be an inactivation pathway 167.  
De-epoxidation of T-2 at the C-12, 13 positions is observed in different animals 168. 
Various de-epoxy metabolites including deepoxy-HT-2, deepoxy-T-2-triol, 
deepoxy-T-2-tetraol and deepoxy-3’-OH-T-2-have been isolated from cow urine, 
swine liver and kidney, and rat excreta, the toxicities of which are all extremely low 
as compared to their epoxy analogs 169.  
 
      Figure 1.3 Metabolic pathways of T-2 toxin (compiled from references 164-169). 
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Glucuronidation is an important in vivo reaction for T-2 elimination. Glucuronide 
conjugates of T-2 and HT-2 were found to be the major product after incubation of T-2 
with uridine-5-diphosphoglucuronic acid and rat hepatic microsomes containing 
glucuronyl transferase. It seems that T-2 could directly conjugate with glucuronic acid, 
or it could be firstly hydrolyzed to HT-2 and then conjugated with glucuronic acid 170. 
 
1.3.7 Metabolism of OTA 
 
Information regarding the metabolism of OTA remains controversial. The complete 
biotransformation pathways of OTA are still unknown. Some of the metabolites have 
been clearly identified in vitro and/or in vivo, while other metabolites remain to be 
unclear 156,171. 
Hydrolysis is one of the most important metabolic pathways of OTA resulting in a 
much less toxic compound ochratoxin α (OTα). It is the dihydroisocoumarin 
derivative produced by cleavage of the peptide bond of OTA and is mainly excreted in 
faeces. OTα was detected as the only metabolite recovered from the caecum and large 
intestine of rats, and the enzymes responsible for the hydrolysis to OTα are 
carboxypeptidase A, and possibly trypsin, α-chymotrypsin and cathepsin C 172. Suzuki 
et al. observed that the ileum, duodenum and pancreas have a high capacity to carry 
out OTA hydrolysis, while this activity is low in liver and kidney 158. OTα has also 
been found in urine by Storen et al. which might be due to the reabsorption from the 
intestine 173, as well as in plasma by Zepnik et al 148. In ruminants, the rumen 
microflora is able to degrade OTA into OTα resulting in a greater resistance of these 
animals to the toxic effects of OTA 174.  
After absorption and distribution of OTA, a small amount of this mycotoxin can be 
hydroxylated into hydroxyochratoxin A through phase I detoxification reactions 
mainly in liver by the action of cytochrome 450 (CYP450) or peroxidases 175. The site 
of the hydroxylation was tentatively considered to be C-4 because two metabolites 
4R- hydroxyochratoxin A (4R-OH-OTA) and 4S-hydroxyochratoxin A (4S-OH-OTA) 
have been identified in different animals by mass and NMR. In rats and humans 
4R-OH-OTA and 4S-OH-OTA were the major and the minor metabolites, respectively, 
while the opposite was observed in pigs 176,177. During long-term exposure to small 
amounts of OTA, the toxic effects could be reduced by the formation of the 4R and 4S 
isomers. Another hydroxylated compound of OTA, namely 10-hydroxyochratoxin A 
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(10-OH-OTA), was also identified in addition to 4R-OH-OTA and 4S-OH-OTA when 
OTA was incubated with rabbit liver microsomes, but this compound has never been 
found in vivo 178-180. The formation of this metabolite was catalyzed by cytochrome 
P450 as well. Two other ochratoxin derivatives that naturally co-occur with OTA in 
cereal crops, namely ochratoxin B and ochratoxin C, have been identified as OTA 
metabolites as well. OTB, the dechloro-derivative of OTA that is much less toxic than 
OTA, has been observed in vitro as a metabolite of OTA after incubation of monkey 
kidney cells with OTA 181 and also has been detected in urine of OTA-treated rats 182. 
OTC has been identified as a metabolite of OTA in ruminal fluid 182. Contrary to OTB, 
OTC could be converted into OTA in the body, and therefore, the toxicity of OTC was 
considered to be the same as OTA. The lactone-opened OTA (OP-OTA) was also 
detected in the bile and urine after administration of OTA to rats. It has also been 
reported that the toxicity of OP-OTA was the same or higher than that of OTA, and 
this metabolite could be conversely transformed to OTA 183. The OTA derived 
quinones i.e. OTA quinone/OTA hydroquinone redox couple (OTAQ/OTAHQ) could 
be generated in vitro through OTA oxidation by photochemical and electrochemical 
processes, as well as in a chemical system mimicking CYP450 and in enzymatic 
systems (horseradish peroxidase or rat liver microsomes) 133,184. Until now, 
OTAQ/OTAHQ have been hypothesized as possible reactive metabolites and related 
to the genotoxic effects of OTA 185. 
OTA was considered to be conjugated with glucuronide, and excreted in bile in rat. 
Natural forms of OTA-glucuronides have not been found, but they were indirectly 
determined by using β-glucuronidase hydrolysis 186. The presence of O-labile ester 
conjugates of OTA including pentose and hexose conjugates was firstly identified in 
cultures of rat and human hepatocytes 187 and also in the urine of rats 148. Until now, 
there are scarce data available on the toxicity of these conjugated compounds. 
Generally, conjugation is a detoxification step, but in some cases it might be a 
bioactivation process. OTA could also combine with glutathione (OTA-GSH), which 
is considered to be a detoxification reaction. However, this reaction frequently 
occurred in vitro and the amounts of OTA-GSH in vivo were too low (not more than 
1%) to be detected 188. With regard to OTA-DNA adducts, currently, there is a debate 
about their formation. Some research teams found the DNA adducts and considered 
them to induce the genotoxicity, whereas others did not and argued that the 
genotoxicity was not caused by the OTA-DNA, but OTA itself or its reactive 
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oxidation species 189,190. A summary of OTA metabolic pathways is given in Fig.1.4. 
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         Figure 1.4 Metabolic pathways of ochratoxin A (compiled from references 133,148,156,158,171-190) 
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1.4 RISK ASSESSMENT OF SELECTED ASPERGILLUS AND 
FUSARIUM MYCOTOXINS 
 
In general, risk assessment is the systematic characterization of the potential adverse 
effects resulting from exposure to hazardous agents. It is a multi-step process in which 
the hazard identification, hazard characterization, exposure assessment and risk 
characterization are typically conducted and the results of these assessments are 
compared to provide an estimation of risk to contribute to improving food safety and 
to building public confidence. Mycotoxins, mainly including Aspergillus and 
Fusarium mycotoxins, have received more and more attention due to their high 
toxicity and widespread occurrences. For example, OTA, produced by Aspergillus 
fungi, has been found in various samples around the world, including Chinese wine 
191, sultanas and dried apricots destined for export from Turkey to the European Union 
192, dates and dried fruits in Tunisia and Spain 193. DON and its derivatives, produced 
by Fusarium fungi, have been found in cereal-based products in Belgium 72, in 
northern Iran 194, in Japan 195, in Denmark 196, in Pakistan 197, and also in China 36,198. 
In this thesis, focus has been put on OTA and DON (and its derivatives) to provide 
comprehensive data on their risk assessment. 
 
1.4.1 Hazard identification 
 
Hazard identification is the process of determining whether exposure to the targets 
can lead to adverse health effects. It is based on analyses of a variety of data that may 
range from observations in animal and human to analysis of mechanisms of action 
and structure–activity relationships. 
Toxicology studies of OTA have demonstrated its renal toxicity, hepatotoxicity, 
teratogenicity, mutagenicity, carcinogenicity, and immunotoxicity; moreover, species 
and gender-related differences in sensitivity have been noted. IARC has classified 
OTA as “possible human carcinogen (Group 2B)”. As shown in Chapter “1.3.7”, 
OTA is subject to metabolism by several different pathways including hydrolysis, 
hydroxylation, lactone-opening, and conjugation, yielding numerous different 
metabolites characterized with different toxicities. 
With respect to DON, it can inhibit protein synthesis and modulate immune 
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responses resulting in a variety of toxic effects, i.e., feed refusal, weight loss and 
vomiting after acute and chronic ingestion by humans and animals. There are no 
experimental or epidemiological evidences for carcinogenic and/or mutagenic 
properties of DON, and therefore, it was classified by the IARC in Group 3. In vitro 
metabolic studies revealed that the majority of DON could be transferred by humans 
and animal microsomes as glucuronide conjugates 199. The metabolism of DON is 
strongly species dependent. After single and multiple oral administration of the 
chemically synthesized 3β-[3H]-DON to both sexes of rats and chickens, it was found 
that DON was widely distributed and quickly eliminated. The highest concentration 
level was observed in the gastrointestinal tract at 6 h post-administration, while 
obviously lower levels were found in the kidney, liver, heart, lung, spleen, and brain. 
The major metabolites of DON were DON-3α-sulfate in chickens, and 
de-epoxy-deoxynivalenol (DOM-1) in rats. A higher urinary excretion rate was 
observed in female than in male rats, indicating differences between gender in 
tolerance and ability to detoxify DON 200. After administration of a single dose of 
DON to Sprague–Dawley rats, overall 37% of the total DON was excreted in urine 
and DON-glucuronide was the major urinary metabolite 200. In pig, DON could be 
converted mainly to DOM-1 in serum and excreted in urine 201. The metabolism of 
DON in humans was also studied. After consuming a special diet over a period of 
eight days by a 27 year old volunteer, DON, DON-3-glucuronide and 
DON-15-glucuronide were detected in urine samples 202. Some derivatives, especially 
the acetylation products of the original forms, have been observed to be excreted 
directly by fungi. The best known substances in this respect are 
3-acetyldeoxynivalenol (3-ADON) and 15-acetyldeoxynivalenol (15-ADON), arising 
from a common precursor of 3, 15-diacetyldeoxynivalenol and both are biosynthetic 
precursors of DON. Consumer health risks may result from hydrolysis of these 
derivatives into their toxic parent forms during mammalian digestion 72,202,203.   
 
1.4.2 Hazard characterization 
 
Hazard characterization considers the nature of the effect to identify the lowest 
observed-adverse-effect level (LOAEL) and/or the no-observed-adverse-effect level 
(NOAEL) for animals and humans. The characterization includes dose-response 
considerations and consequently, the establishment of health-based-guidance values 
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such as TDI for humans.  
For OTA, the LOAEL was noted (i.e. renal enzyme and renal function changes) 
after pigs were exposed to a dose of 8 μg/kg b.w./day of OTA in a 90-day subchronic 
study. Derived from that, EFSA proposed the tolerable weekly intake (TWI) of 120 
ng/kg b.w./week for humans by applying an uncertainty factor of 450 to account for 
interspecies toxicodynamic differences between the pig and human (2.5 fold), 
intraspecies variability (10 fold), kinetic differences based on the t1/2 of OTA (6 fold), 
and the use of a LOAEL instead of a NOAEL (3 fold); correspondingly, TDI would 
be 17 ng/kg b.w./day 204. Using a similar approach to EFSA, JECFA proposed a PTWI 
for OTA of 100 ng/kg b.w./week, and PTDI of 14 ng/kg b.w./day, based on the 
aforementioned study 205. These two TDI values are obviously higher than the PTDI 
(5 ng/kg b.w./day) previously proposed by Scientific Committee on Food (SCF) 206. 
For DON, in pigs, the most studied species, 1–2 μg/kg b.w./day causes partial 
rejection of feed, while 12 μg/kg b.w./day leads to total refusal. In 2002, a temporary 
TDI of 1 μg/kg b.w./day was established by the SCF, the same as the PTDI 
established by JECFA 207. The two important derivatives, i.e., 3-ADON and 
15-ADON, can co-occur with DON. As reported, more than 30% of the 
DON-contaminated samples contained one or both of these toxins 67,208,209. The issue 
of combined toxicity is very complicated, but generally it can be concluded that 
co-exposure to several different mycotoxins often results in an additive effect, 
consequently, the acetylated forms 3-ADON and 15-ADON have received more and 
more attention. In 2010, JECFA considered the toxicity of the acetylated derivatives 
(3-ADON and 15-ADON) equal to that of DON and extended the previous PTDI of 1 
μg/kg b.w./day 207 to a group PTDI for the three compounds 45. 
 
1.4.3 Exposure assessment 
 
The exposure of the population to hazardous agents is assessed by the integration of 
consumption and occurrence data. 
 
1.4.3.1 Consumption data 
 
In different countries, dietary habits of inhabitants are completely different. In most of 
the western countries, meat, bread and potatoes are major diet components to provide 
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enough energy for people. In China, maize, wheat (northern part), rice (southern part), 
a large amount of different vegetables (more than 600 kinds) and a small amount of 
meat are the major components for the diet mainly concerning taste. Also foods are 
prepared in different ways. In China, people donot like raw vegetables and the food is 
always prepared through frying, deep-frying, boiling and mixed approaches. Based on 
the dietary habits of consumers in different countries, frequently consumed food items, 
including (a) cereals and derived products: rice, maize, wheat and flour; (b) grapes 
and derived products: grapes, red wine and grape juice; (c) beans and derived 
products: dried beans and fresh beans; (d) dried fruits and derived products: peanut, 
walnut and almond, were investigated depending on the mycotoxin of interest. For 
DON, cereals and derived products are the major contribution for human exposure. 
With regard to OTA, grapes and derived products and dried fruits and derived 
products are two types of frequently contaminated foodstuffs 210-213. Therefore, in this 
PhD thesis, the consumption data of different food items were surveyed for different 
mycotoxins (See Chapter 4).  
 
1.4.3.2 Occurrence data 
 
The occurrence of OTA in various commodities has been extensively investigated in 
different regions of the world. Some examples are given in this paragraph (Table 1.5). 
Results from a recent study for investigating a total of 223 Chinese wine samples 
revealed that the incidence of OTA in Chinese wine was 45.2%, with concentration 
levels of 0.01−0.98 μg/L 191. A total of 98 dried figs, 53 sultanas and 20 dried apricots 
destined for export from Turkey to the European Union were also investigated for 
OTA contamination. The results showed that 18 dried figs contained detectable levels 
of OTA in the range of 0.87–24.37 (μg/kg) 192. The incidence for OTA contamination 
in a total of 228 dates and dried fruit samples purchased from markets in Tunisia and 
Spain was 22% and the contamination levels were in the range of 0.25-5.5 μg/kg 193. 
The occurrence of OTA in a total of 30 Madeira wine samples was investigated; only 
two of the analyzed samples contained OTA with concentrations of 0.41 and 0.45 
μg/kg, respectively 29. All these investigations indicate that OTA is widespread in 
different foodstuffs and poses potential health risks to humans. 
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   Table 1.5 Occurrence data of ochratoxin A (OTA), deoxynivalenol (DON), 3-acetyldeoxynivalenol 
(3-ADON) and 15-acetyldeoxynivalenol (15-ADON) in various foods in different countries. 
Mycotoxin Sample Country Incidence Concentration 
OTA Chinese wine China 101/223 0.01-0.98 μg/L 191 
Dried fig Turkey 18/98 0.87-24.37 μg/kg 192 
Dates and dried 
fruit 
Tunisia and 
Spain 
50/228 0.25-5.5 μg/kg 193 
Madeira wine Portugal 2/20 0.41 and 0.45 μg/kg 29 
     
DON Cereal-based 
sample 
Belgium 111/174 Maximal concentration=718 
μg/kg 72 
 Wheat flour Northern Iran 80/96 23-1270 μg/kg 194 
 Wheat, barley and 
Japanese retail food 
Japan 286/557 Maximal 
concentration=1093 μg/kg 
194 
 Wheat grain Poland 128/129 Maximal concentration=51 
μg/kg 195 
 Cereal and 
derivative product 
China 61/69 2.7-311.2 μg/kg 118 
     
3-ADON Cereal-based 
samples 
Belgium 89/174 Maximal concentration=431 
μg/kg 70 
 Cereal and 
derivative product 
China 35/69 2-8.1 μg/kg 119 
     
15-ADON Cereal-based 
samples 
Belgium 76/174 Maximal concentration=218 
μg/kg 72 
 Cereal and 
derivative product 
China 60/69 2.1-32.5 μg/kg 119 
 
With respect to DON and its acetylated derivatives (3-ADON and 15-ADON), 
occurrence data have been reported in different countries. In Belgium, a total of 174 
cereal-based samples were analyzed for the presence of DON, 3-ADON and 
15-ADON. The incidence of DON was 63.8% with the maximum value of 718 μg/kg, 
while the incidences of 3-ADON and 15-ADON were 51.1% and 43.7%, respectively 
72. In northern Iran, a total of 80 out of 96 wheat flour samples (83.33%) were 
contaminated with DON with concentrations ranging from 23 to 1270 µg/kg 194. In 
Japan, DON was frequently detected in wheat, barley and Japanese retail food. The 
maximum level of DON was exceeded in a sample of a Job's tears product (1,093 
μg/kg) 195. In Poland, a total of 129 grain samples collected in the period 2006-2009 
were investigated; in none of these samples DON exceeded the regulatory limits 196. 
In China, after investigation of 69 cereals and derived products, a total of 61 samples 
were found to be contaminated with DON with concentrations in the range of 
2.7–311.2 μg/kg, while for 3-ADON and 15-ADON, the incidences were 50.7% and 
87.0%, respectively 119. Overall, high contamination levels of DON and its derivatives 
have been observed for a variety of commodities in different countries, and therefore, 
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these mycotoxins have been regarded as among the most important contaminants 
around the world. 
 
1.4.3.3 Exposure assessment 
 
Two mathematical approaches namely the deterministic endpoint evaluation and the 
Monte Carlo assessment model 72 are frequently used to perform the exposure 
assessment of mycotoxins according to the equation 1-1: 
y=x·c/w                                             1 -1 
Where y is the daily intake (DI) values of the analyte (ng/kg b.w./day), x is the food 
consumption (g/day), c is the concentration level of the target in different food (ng/g), 
w is the body weight (kg) of the investigated population 214. The deterministic 
endpoint evaluation multiplies mean/maximal food-consumption data by the 
mean/maximal analyte-exposure data. However, exposure assessment by 
deterministic endpoint evaluation neglects the variability and uncertainty of the food 
consumption and the contamination levels, resulting in an overestimation of exposure. 
In an effort to account for the highly variable occurrence data and to provide more 
realistic estimates of exposure, the full probabilistic method (Monte-Carlo model), 
which combines distributions of food-consumption data with distributions of the 
analyte in food, is frequently employed for exposure assessment of mycotoxins 214,215. 
Risk assessments of OTA in different food commodities have been performed in 
Canada 214,216-218, Spain 219,220 and other countries 217,221. In China, the health risks 
related to OTA have also received more and more attention. In a recent publication, 
the health risks of OTA contamination of wine were assessed by the deterministic 
endpoint evaluation. The results showed that DI of OTA varied between 0.86 and 1.08 
ng/kg b.w./week, which was obviously lower than all existing norms. However, the 
DI values in the high percentile (97.5th) were a little higher than the TDI set by 
JECFA 191. 
In contrast to OTA, DON, 3-ADON and 15-ADON frequently co-occur in cereal 
and cereal-based products (more than 30% of the DON-contaminated samples 
contained one or two derivatives 67,208,209, resulting in increased health risks). Several 
studies have been performed to evaluate the health risks of DON, 3-ADON and 
15-ADON, as single compounds 212,213,222. However, compounds in a mixture can 
work synergistically and cause effects greater than the individual components. Hence, 
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assessing this type of mycotoxins individually may underestimate the total risk. 
A number of methods for exposure assessment of chemical mixtures of 
environmental contaminants have been developed to predict the combined toxicity of 
mixtures and their risks. The most straight forward way is to test the mixture of 
interest in its totality, which closely follows single substance assessments and does 
not require any special methodology. However, this approach has several bottle-necks, 
the most important one of which is to obtain the mixture itself making this approach 
largely unfeasible 223. Recently, cumulative risk assessments of environmental 
contaminants, i.e., perfluoroalkylated and polyfluoroalkylated substances (PFASs), 
have employed the methods based on the concepts of independent action (IA) and 
concentration addition (CA) 224,225. IA assumes that the individual components act 
independently of each other, whereas CA considers that the mixture components act 
in the same way only differing in the concentrations for eliciting their toxic effects. 
The latter approach seems much more suitable for the cumulative risk assessment of 
the concomitant mycotoxins DON, 3-ADON and 15-ADON because of their similar 
actions and toxicities. 
 
1.4.4 Risk characterization 
 
Risk characterization integrates the information derived from hazard identification, 
hazard characterization and exposure assessment into scientific statements or opinions 
for definition of the health risk related to the targeted consumers, which could be 
further utilized for making risk management decisions. These can be quantitatively 
estimated by comparing the daily intake values (DI) of targeted mycotoxins with a 
level of exposure without significant adverse health effect, such as TDI (including 
provisional and temporary values) regulated by EU or different countries. The margin 
of safety (MOS) is calculated according to equation 1-2. Significant adverse effects of 
the analytes can be speculated if MOS≥1. Otherwise, no potential adverse effects can 
be deduced.  
MOS=DI/TDI                                 1-2 
Overall, due to the high toxicity and widespread occurrence of mycotoxins, the risk 
assessments of OTA, DON and its derivatives have been performed, as single 
compound in isolation, to provide necessary information to ensure food safety 
212,213,222. However, cumulative health risk assessments of multiple mycotoxins, which 
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will fully reveal the combined toxicities, have not been reported. 
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2.1 TARGETED ANALYSIS OF FREQUENTLY 
OCCURRING MYCOTOXINS 
 
As introduced in Chapter 1.1, there are a total of about 30 frequently occurring 
mycotoxins in different agricultural products. Therefore, a reliable analytical 
method was developed for simultaneous determination of these targeted 
mycotoxins. Lentinula edodes, a kind of mushrooms, which has not yet been 
screened for mycotoxin contamination, was taken as an example for method 
development and validation. The developed extraction, clean-up and quantification 
strategies based on LC-MS/MS were the foundation for the whole thesis.  
 
 
Redrafted from: 
Zheng Han, Zhihong Feng, Wen Shi, Zhihui Zhao, Yongjiang Wu and Aibo Wu.  
A quick, easy, cheap, effective, rugged and safe sample pretreatment-based liquid 
chromatography tandem mass spectrometry method for simultaneous quantification of 
33 mycotoxins in Lentinula edodes. Journal of Separation Science, 2014, 37, 
1957-1966. 
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2.1.1 Introduction 
 
Lentinula edodes, commonly known as the shiitake mushroom, is one of the most 
cultivated edible mushrooms worldwide, which has long history for use in foods due 
to its beneficial effects for health 1-3. With regard to their safety, some endogenous 
mushroom toxins, i.e., amanita smithiana toxin, causing nausea, vomiting, abdominal 
pain 4, acute kidney injury 5 and renal failure 6,7, are the current research priorities and 
have been extensively studied. The exogenous toxins such as mycotoxins are usually 
neglected due to the consideration of the mushroom as the definitely dominant fungi, 
in addition that the various metabolites of the mushroom, i.e., beta-glucans, might act 
as anti-toxicant inhibiting mycotoxin production 8. Recently, contaminating fungi and 
the mycotoxins they produce have caused concern. Seven fungi and four AFs were 
identified in stored mushrooms under laboratory conditions in Nigeria 9. Typical 
moulds such as Fusarium, Penicillium,Trichoderma and aflatoxigenic species of 
Aspergillus (A. flavus and A. parvisclerotigenus) were also recovered by Ezekiel et al. 
from mushrooms at varying levels 10. Though the literature is still sparse on the 
presence of mycotoxins as contaminants of mushrooms especially L. edodes, the 
potential health risk originating from mycotoxins (See Chapter 1) should be 
considered to ensure their safe use. In contrast to regulated food and feedstuff, a 
correct evaluation of this potential risk cannot be achieved because only very little 
occurrence data are currently available. 
Therefore, validated qualitative and quantitative data of different mycotoxins in L. 
edodes are indispensable. But, there is no method for determination of different 
mycotoxins in L. edodes. Recently, an ultra high performance liquid chromatography 
tandem mass spectrometry (UHPLC-MS/MS) method was developed for 
simultaneous determination of 35 mycotoxins in different traditional Chinese 
medicines 11. Application of this method to L. edodes resulted in low sensitivities for 
some key mycotoxins, i.e., DON, 3-ADON and 15-ADON due to matrix interferences. 
Furthermore, co-occurring FB1 and FB2 contaminating a wide range of food and 
feedstuff 12,13, could not be quantified by the previous method. 
The major purpose of the current work was to develop an accurate and sensitive 
UHPLC-MS/MS analytical method implying an easy, economical and effective 
sample preparation based on the Quick Easy Cheap Effective Rugged Safe 
(QuEChERS) approach, which should not only allow to cover a vast number of 
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mycotoxins but also be applicable for the complex matrix of L. edodes thereby 
allowing to investigate the actual contaminant situations for the first time. 
 
2.1.2 Materials and methods 
 
2.1.2.1 Chemicals 
 
The standards of AFB1, AFB2, AFG1, AFG2, AFM1, AFM2, HT-2, T-2, and OTA 
were got from Alexisa (San Diego, CA, USA). 15-ADON and 3-ADON were 
purchased from Biopure (Tulln, Austria). Fusaric acid, ZEN, ZAN, α-zearalenol 
α-ZOL, α-ZAL, β-ZAL, DON, NIV, DOM-1, β-ZOL, STC, Fus X, CIT, NEO, DAS, 
MPA, CPA, VER, FB1, FB2, PAT and GT were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 13C20-OTA, 13C17-AFB1, 13C15-DON, 13C24-T2 and 13C18-ZEN, also 
from Sigma-Aldrich (St. Louis, MO, USA), were used as the internal standards.  
Acetonitrile and methanol, both HPLC grade, were purchased from Merck 
(Darmstadt, Germany). Milli-Q quality water (Millipore, Billerica, MA, USA) was 
used during the whole analysis. Other solvents and chemicals were of HPLC or 
analytical grade from local suppliers. 
 
2.1.2.2 Apparatus 
 
LC-MS/MS (SHIMADZU, Kyoto, Japan) was utilized for the determination of the 
mycotoxins. Separation was performed at 35 °C using an Agilent Poroshell 120 
EC-C18 column (100 mm×3 mm, 2.7 µm) with a linear gradient elution using (A) 
water containing 5 mM ammonium acetate and (B) methanol as the mobile phase. The 
elution program was set as follows: 5% B (initial), 5–20% B (0-2 min), 20-100% B 
(2-13 min), 100% B (13-14.5 min), 100-5% B (14.5-15 min) and hold on for a further 
3 min for re-equilibration, giving a total run time of 18 min. The flow rate was 0.2 
mL/min and the injection volume was 5 μL (full loop). MS/MS detection was 
performed with the following parameters: nebulizing gas flow of 3 L/min, drying gas 
flow of 15 L/min, interface voltage of 4.5 kV, desolvation line (DL) temperature of 
250 °C, heat block temperature of 400 °C. Quantification was performed in multiple 
reaction monitoring (MRM) mode and the conditions were optimized for each 
mycotoxin during infusion. 
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2.1.2.3 Preparation of standard solutions 
 
The standard solutions were prepared according to a previous study 11 with minor 
modifications: accurately weighed solid portions of each mycotoxin standard were 
dissolved in acetonitrile to prepare 0.1 mg/mL of stock solutions and stored at -20 ◦C 
in the darkness.The work solutions were prepared by diluting each stock solution step 
by step with acetonitrile/water containing 5 mM ammonium acetate (20/80, v/v). The 
commercial solutions of the five internal standards were directly diluted with the same 
combined solution to 20 ng/mL for 13C17-AFB1, 100 ng/mL for 13C20-OTA and 
13C18-ZEN, as well as 500 ng/mLfor 13C24-T-2 and 13C15-DON, respectively. All work 
solutions were prepared immediately before use. 
 
2.1.2.4 Sample pretreatment 
 
Samples of 2 g of dried and powdered L. edodes were spiked with 200 μL of each 
internal standard solution (20 ng/mL for 13C17-AFB1, 100 ng/mL for 13C20-OTA and 
13C18-ZEN, as well as 500 ng/mL for 13C24-T-2 and 13C15-DON). After setting this 
aside for 1 h at room temperature, the spiked samples were macerated with 5 mL of 
water for 5 min, and ultrasonicated for 40 min. Then, 5 mL of acetonitrile containing 
1% formic acid was added. The mixture was vortexed for 30 s and ultrasonicated for 
another 40 min. Thereafter, 1 g of anhydrous MgSO4 and 0.5 g of NaCl were added to 
the slurry, and severely shaken for 30 s immediately, and then ultrasonicated for 10 
min. The mixture was subsequently centrifuged at 10000 g for 15 min at room 
temperature. An aliquot of supernatant (3 mL) was dried at 40 °C under a flow of 
nitrogen gas. The residue was redissolved with 200 μL of acetonitrile and then 
vortexed for about 30 s, and 800 μL of a mixture of acetonitrile/water containing 5 
mM ammonium acetate (20/80, v/v) was added. The tube was then briefly shaken for 
another 30 s. Finally, the solution was passed through a 0.22 μm nylon filter and was 
ready for injection.  
 
2.1.2.5 Evaluation of matrix effects 
 
The stock solutions were diluted with a blank matrix solution prepared using an 
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analyte-free L. edodes that underwent the whole sample preparation, to yield a serial 
of analyte concentrations (0.5, 1, 2, 5, 10, 20, 50, 100, 200, 500 and 800 ng/mL). The 
slope of the standard calibration plot in the matrix was compared with that of the 
standard calibration plot in a neat solvent to evaluate the signal 
suppression/enhancement (SSE), which is an estimate of the matrix effects 14. 
 
2.1.3 Results and discussion 
 
2.1.3.1 Optimization of the LC-MS/MS conditions 
 
Three different mobile phases, including (1) methanol-water containing 0.1% formic 
acid, (2) methanol-water containing 0.1% acetic acid and (3) methanol-water 
containing 5 mM ammonium acetate were selected as candidates for optimization. 
When mobile phase (1) or (2) was applied, the peaks of six type B trichothecenes 
(DON, NIV, Fus X, 3-ADON, 15-ADON and DOM-1) were not observed (either 
under the full scan mode or MRM) due to the poor ionization efficiency, although the 
other compounds could generate ions with relatively high responses under ESI+ and in 
negative electrospray ionization mode (ESI-), respectively. Using mobile phase (3), the 
[M-H]- signal for the six type B trichothecenes was also very low. However, by 
checking these target analytes in the full scan mode, it became apparent that, for all 
these compounds, the [M+CH3COO]- signal was significantly higher than that of the 
[M-H]- ions. As a consequence, [M+CH3COO]- was selected as the precursor ion for 
DON, NIV, Fus X, 3-ADON, 15-ADON, DOM-1 and 13C15-DON. The final 
parameter settings for the precursor ions, product ions, and collision energies are 
summarized in Table 2.1. A Poroshell 120 EC-C18 column was used as it has been 
shown to deliver high separation efficiency for multiple mycotoxin analysis 15, and a 
gradient elution of the mobile phases was implemented as described in 2.1.2.2 to 
achieve good analyte rentention and short run time. Typical MRM chromatograms 
obtained for the analysis of 33 mycotoxins in standard solution are shown in Fig. 2.1. 
Good peak shapes and satisfactory separation efficiency were achieved, and all the 
analytes could be identified by their retention times and by two MRM transitions in a 
single injection with a total run time of 18 min. 
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Table 2.1 MS/MS parameter settings for 33 mycotoxins and 5 internal standards. 
Name 
Precursor 
 ion (m/z) 
Primary 
product 
ion (m/z) 
Collision 
energy 
(eV) 
Secondary 
product 
 ion (m/z) 
Collision 
energy 
(eV) 
AFB1 313(+H) 285 26 241 37 
AFB2 315(+H) 259 31 287 29 
AFG1 329(+H) 243 30 214 40 
AFG2 331(+H) 245 33 189 45 
AFM1 329(+H) 273 28 259 25 
AFM2 331(+H) 273 23 285 24 
STC 325(+H) 281 39 310 26 
NEO 400(+NH4) 215 20 185 23 
OTA 404(+H) 239 25 358 13 
DAS 384(+NH4) 307 14 247 14 
T-2 484(+NH4) 215 14 305 16 
HT-2 442(+NH4) 263 15 215 17 
MPA 321(+H) 207 24 159 39 
FB1 722(+H) 334 44 352 37 
FB2 706(+H) 336 40 74 48 
VER 534(+Na) 392 16 435 16 
DON 355(+CH3COO-) 295 11 59 20 
Fus X 413(+CH3COO-) 353 11 187 28 
DOM-1 
279(-H) 249 15 -a) - 
339(+CH3COO-) - - 59 25 
15-ADON 397(+CH3COO-) 150 18 337 11 
3-ADON 397(+CH3COO-) 307 15 173 16 
CPA 335(-H) 154 35 140 28 
ZEN 317(-H) 131 31 175 25 
ZAN 319(-H) 205 24 275 20 
α-ZOL 319(-H) 130 38 275 20 
α-ZAL 321(-H) 277 22 303 22 
β-ZOL 319(-H) 130 34 160 30 
β-ZAL 321(-H) 277 22 303 22 
Fusaric acid 180(+H) 134 18 162 14 
GT 327(+H) 263 13 245 21 
CIT 251(+H) 233 18 91 49 
PAT 153(-H) 109 16 81 16 
NIV 371(+CH3COO-) 281 15 311 11 
13C17-AFB1 330(+H) 255 12 301 17 
13C20-OTA 424(+H) 250 33 232 26 
13C24-T-2 508(+NH4) 322 17 198 22 
13C15-DON 370(+CH3COO-) 310 11 59 24 
13C18-ZEN 335(-H) 140 31 185 26 
a) No product ions for this precursor ion in this transition. 
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Figure 2.1 MRM chromatograms of 33 mycotoxins including 19 positive ions (a) and 14 negative 
ions (b) in standard solution. The concentration of the mycotoxins was 50 ng/mL, while the 
concentrations for the internal standards were 2 ng/mL for 13C17-AFB1, 10 ng/mL for 13C20-OTA 
and 13C18-ZEN, 50 ng/mL for13C24-T-2 and 13C15- DON. 
 
2.1.3.2 Optimization of the sample pretreatment method 
 
An optimized cleanup protocol for purification of L. edodes extracts was needed to 
obtain satisfactory recovery and sensitivity of the targeted mycotoxins. Three different 
extraction solutions, commonly used for multiple mycotoxins extraction, i.e., (1) 
acetonitrile/water (84/16, v/v) 16, (2) acetonitrile/water/acetic acid (79/20/1, v/v/v) 
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17and (3) methanol/dichloromethane/methyl acetate (1/2/3, v/v/v) containing 1% 
formic acid 18, were compared in the pilot test. Blank samples of L. edodes (n=3) 
spiked with 50 μg/kg of targeted mycotoxins were extracted with each of the three 
extraction solvents; the extracts were purified with home-made clean-up cartridges 
filled with silica 11, and then injected into LC-MS/MS. Among the three extraction 
solutions, acetonitrile/water (84/16, v/v) showed the highest extraction effeciency for 
most of the mycotoxins. However, this solvent could not be used for the extraction of 
FB1, FB2 and fusaric acid (Fig. 2.2), indicating the need for a more suitable sample 
pretreatment method for the simultaneous determination of 33 mycotoxins in L. 
edodes. 
As generally recognized, the QuEChERS protocol is one of the most efficient 
sample pretreatment methods, which was first developed for the determination of 
pesticides and recently has been adapted for the analysis of various mycotoxins 19. It 
is a quick, cheap and effective extraction procedure with primary and secondary 
amine (PSA) as the base sorbent. However, PSA sorbent can absorb FB1 and FB2 
from samples due to ion exchange, and is thus not suitable in the frame of the present 
study. For optimizing the extraction procedure, acetonitrile and methanol were 
compared in the present study. The results showed that higher extraction recovery and 
better sensitivity for most of the mycotoxins except for FB1 and FB2 were obtained 
when acetonitrile was used, which might be due to the better liquid–liquid partitioning 
with salts. When methanol was used, the extracts obtained were obviously darker in 
color and much more difficult to pass the 0.22 μm nylon filter compared to the 
acetonitrile extracts, indicating the absence of salt-induced partitioning and the 
presence of a great amount of matrix interference. Therefore, acetonitrile was chosen 
for further optimization. In order to improve the extraction efficiency of FB1 and FB2, 
the effect of acidifying this solvent with formic acid (1%) was evaluated. Under these 
conditions, the recoveries of FB1 and FB2 were substantially increased. Therefore, a 
simple and rapid sample pretreatment method was developed. Compared to the dilute 
and shoot approach 17, the method proposed here is more suitable in view of 
protecting the LC-MS system from polar contaminants. In addition, the sensitivities of 
all mycotoxins were improved as the analytes were concentrated by solvent 
evaporation followed by the reconstitution of the extracts in a small amount of 
injection solution. However, using such a simple and rapid sample pretreatment 
method, matrix effects during UHPLC-MS/MS measurement are unavoidable. 
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Therefore, it was decided to investigate the matrix effects in further evaluation of the 
method.  
 
 
Figure 2.2 The extraction efficiencies of 33 mycotoxins from L. edodes by acetonitrile/water 
(84/16, v/v), acetonitrile/water/acetic acid (79/20/1) and formic acid/dichloromethane/methyl 
acetate (1/2/3). 
 
2.1.3.3 Evaluation of the matrix effects 
 
 
Figure 2.3 Signal suppression/enhancements (SSEs) of 33 mycotoxins in L. edodes. 
 
Matrix effects for the 33 mycotoxins in L. edodes, calculated by comparing the 
slope of the calibration plot for the standards spiked in the matrix with that of 
standard in pure solvent, are shown in Fig. 2.3. As expected from the implementation 
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of a simple sample pretreatment, SSEs were observed to a great extent, varying from 
14.6% to 135.5%. In the present study, only five internal standards including 
13C17-AFB1, 13C15-DON, 13C18-ZEN, 13C24-T-2 and 13C20-OTA were used. Utilizing 
these internal standards, matrix effects could not be compensated for all compounds. 
Consequently, matrix matched calibration was chosen as the best approach to 
compensate for the matrix effects, so as to ensure the accuracy of the method. 
 
2.1.3.4 Selection of the internal standard 
 
First, 2 g of mycotoxin-free L. edodes samples were spiked with low, intermediate and 
high concentration levels of 33 mycotoxins (5, 20, 100 μg/kg for AFB1, AFB2, AFG1, 
AFG2, AFM1, HT-2, T-2, OTA, fusaric acid, DAS, MPA, STC; 50, 100, 500 μg/kg for 
DON, AFM2, NEO, VER, NIV, GT, FB1, FB2, CIT, Fus X, DOM-1, 15-ADON, 
3-ADON, ZEN, ZAN, α-ZOL, α-ZAL, β-ZOL, β-ZAL, CPA and PAT) (n=6), and 
pretreated according to the method described in Chapter 2.1.2.4. Then, the samples 
were analyzed by LC-MS/MS and the mycotoxin concentrations were calculated 
using matrix-matched calibration. The absolute recovery was evaluated by 
comparison of the calculated concentrations with the spiked concentrations. As shown 
in Table 2.2, the absolute recoveries ranged from 63.1% to 129.8%, indicating the 
necessity of the internal standards. According to the results in Table 2.2, six groups 
could be distinguished based on the similarity of their absolute recoveries: (1) AFB1, 
AFB2, AFG1, AFG2, AFM1, AFM2, STC and NEO; (2) OTA and DAS; (3) T-2, HT-2, 
MPA, FB1, FB2 and VER; (4) DON, Fus X, DOM-1, 3-ADON, 15-ADON and CPA; 
(5) ZEN, ZAN, α-ZOL, α-ZAL, β-ZOL and β-ZAL; (6) fusaric acid, GT, CIT, PAT, 
NIV. 13C17-AFB1 was selected as the internal standard of group (1), and 13C20-OTA, 
13C24-T-2, 13C15-DON and 13C18-ZEN were used for group (2)-(5), respectively. For 
the last one, the absolute recovery rates ranged from 73.6% to 116.1%, which fulfilled 
the requirements of the accurate quantification of these compounds 14. In addition, 
there was no internal standard suitable for the correction of these mycotoxins in group 
(6) due to their different absolute recoveries. As a result, for the first five groups of 
mycotoxins, matrix-matched calibration curves were used in combination with the 
related internal standards, while for group (6), matrix-matched calibration curves 
without internal standard were sufficient, to ensure the accuracy of the LC-MS/MS 
method. 
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Table 2.2 Absolute recovery without internal standards and relative recovery using 13C17-AFB1, 
13C20-OTA, 13C24-T-2, 13C15-DON, 13C18-ZEN as the internal standards in L. edodes (n=6). 
Names 
Absolute Recovery 
(Mean±SD) 
Relative Recovery 
(Mean±SD) 
Low a) Intermediate b) High c) Low   Intermediate High 
AFB1 69.4±5.3 79.5±2.1 79.2±6.4 83.0±9.6 82.8±7.5 89.6±6.8 
AFB2 74.4±3.3 76.6±1.4 78.4±4.4 92.3±10.1 85.7±4.7 88.5±4.1 
AFG1 77.5±7.7 77.8±3.1 82.7±6.7 86.3±11.9 86.2±1.5 82.1±4.9 
AFG2 67.1±6.3 73.4±1.0 76.6±3.8 82.7±6.7 84.8±6.8 83.4±5.2 
AFM1 63.1±2.3 77.6±1.1 77.3±3.8 82.6±3.4 82.2±9.0 80.8±2.8 
AFM2 71.8±3.6 82.5±1.8 79.8±4.5 80.6±8.0 79.2±4.7 80.7±6.8 
STC 75.3±2.7 77.2±1.4 76.2±4.8 81.1±6.3 95.2±13.0 108.8±14.6 
NEO 75.1±2.6 94.9±2.8 91.6±4.6 84.5±9.3 94.7±7.2 96.0±7.2 
OTA 64.8±3.5 89.7±9.9 88.1±6.2 97.1±5.5 98.9±11.9 98.4±8.6 
DAS 69.4±2.8 75.8±0.6 73.7±3.3 95.2±8.7 93.2±12.1 97.4±10.1 
T-2 72.2±3.0 78.3±3.5 76.9±6.9 96.4±2.4 94.7±4.9 102.7±3.4 
HT-2 77.7±3.8 79.9±1.5 75.4±3.2 100.1±4.3 94.6±4.7 101.7±4.5 
MPA 79.6±7.3 76.5±2.0 74.8±3.5 95.0±2.0 92.2±3.9 100±3.1 
FB1 73.4±3.9 71.2±4.1 75.6±2.5 104.5±1.9 96.3±6.8 97.1±2.9 
FB2 71.8±10.1 73.7±5.0 67.8±2.3 96.5±10.2 87.2±2.5 89.6±7.4 
VER 74.2±10.9 84.2±3.7 79.0±3.6 97.1±11.1 101.7±6.6 100.1±9.5 
DON 57.7±7.7 64.2±5.5 68.6±3.7 86.5±9.1 100.9±8.3 113.4±2.8 
Fus X 80.3±4.5 74.2±2.5 78.3±4.3 110.3±12.3 103.9±7.6 115.3±6.4 
DOM-1 79.7±4.5 83.4±5.3 70.6±3.7 113.8±7.2 117.9±11.7 107.9±11.4 
15-ADON 84.4±5.7 82.5±9.7 77.8±4.6 96.8±4.2 94.5±9.1 115.5±8.7 
3-ADON 73.8±4.4 77.0±2.2 74.7±4.4 111.2±12.3 95.1±8.2 107.5±9.1 
CPA 68.6±9.9 91.3±9.7 92.1±3.1 98.7±4.9 106.4±13.6 86.2±10.1 
ZEN 89.0±6.4 85.8±2.9 91.1±2.8 102.2±5.5 104.1±7.6 103.3±4.8 
ZAN 84.0±3.0 83.0±3.6 91.4±4.4 105.4±7.2 110.3±8.5 110.9±5.8 
α-ZOL 108.8±12.5 82.9±2.9 96.8±7.9 97.3±3.8 99.1±8.0 93.0±3.6 
α-ZAL 117.2±10.3 95.8±8.5 129.8±5.1 104.9±6.8 102.1±7.4 102.3±5.1 
β-ZOL 116.7±22.7 125.4±11.4 119.3±2.3 96.8±11.2 101.9±7.3 100.7±5.6 
β-ZAL 87.2±3.4 79.7±4.4 105.6±2.9 95.9±3.8 98.8±8.6 102.7±6.8 
Fusaric acid 87.9±9.7 111.5±3.0 116.1±7.0 -d) - - 
GT 87.1±6.8 89.1±13.1 73.6±5.4 - - - 
CIT 95.7±5.3 98.7±18.0 89.7±8.1 - - - 
PAT 89.6±14.7 83.1±5.7 102.6±5.7 - - - 
NIV 90.7±9.5 87.4±5.8 103.3±7.2 - - - 
a) Low levels were designed as 5 μg/kg for AFB1, AFB2, AFG1, AFG2, AFM1, HT-2, T-2, OTA, fusaric 
acid, DAS, MPA, STC, and 50 μg/kg for the others; 
b) Intermediate levels were designed as 20 μg/kg for AFB1, AFB2, AFG1, AFG2, AFM1, HT-2, T-2, OTA, 
fusaric acid, DAS, MPA, STC, and 100 μg/kg for the others; 
c) High levels were designed as 100 μg/kg for AFB1, AFB2, AFG1, AFG2, AFM1, HT-2, T-2, OTA, fusaric 
acid, DAS, MPA, STC, and 500 μg/kg for the others; 
d) No internal standard used. 
 
2.1.3.5 Method validation 
In accordance with the European Commission Decision 2002/657/EC and 
Commission Regulation 401/2006/EC 20,21, the method validation was further carried 
out to evaluate the performance of the established method. Blank  L. edodes matrices 
were spiked with mycotoxin standard solutions to obtain serial concentrations of 0.5, 
1, 2, 5, 10, 20, 50, 100, 200, 500, 800 ng/mL for the analytes, and the desired 
concentration for the internal standard i.e. 2 ng/mL for 13C17-AFB1, 10 ng/mL for 
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13C20-OTA and 13C18-ZEN, and 50 ng/mLfor 13C24-T-2 and 13C15-DON. Calibration 
curves were created using internal standards except for fusaric acid, GT, CIT, PAT and 
NIV (Table 2.3). For these five mycotoxins, the linearity of the MS/MS responses 
versus concentrations was evaluated in the blank matrix. Good linear relationship 
(R2>0.99) was obtained for all mycotoxins within the reported concentration ranges 
(Table 2.3). A lack of fit test was also performed to assess the adequacy of the linear 
model. As shown in Table 2.3, all p values were higher than 0.05 verifying the 
reliability of the chosen calibration ranges for the quantification of the different 
analytes. Data for the limit of detection (LOD) defined as signal to nosie (S/N) =3/1 
and the limit of quantification (LOQ) as S/N=10/1, shown in Table 2.3, were in the 
range of 0.1-6 μg/kg and 0.5-20 μg/kg, respectively.  
For evaluation of the recovery of the method, blank L. edodes samples were spiked 
with the analyte at three different concentration levels (low, intermediate and high). 
The low, intermediate and high concentration levels were set as follows: 5, 20, 100 
μg/kg for AFB1, AFB2, AFG1, AFG2, AFM1, HT-2, T-2, OTA, fusaric acid, DAS, 
MPA, STC; 50, 100, 500 μg/kg for DON, AFM2, NEO, VER, NIV, GT, FB1, FB2, 
CIT, Fus X, DOM-1, 15-ADON, 3-ADON, ZEN, ZAN, α-ZOL, α-ZAL, β-ZOL, 
β-ZAL, CPA and PAT. The samples were prepared in replicates (n=6) and analyzed by 
the proposed method. The average recoveries were in the range of 73.6-117.9% (Table 
2.2). 
With respect to intra- and inter-day precision of the method, low, intermediate and 
high concentration levels of mycotoxins (5, 20, 100 μg/kg for AFB1, AFB2, AFG1, 
AFG2, AFM1, HT-2, T-2, OTA, fusaric acid, DAS, MPA, STC; 50, 100, 500 μg/kg for 
DON, AFM2, NEO, VER, NIV, GT, FB1, FB2, CIT, Fus X, DOM-1, 15-ADON, 
3-ADON, ZEN, ZAN, α-ZOL, α-ZAL, β-ZOL, β-ZAL, CPA and PAT) were spiked 
into the blank L. edodes (n=6), and analyzed by the developed method in one day and 
five consecutive days. As shown in Table 2.4, the relative standard deviation (RSD) 
values ranged from 0.8% to 19.5%.  
The validation details described above suggested that the current LC-MS/MS 
method and sample pretreatment procedures were selective, robust, accurate and 
sensitive enough for determination of various mycotoxins in L. edodes. 
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Table 2.3 Linearity and sensitivity data for 33 mycotoxins in L. edodes. 
Analyte a) Slope Intercept R2 
Lack of fit 
 (p value) 
Range 
(ng/mL) 
Sensitivities 
(μg/kg) 
LOD LOQ 
AFB1 0.4192 0.3170 0.9994 0.098 0.5-100 0.3 0.5 
AFB2 0.3714 -0.1877 0.9997 0.087 1-100 0.4 1 
AFG1 0.2040 -0.0336 0.9969 0.132 1-100 0.5 1 
AFG2 0.5867 0.5245 0.9995 0.109 0.5-100 0.3 0.5 
AFM1 0.2569 1.7553 0.9994 0.228 1-100 0.3 1 
AFM2 0.1685 0.2663 0.9997 0.113 5-800 1.4 5 
STC 1.0377 1.0121 0.9989 0.245 0.5-100 0.2 0.5 
NEO 0.2900 1.5753 0.9984 0.089 5-500 1.4 5 
OTA 0.0353 -0.0051 0.9998 0.324 0.5-100 0.2 0.5 
DAS 0.1055 -0.0583 0.9999 0.107 1-100 0.4 1 
T-2 0.0157 -0.0015 0.9999 0.352 1-100 0.5 1 
HT-2 0.0133 0.0358 0.9992 0.108 1-100 0.5 1 
   MPA     0.0179    0.0901     0.9998     0.079     0.5-100     0.2    0.5 
FB1 0.0029 0.0082 0.9997 0.202 5-800 1.3 5 
FB2 0.0057 0.0095 0.9998 0.080 5-800 1.3 5 
VER 0.0061 -0.0451 0.9990 0.379 10-500 3 10 
DON 0.0178 1.2149 0.9995 0.227 10-500 3 5 
Fus X 0.0615 0.6075 0.9989 0.189 5-800 1.3 5 
DOM-1 0.0092 -0.0520 0.9987 0.099 20-500 5 15 
15-ADON 0.0120 0.3215 0.9908 0.168 20-800 6 20 
3-ADON 0.0320 -0.1893 0.9942 0.342 10-800 3 10 
CPA 0.0026 -0.0064 0.9982 0.102 10-800 3 10 
ZEN 0.0141 0.0062 0.9999 0.289 5-500 1 3 
ZAN 0.0110 -0.0416 0.9992 0.178 5-500 1 3 
α-ZOL 0.0073 -0.0228 0.9995 0.202 5-800 1 3 
α-ZAL 0.0158 -0.0730 0.9987 0.190 5-500 1 3 
β-ZOL 0.0019 -0.0047 0.9995 0.090 5-500 1 3 
β-ZAL 0.0083 -0.0410 0.9993 0.087 5-500 1 3 
Fusaric acid b) 10364.5 58273.6 0.9991 0.062 1-100 0.1 0.5 
GT b) 907.1 -3710.5 0.9991 0.077 5-800 1 3 
CIT b) 2778.6 13055.4 0.9993 0.098 5-500 0.5 2 
PAT b) 149.0 285.4 0.9992 0.086 5-500 3 10 
NIV b) 27.7 50.8 0.9997 0.133 20-500 6 20 
a) 13C17-AFB1, 13C20-OTA, 13C24-T-2, 13C15-DON and 13C18-ZEN were used as the internal 
standards as described under Chapter 2.1.3.4. 
b) The calibration curves of fusaric acid, GT, CIT, PAT and NIV were constructed in the matrix of 
L. edodes without internal standards. 
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Table 2.4 Intra- and inter-day precision of 33 mycotoxins in L. edodes. 
Names 
Intra-day 
RSD (%) 
Inter-day  
RSD (%) 
Low a Intermediate b High c Low a Intermediate b High c 
AFB1 7.7 2.6 8.1 4.6 2.5 4.9 
AFB2 4.4 1.8 5.6 8.8 7.2 5.7 
AFG1 10.0 4.0 8.1 11.9 13.6 7.7 
AFG2 12.2 7.0 11.9 12.6 13.1 11.9 
AFM1 4.0 1.4 4.9 9.6 4.3 3.9 
AFM2 4.9 2.2 5.7 4.3 5.7 11.2 
STC 3.7 1.9 6.3 3.2 2.0 1.1 
NEO 3.4 3.0 5.1 8.8 7.2 6.9 
OTA 5.4 11.2 7.1 13.1 10.9 8.2 
DAS 4.1 0.8 4.5 3.9 5.6 4.6 
T-2 4.2 4.4 4.5 3.1 3.9 4.6 
HT-2 4.9 1.9 4.2 8.8 5.6 6.9 
MPA 9.2 2.6 3.4 4.6 2.9 1.7 
FB1 5.4 5.7 3.3 5.6 4.2 7.1 
FB2 14.1 6.9 3.4 17.1 10.5 3.9 
VER 14.8 4.4 18.3 15.6 13.2 11.8 
DON 13.5 6.2 5.4 11.2 15.6 17.1 
Fus X 5.7 3.4 5.5 15.1 16.2 11.4 
DOM-1 6.3 5.6 5.3 5.5 2.9 3.3 
15-ADON 6.8 11.8 5.9 4.1 3.1 4.6 
3-ADON 6.0 2.8 5.9 11.3 8.3 6.9 
CPA 14.5 10.6 16.7 12.5 6.3 8.7 
ZEN 7.2 3.4 3.1 6.6 7.1 8.2 
ZAN 3.6 4.3 4.5 3.8 5.9 3.3 
α-ZOL 11.5 3.5 8.2 12.5 10.3 9.9 
α-ZAL 8.8 8.9 3.9 4.6 7.2 6.5 
β-ZOL 19.5 9.1 2.0 15.4 11.2 3.9 
β-ZAL 3.9 5.5 2.8 11.2 8.9 6.5 
Fusaric acid 11.1 2.7 6.0 13.2 8.9 9.2 
GT 7.9 14.8 7.4 11.9 12.4 10.5 
CIT 18.3 4.5 2.0 8.4 4.8 4.9 
NIV 16.5 6.9 5.6 12.3 9.9 7.8 
PAT 10.5 6.7 7.0 4.6 5.7 10.2 
a 5 μg/kg for AFB1, AFB2, AFG1, AFG2, AFM1, HT-2, T-2, OTA, fusaric acid, DAS, MPA, STC, and 50 
μg/kg for the others; 
b 20 μg/kg for AFB1, AFB2, AFG1, AFG2, AFM1, HT-2, T-2, OTA, fusaric acid, DAS, MPA, STC, and 100 
μg/kg for the others; 
c 100 μg/kg for AFB1, AFB2, AFG1, AFG2, AFM1, HT-2, T-2, OTA, fusaric acid, DAS, MPA, STC, and 
500 μg/kg for the others. 
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2.1.3.6 Method application 
 
The validated method was subsequently applied to investigate the occurrence of 
mycotoxins in L. edodes in China. A total of 30 samples were randomly collected 
from different supermarkets in Shanghai, and then analyzed by the newly developed 
method.    
Among the 30 samples, 22 samples were contaminated with mycotoxins (73.3% of 
incidence), ranging from 3.3 μg/kg to 28,850.7 μg/kg (Table 2.5), indicating that 
though L. edodes is an edible fungus, some mycotoxin-producing fungi can also easily 
infect it. MPA was the most frequently found mycotoxin (40%) with a concentration 
range of 3.3-28,819.5 μg/kg. The large amounts of this mycotoxin indicate that the 
matrix, environment and storage conditions of L. edodes are favorable for the 
infection of Penicillium spp. to produce MPA. Although toxicity and mechanism of 
toxicity of MPA are not fully understood until now, the cytotoxicity has been proved 
22. Therefore, the high content of MPA in L. edodes found in the present study posed 
potential health risks to consumers. FB1 and FB2 were also found, with incidences of 
20% and 16.7%, and concentration levels of 8.2-78.7 μg/kg and 8.2-71.5 μg/kg, 
respectively. DON was detected in five samples with a concentration range of 
6.3-33.2 μg/kg. It is not surprising to find so many mycotoxins in L. edodes since 
previous reports have indicated the presence of Fusarium species in this food 
commodity. In addition, some other fungi, i.e., Trichoderma and Aspergillus were also 
isolated from L. edodes highlighting the potential risks from the mycotoxins these 
fungi can produce. The achieved data underpin the practical application of the 
HPLC−MS/MS method as a valuable tool for trace analysis of multiple mycotoxins in 
L. edodes. 
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Table 2.5 Contamination levels of 33 mycotoxins in L. edodes in China (μg/kg). 
Sample number MPA FB1 FB2 DON 
1 -a - 8.2 - 
2 - - - - 
3 50.7 - - - 
4 28,819.5 31.2 - - 
5 - - - - 
6 - - - - 
7 14 - - - 
8 - 78.7 21.3 - 
9 3.3 - - - 
10 13.3 - - - 
11 27.5 - - - 
12 5133.4 8.2 - - 
13 6393.6 - - - 
14 - - - - 
15 4.2 46.8  - 
16 34.8 - 71.5 - 
17 - 32 - - 
18 31.1 - - - 
19 - - 36.1 - 
20 - 13.7 - - 
21 - - - - 
22 - - 19.9 - 
23 - - - 33.2 
24 8.7 - - 8.2 
25 - - - - 
26 - - - 8.8 
27 - - - 6.6 
28 - - - 6.3 
29 - - - - 
30 - - - - 
a) <LOD. 
 
2.1.4 Conclusions 
 
For the first time, a straightforward LC-MS/MS method based on a QuEChERS 
sample pretreatment was developed for simultaneous determination of 33 mycotoxins 
in L. edodes. The validation data, including linearity, sensitivity, recovery and 
precision showed that the developed method could not only be used for determination 
of six major groups of commonly found mycotoxins including AFs, ochratoxins, 
type-A trichothecenes, type-B trichothecenes, FBs, ZEN and its derivatives, but also 
could cover some other mycotoxins such as fusaric acid, MPA, STC, PAT and CIT in 
L. edodes. The 30 analyzed samples indicated that edible macro-fungi can be infected 
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by mycotoxigenic fungi leading to mycotoxins related health risks. 
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2.2 TARGETED ANALYSIS OF FUSARIC ACID, FUSARIN C, 
FUMONISIN B1, B2 AND B3 UNVEILS TOXIN-PRODUCING 
ABILITIES OF MYCOTOXIGENIC FUSARIUM SPECIES IN 
BELGIUM 
 
As indicated in Chapter 1.2, Fusarium species are important toxigenic fungi occurring 
around the world. They can produce a serious of mycotoxins, including fusaric acid, 
fusarin C, fumonisin B1, B2 and B3, posing potential health risks to humans. 
Therefore, the toxin-producing abilities of Fusarium fungi isolated from Belgium 
were investigated by LC-MS/MS, to fully understand their harmful effects, so as to 
enable efficient prevention and control. 
 
 
Redrafted from: 
Zheng Han, Emmanuel K. Tangni, Bart Huybrechts, Françoise Munaut, Jonathan 
Scauflaire, Aibo Wu and Alfons Callebaut.  
Assessment of the ability of 19 Fusarium isolates from Belgium for the production of 
fusaric acid, fusarin C, fumonisin B1, B2 and B3 in liquid medium and maize-based 
grains. Mycotoxin Research, 2014, 30, 21-240. 
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2.2.1 Introduction 
 
Over the past years, it was demonstrated that Fusarium species can produce 
mycotoxins such as fusarin C, fusaric acid, FB1, FB2 and FB3. Fig. 2.4 presents the 
chemical structures of these mycotoxins. FBs are a group of important mycotoxins 
and they are frequently found in different foods and feedstuff. Due to the high toxicity 
and widespread occurrence, various regulations have been set for FBs around the 
world (See Chapter 1.1.4). Fusarin C has demonstrated mutagenic activity and 
immunosuppresive effects comparable to those of AB1 and STC 23. It has also been 
reported that fusarin C stimulates growth of the breast cancer cell line MCF-7 and can 
act as an estrogenic agonist 24. Fusaric acid is considered to be directly related to the 
severity of damping-off, vascular wilt and root rot diseases of numerous vegetable 
crops 25,26. In addition to the critical roles in plant pathogenesis, fusaric acid can be 
mildly toxic to some animals such as rat 27. Furthermore, since fusaric acid can 
increase the overall toxicity of other mycotoxins, the synergistic interactions with 
other naturally co-occurring mycotoxins deserve further attention 25.  
 
 
Figure 2.4 Chemical structures of fumonisin B1, fumonisin B2 and fumonisin B3, fusarin C and 
fusaric acid. 
 
The mycotoxins’ production ability is influenced by a complex interaction of 
several factors, mainly strain types and substrates (See Chapter 1). Therefore, the 
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major purpose of the present study was first to prepare the standard of fusarin C, and 
then to evaluate for the first time the effects of fungal strains and culture media on the 
production of fusarin C, fusaric acid, FB1, FB2 and FB3 by 12 representative strains 
of Fusarium species collected from Belgium. The results were used to understand the 
optimal conditions necessary for production of these mycotoxins. 
 
2.2.2 Materials and methods 
 
2.2.2.1 Chemicals and reagents 
 
All chemicals including (NH4)2HPO4, KH2PO4, MgSO4·7H20, NaCl, sucrose, 
glycerol and potato dextrose agar were purchased from Sigma-Aldrich (St. Louis, 
MO). The standards of FB1, FB2, FB3 and fusaric acid were also obtained from 
Sigma-Aldrich (St. Louis, MO, USA).  
Methanol and acetonitrile were of LC-MS grade. Water used during the whole 
analysis was purified by a Milli-Q system (Millipore, Brussels, Belgium). 
 
2.2.2.2 Medium preparation 
 
Myro medium (glucose 30.0 g, (NH4)2HPO4 1.0 g, KH2PO4 3.0 g, MgSO4·7H2O 2.0 g, 
NaCl 5.0 g per L (pH 6)) was prepared according to Jackson et al. 28, whereas the 
modified Myro (the second medium) was prepared according to Farber and Sanders 29 
and constituted of sucrose 40.0 g, (NH4)2HPO4 1.0 g, KH2PO4 3.0 g, MgSO4·7H2O 
2.0 g, NaCl 5.0 g and glycerol 10.0 g per L (pH 5.9).  
Maize grains (40 g) were autoclaved twice after adjusting the moisture content (to 
50 %) in 100 mL flasks 30. 
 
2.2.2.3 Test microorganisms and culture conditions 
 
F. graminearum (strains II F030, III R048, II S002, III T010), F. venenatum (strains II 
Q002, III A048, IV A034, IV B035) and F. verticillioides (strains II R078, III K048, 
IV B011, IV B133) obtained from maize in Belgium (Table 2.6) were chosen and 
cultivated both in modified Myro medium (100 mL) and sterilized maize cultures. 
The identification of strains at species level was achieved by sequencing of the 
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elongation factor 1 alpha gene 31. Non-inoculated medium (broth or maize cultures) 
was used as the negative control to check any incurred mycotoxin production during 
the trials. The liquid cultures were incubated for 2 weeks at 27 °C under regular 
shaking at 100 rpm.The samples were stored against light by wrapping the flask with 
aluminium foil at -30 °C until analysis. As for maize culture, inoculation was 
performed with 4 plugs of 25 mm² of 7-dold mycelium grown on potato dextrose agar 
(PDA; Sharlau, Spain). Cultures were incubated at 25 °C for 3 weeks in the dark. 
Incubation was stopped by autoclaving at 121 °C for 20 min and samples were 
thereafter dried at 50-60 °C for 18 hours, ground (< 800 µm) and stored at -20 °C 
until analysis. 
 
Table 2.6 List of the investigated strains 
Original Country Species Strain number Substratum References 
Belgium 
F. graminearum 
II F030 Zea mays this study 
III R048 (MUCLa 53453) Zea mays Reference 30 
III S002 (MUCL 53454) Zea mays Reference 30 
III T010 (MUCL 53455) Zea mays Reference 30 
    
F. venenatum 
II Q002 Zea mays this study 
III A048 Zea mays this study 
IV A034 Zea mays this study 
IV B035 Zea mays this study 
    
 II 078 Zea mays this study 
 III K048 (MUCL 53471) Zea mays Reference 30 
F. verticillioides IV B011 (MUCL 53472) Zea mays Reference 30 
 IV B133 Zea mays this study 
a MUCL = Mycothèque de l’Université catholique de Louvain, Louvain-la-Neuve (Belgium) 
 
2.2.2.4 Identification and isolation of fusarin C 
 
An aliquot (1 mL) of the supernatant of liquid medium was diluted with 
methanol/water solution (50/50, v/v) to 10 mL. The dilution was vortexed for 1 min, 
passed through a 0.22 μm filter and injected into HPLC with diode array detector 
(DAD) and UHPLC-MS/MS for identification and isolation. All experiments were 
performed in a dark room (against light) due to the instability of fusarin C. The 
concentration of fusarin C was corrected by comparing the peak areas detected by 
DAD with its ξ =33000 (350 nm) reported in the literature 32. 
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2.2.2.5 Sample pretreatment 
 
Crushed maize grains (4.00 g ± 0.02 g) of each culture were macerated with 20 mL 
acetonitrile/2-propanol/water solution (50/30/20, v/v/v) for 10 min, and then 
rotatingly shaken for 1 h. Thereafter, 6 g of anhydrous MgSO4 and 1.5 g of NaCl were 
added to the slurry and shaken for 5 min. The mixture was subsequently centrifuged 
at 10000 g for 15 min. An aliquot of supernatant (5 mL) was diluted with 
methanol/water (50/50, v/v) to 50 mL and passed through a 0.22 μm filter for 
injection. 
For liquid medium, the samples were first centrifuged and the supernatant (1 mL) 
was diluted with methanol/water (50/50, v/v) to 50 mL, passed through a 0.22 μm 
filter and ready for analysis. 
 
2.2.2.6 HPLC-DAD conditions 
 
Separation was carried out on an Atlantis T3 column (150 mm×4.6 mm, 5 µm, Waters, 
Milford, MA, USA) maintained at 30 °C. The mobile phase consisted of solvent (A), 
0.05% trifluoroacetic acid (TFA) in water and solvent (B), 0.05% TFA in acetonitrile 
eluting at a flow rate of 1 mL/min. Isocratic elution was used with 40% solvent (B) 
and the injection volume was 10 µL throughout a total run time of 20 min. The 
separated compounds were analyzed by DAD (Waters, Milford, MA, USA). The 
wavelength range of 200-450 nm was recorded and chromatograms were monitored at 
a wavelength of 363 nm. 
 
2.2.2.7 UHPLC-MS/MS analysis 
 
UHPLC was performed using a Waters Acquity Ultra-high performance LC system 
(Waters, Milford, MA, USA). The targets were separated on an Acquity UPLC T3 
column (100 mm×2.1 mm, 1.8 µm, Waters, Milford, MA, USA) at 35 °C, with a 
mobile phase flow rate of 0.5 mL/min. The mobile phase consisted of (A) 1% acetic 
acid in water, (B) methanol and (C) water. A linear gradient elution program was 
applied as follows: 0 min 5% A, 24% B; 3 min 5% A, 69% B; 5 min 5% A, 69% B; 
5.2 min 5% A, 95% B; 5.7 min 5% A, 95% B; 5.8 min 5% A, 24% B. The 
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composition was held at 5% A and 24% B for 2.2 min of equilibration, giving a total 
run time of 8 min. The injection volume was 2.0 μL (partial loop with needle overfill). 
Waters XEVO TQ-S MS (Waters, Milford, MA, USA) with an electrospray source 
in ESI+ was used for detection. The ionization source conditions were set as follows: 
capillary voltage of 0.5 kV, cone voltage of 60 eV, source offset voltage of 50 eV, 
source temperature of 150 °C, desolvation temperature of 450 °C, nebulizer of 7.0 bar. 
The cone and desolvation gas flows were 150 and 1000 L/h, respectively. Data 
acquisition and processing were performed using MassLynx v4.1 (Waters, Milford, 
MA, USA). 
 
2.2.3 Results and discussion 
 
2.2.3.1 Isolation and tentative identification of fusarin C 
 
Out of twelve strains cultivated in Myro medium, LC-DAD analyses revealed two 
different peaks for F. verticillioides (IV B011) against the control (Fig. 2.5). 
Meanwhile, the UV spectra of the two peaks were investigated to ascertain the 
presence of the related chromophore. The results showed that the spectra of the two 
peaks were very similar with maximum absorption at about 363 nm reflecting the 
presence of pentane chain. A minor difference was the spectrum in the range of 
200-250 nm (Fig. 2.6a), which was crucial because this absorption range reflected the 
pyrrolidone ring 33. Then, the sample solution was injected into LC-DAD for several 
times and the fractions corresponding to each peak were collected, pooled and dried 
by nitrogen gas avoiding the light. The residues were re-dissolved in 50% methanol (2 
mL). They were noted as Peak 1 and Peak 2 according to the different retention times 
and then analyzed by LC-MS/MS for further identification. 
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Figure 2.5 LC-DAD chromatographs of the medium solutions of F. verticillioides 
(IV BO11) (a) and the control (b) 
 
 
 
Figure 2.6 Identification of fusarin C by UV spectra using HPLC with diode array detector (DAD) 
(a) and by fragmentation upon LC-MS/MS analysis for Peak 2 (b). 
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As for LC-MS/MS analysis, the full scan mode was used and multiple injections 
indicated that the Peak 1 solution only showed precursor ion m/z 432 ([M+H]+) while 
Peak 2 showed different precursor ions of m/z 432 ([M+H]+), 454 ([M+Na]+) and 470 
([M+K]+). As indicated by a previous study 33, the response of [M+Na]+ should be 
higher than that of [M+H]+ for fusarin C, thus, Peak 2 was more likely to be identified 
as fusarin C. After investigation of the fragments of Peak 2, the main product ions, i.e., 
m/z 436, 419, 406, 396, 368, 352, 335, 290, 267 (Fig. 2.6 b) were in accordance to 
that of the previous report. As confirmed by the results of LC-DAD and LC-MS/MS, 
Peak 2 was identified to be fusarin C.  
Considering the UV spectrum of Peak 1 being similar to that of fusarin C with the 
same molecular weight, this compound might be the “open-chain fusarin C” or its 
stereoisomer (epi-fusarin C). Interestingly, after leaving the standard methanol 
solution of fusarin C at room temperature for 2 days, peak 1 appeared, indicating that 
fusarin C was instable and could be transformed to another compound under such 
conditions 33,34.  
 
2.2.3.2 Optimization of LC-MS/MS conditions 
 
An Acquity UPLC T3 column was used since this column was previously shown to 
deliver high separation efficiency for multiple mycotoxin analysis 14,35. A mixture of 
methanol and water was initially used as the mobile phase for separation of the five 
targeted analytes but the peak shape of fusaric acid was unsatisfactory (Fig. 2.7 a). 
Three mobile phases: (1) methanol-water containing 5 mM ammonium acetate, (2) 
methanol-water containing 5 mM ammonium acetate and 0.05% acetic acid and (3) 
methanol-water containing 0.05% acetic acid were compared (Fig. 2.7b-d). Solution 
(2) or (3) allowed all mycotoxins to be efficiently separated with good peak shapes. 
Methanol-water containing 0.05% acetic acid was selected due to the relatively higher 
sensitivity. A gradient elution program was used as described in 2.2.2.7 to achieve 
good analyte rentention and short run time. Under such situation, fusarin C, fusaric 
acid, FB1, FB2 and FB3 were base-line separated in less than 8 min, providing 
narrow peaks with good peak symmetry.  
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Figure 2.7 Comparison of separation and ionization efﬁciencies of the five mycotoxins using four 
candidate mobile phases. (a) methanol-water; (b) methanol-water containing 5 mM ammonium 
acetate, (c) methanol-water containing 5 mM ammonium acetate and 0.05% acetic acid, (d) 
methanol-water containing 0.05% acetic acid. 
 
The MS/MS conditions were optimized for each mycotoxin by direct injection of 
the standard solution. Identification of precursor ions was performed under full scan 
mode by recording from m/z 100 to m/z 800, both in ESI+ and ESI−. The results 
showed that fusarin C could generate the precursor ion of [M+Na]+ with much higher 
abundance than that of [M+H]+ while all the other compounds formed [M+H]+ 
precursor ions with the highest intensity under ESI+. On the basis of the confirmation 
of precursor ions, two product ions for each precursor ion were selected according to 
the highest sensitivity and optimal selectivity for the targets. Cone voltages were 
selected according to the sensitivity of the precursor ions and collision energies were 
chosen to give the maximum intensity of the product ions. The final selections of 
precursor ions, product ions, cone energies, and collision energies are reported in 
Table 2.7. 
 
Table 2.7 The MS/MS parameters for the five mycotoxins. 
Names 
Precursor 
ion (m/z) 
Cone 
energy 
(eV) 
Primary 
product 
ion (m/z) 
Collision 
energy 
(eV) 
Secondary 
product ion 
(m/z) 
Collision 
energy 
(eV) 
Fusaric acid 180 15 92 24 65 30 
Fusarin C 454 20 290 18 335 20 
FB1 722 50 334 38 352 34 
FB2 706 50 336 37 318 39 
FB3 706 50 336 37 318 39 
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2.2.3.3 Sample preparation and method validation 
 
The QuEChERS protocol is a quick, cheap and effective extraction procedure for 
purification of various mycotoxins with primary and secondary amine (PSA) as the 
base sorbent 19. However, PSA sorbent removes FB1, FB2 and FB3 from samples due 
to ion exchange, and thus could not be utilized in the present study. Therefore, a 
modified QuEChERS procedure without using sorbents was developed in the present 
study. Due to the simple sample pretreatment, matrix effects could not be eliminated, 
as a consequence, matrix-matched calibration curves were used for the compensation 
of the recovery losses during the ionization process. The matrix-matched calibration 
was done with concentrations in the range of 1-100 ng/mL for fusarin C and 1-1000 
ng/mL for fusaric acid, FB1, FB2 and FB3, respectively, in the freshly prepared 
matrices. Sample solutions with high concentration levels of analytes were diluted 
with blank matrices to fit into the linear range. The respective LOD and LOQ were 
0.1 ng/mL and 0.3 ng/mL for fusarin C,fusaric acid, FB1, FB2 and FB3, indicating 
that the sensitivity of the method was high enough to fulfill the requirements for the 
simultaneous determination of these five mycotoxins. 
 
2.2.3.4 Toxin-producing ability of different fungal strains under various conditions 
 
After investigation of the Myro medium inoculated with twelve Fusarium strains, it 
was shown that four strains were fusaric acid producers and eight strains were fusarin 
C producers. Both FB1 and fusaric acid were co-produced by F. verticillioides (Table 
2.8) and thus may co-exist in the same medium. Among the different fungi, F. 
verticillioides IV B011 was able to produce relatively high amounts of toxin (136.5 
mg/L for fusaric acid and 1.8 mg/L for FB1) together with 0.5 mg/L for fusarin C, 0.7 
mg/Lfor FB2 and 0.3 mg/L for FB3. The highest concentration of fusarin C (0.7 mg/L) 
was produced by the strain of F. verticillioides III K048. These results demonstrated 
that F. verticillioides could simultaneously produce fusarin C, fusaric acid, FB1, FB2 
and FB3 in contrast to F. graminearum or F. venenatum that produced only fusarin C 
under the same culture conditions.  
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Table 2.8 Concentrations of the five mycotoxins produced by twelve different strains of F. 
graminearum, F. venenatum and F. verticillioides in Myro medium (mg/L). 
Species Samples Fusaric acid Fusarin C FB1 FB2 FB3 
F. graminearum 
II F030 — a — — — — 
III R048 — 0.1 — — — 
III S002 — — — — — 
III T010 — — — — — 
F. venenatum 
II Q002 — 0.1 — — — 
III A048 — 0.1 — — — 
IV A034 — — — — — 
IV B035 — 0.1 — — — 
F. verticillioides 
II R078 127.7 0.3 0.2 — — 
III K048 54.7 0.7 0.3 — — 
IV B011 136.5 0.5 1.8 0.7 0.3 
IV B133 1.4 0.3 0.1 — — 
a not detected       
 
MRM chromatograms of the five mycotoxins in standard solution (a) and in a 
representative contaminated sample (F. verticillioides IV B011, maize) (b) are shown in 
Fig. 2.8. For this strain, the concentration of fusaric acid was similar in both media, 
while the concentrations of fusarin C, FB1, FB2 and FB3 in maize cultures were much 
higher than those in the modified Myro medium (Table 2.9).  
 
 
Figure 2.8 Chromatograms of five mycotoxins in standard solution (a) and in a sterilized maize 
culture (diluted 10 times) of F. verticillioides IVBO11(b).The concentrations of the five 
mycotoxins in (a) are 20 ng/mL for fusaric acid, 10 ng/mL for fusarin C, fumonisin B1 (FB1), 
fumonisin B2 (FB2) and fumonisin B3 (FB3), respectively. The concentrations of the five 
mycotoxins are 20 ng/mL for fusaric acid, and 10 ng/mL for fusarin C, fumonisin B1 (FB1), 
fumonisin B2 (FB2) and fumonisin B3 (FB3), respectively 
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Table 2.9 Concentrations of the five mycotoxins produced by F. verticillioides (IV B011) in 
modified Myro medium and in sterilized maize cultures. 
 
Modified Myro 
(mg/L) 
 Sterilized maize cultures 
(mg/kg) 
Number 
Fusaric 
acid 
Fusarin 
C 
FB1 FB2 FB3 
 Fusaric 
acid 
Fusarin 
C 
FB1 FB2 FB3 
IV B011 125.7 3.4 0.3 —a —  30.8 20.3 967.6 268.4 753.3 
a not detected (<LOD= 0.1 ng/mL) 
 
The observations in the present study were consistent with the results obtained by 
Baird et al. 36, which indicated that FBs production in liquid medium was obviously 
lower than that in rice. Myro and maize were completely different and consequently, 
several factors could affect in vitro production of FBs including limited nitrogen, 
moderate water activity and pH levels. Whilst a medium of pH 5.9 was used by Baird 
et al. 36, an optimum pH of 2.0 was reported by Miller 37 for FBs production. The 
higher pH of the liquid medium might be an important limiting factor in FBs 
biosynthesis. It could also be obviously seen that fusarin C, fusaric acid and FB3 were 
easily produced along with FB1 and FB2 when maize was infected by F. verticillioides. 
If the same is true in maize-based food or feeds, co-occurrence of these mycotoxins 
should be a matter of concern for human and animal health. Variability of these toxins 
may occur according to the strain. We therefore emphasize monitoring of these five 
mycotoxins in control programs of agricultural practices, crop management and food 
production. Also, one should focus not only on F. verticillioides, but also F. 
temperatum population, that is newly observed in Belgium by Scauflaire et al. 30. 
Furthermore, early detection methods of the high fusarin C, fusaric acid, FB1, FB2 and 
FB3 producers (F. verticillioides) should be developed and used for taking corrective 
actions in the field or during storage for discarding the contaminated batches from the 
food chain. FB1 is stable during most types of processing 38 and we therefore suggest 
further study on the stability of fusarin C and fusaric acid in food (i.e. popcorn, 
cornflakes, tinned maize, tortilla chips, beer and maize starch) processing. 
 
2.2.4 Conclusions 
 
The present study provided new information on production of fusarin C, fusaric acid, 
FB1, FB2 and FB3 in liquid (Myro) medium and maize-based cultures from 
frequently found Fusarium strains in Belgium. Compared to the strains belonging to F. 
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graminearum or F. venenatum, relatively higher toxin-producing ability could be 
observed in the strains of F. verticillioides under the same culture conditions. With 
regard to the effects of culture medium, in contrast to the Myro medium, significant 
increase in the production of all mycotoxins was found in the maize-based media 
probably due to the effects of nitrogen, water activity and pH levels. 
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2.3 UNTARGETED ANALYSIS OF THE SECONDARY 
METABOLITES REGULATED BY THE ASPERGILLUS 
FLAVUS GENE CLUSTER 39 
 
As indicated in Chapter 1.2, next to Fusarium species investigated in Chapter 2.2, 
Aspergillus fungi, especially Aspergillus flavus, are also important toxigenic fungi, 
responsible for AFs’ and ochratoxins’ production. In order to fully understand the 
production mechanisms of the secondary metabolites by Aspergillus flavus, untargeted 
analysis should be performed for determination of the functions of the gene clusters. 
Here, gene cluster 39, which was not previously investigated, was selected and 
studied.  
 
 
Redrafted from: 
J. W. Cary, Z. Han, Y. Yin, J. M. Lohmar, S. Shantappa, P. Y. Harris-Coward, B. 
Mack, K. C. Ehrlich, Q. Wei, N. Arroyo-Manzanares, V. Uka, L. Vanhaecke, D. 
Bhatnagar, J. Yu, W. C. Nierman, M. A. Johns, D. Sorensen, H. Shen, S. De Saeger, J. 
Diana Di Mavungu and A. M. Calvo. 
Biosynthetic pathways of aflavarin regulated by an Aspergillus flavus secondary 
metabolic gene cluster. Eukaryotic Cell, 2015, 14, 983-997. 
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2.3.1 Introduction 
 
A. flavus is a saprophytic filamentous fungus that is able to colonize economically 
important crops such as peanuts, cotton, maize and other oil seed crops during 
pre-harvest or storage. Its most efficient mode of dissemination is the production of 
air-borne conidia. In addition, A. flavus produces resistant structures called sclerotia, 
which allow this fungus to survive adverse environmental conditions for long periods 
of time 39,40. This opportunistic pathogen produces a wide range of secondary 
metabolites, including AFs, which are very toxic natural compounds (See Chapter 
1.1.1). In addition to AFs, A. flavus is known to produce other mycotoxins, including 
CPA, a suppressor of the calcium dependent ATPase in the sarcoplasmic reticulum, 
and aflatrem, a tremogenic mycotoxin causative of neurological disorders 41,42. 
Studies of the A. flavus genome revealed many gene clusters possibly connected to 
the synthesis of other secondary metabolites. Specifically, fifty-six different clusters 
were predicted based on the presence ofgenes encoding polyketide synthases (PKSs), 
non-ribosomal peptide synthetases (NRPSs), hybrid PKS-NRPS and 
prenyltransferases (PTRs) within the clusters 43,44. An additional gene cluster, 
responsible for the synthesis of kojic acid has also been recently identified 45. In spite 
of these new findings, only a few metabolites have been associated with these clusters 
46, among them the clusters associated with the synthesis of kojic acid, as well as the 
synthesis of AFs, CPA, aflatrem and asparasone. Expression of these last four gene 
clusters was shown to be dependent on the global regulatory gene veA, also involved 
in developmental regulation in A. flavus 47,48 and in other fungi 49. Previous studies, 
mainly conducted with the model fungus A. nidulans, revealed that the veA protein 
forms a complex with LaeA, a chromatin modifying protein, and the regulator velB, 
another protein of the velvet family. By whole genome microarray transcript profiling 
it was confirmed that expression of a number of genes associated with putative 
secondary metabolic gene clusters in A. flavus are affected by veA mutation 50. In the 
course of these studies it was found that among the genes significantly 
down-regulated in the veA deletion mutant was a pks in cluster 39. In the present 
study, by applying an untargeted metabolic profiling of extracts of A. flavus wild-type 
and mutant strains for various genes in cluster 39, we showed that this gene cluster is 
responsible for the biosynthesis of aflavarin, which is known to have 
anti-insectantactivity. 
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2.3.2 Materials and methods 
 
2.3.2.1 Strains and culture conditions (done at USDA, New Orleans) 
 
The strains used in this study are listed in Table 2.10. They were provided by the Food 
and Feed Safety Research Unit, USDA/ARS (Southern Regional Research Center, 
New Orleans, Louisiana, USA), while also the moleculars work was performed by 
them. A. flavus CA14 (ku70-, niaD-, pyrG-, ptrA-) served as host for transformation 
experiments. A. flavus CA14 pyrG-1 served as a control (referred to as wild-type) for 
cluster 39 afvA-E deletion strains. The strains were cultured on YGT medium, 
GMM-2% sorbitol medium (GMM-S) or Wickerham medium as indicated in each 
case. Cultures were incubated at 30 oC and stored at -80 oC as glycerol stocks. 
Cultures were point-inoculated onto 2X V8 agar (per liter: 50 mL V8 juice, pH 5.2) 
supplemented when required with 3 mg/mL (NH4)2SO4 and/or 1 mg/mL uracil, and 
incubated at 30 °C in the light.  
 
Table 2.10 Fungal strains used in this study 
Strain Name Pertinent Genotype Source 
A. flavus CA14 pyrG-, ptrA-, niaD-, ku70- USDA, New Orleans 
A. flavus CA14 pyrG-1 ptrA-, niaD-, ku70- USDA, New Orleans 
A. flavus ∆afvA ∆afvA::pyrG, ptrA-, niaD-, ku70- USDA, New Orleans 
A. flavus ∆afvB ∆afvB::pyrG, ptrA-, niaD-, ku70- USDA, New Orleans 
A. flavus ∆afvC ∆afvC::pyrG, ptrA-, niaD-, ku70- USDA, New Orleans 
A. flavus ∆afvD ∆afvD::pyrG, ptrA-, niaD-, ku70- USDA, New Orleans 
A. flavus ∆afvE ∆afvE ::pyrG, ptrA-, niaD-, ku70- USDA, New Orleans 
 
2.3.2.2 Generation of the deletion strains (done at USDA, New Orleans) 
 
The A. flavus wild-type and mutant strains were mainly prepared at the Food and Feed 
Safety Research Unit, USDA/ARS (Southern Regional Research Center, New Orleans, 
LA 70124, USA). The cluster includes five genes encoding a putative NADH oxidase 
(AFLA_108540, afvA), a PKS (AFLA_108550, afvB), an O-methyltransferase 
(AFLA_108560, afvC), a hypothetical protein (AFLA_108570, afvD) and a 
cytochrome P450 monooxygenase (AFLA_108580, afvE). The possible conservation 
of this gene cluster in other species of the genus Aspergillus was examined. Cluster 39 
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genes were used as a query against other genome databases of 
phylogenetically-related species using BLAST (blastp) analysis. Sequence 
information was obtained from the Aspergillus comparative database 
(http://www.broadinstitute.org/annotation/genome/aspergillus_group) and from the 
National Center for Biotechnology Information [NCBI] (http://blast.ncbi.nlm.nih.gov). 
Gene entry with the highest bit score and the lowest e-value for each one of the 
species, including A. oryzae, A. nidulans, A. niger, A. terreus, A. fumigatus, A. 
fischerium and A. clavatus were selected and their locations on the chromosome were 
mapped. 
A ΔafvB::pyrG knockout plasmid, in which a 1.1 kb region within the beta-ketoacyl 
synthase N-terminaldomain of the afvB coding region was replaced by the A. 
parasiticus pyrG selectable marker gene, was generated as described in Cary et al., 
2014 51. Transformation was performed as previously described 52 using A. flavus 
CA14 as the host. Conidia were inoculated in potato dextrose broth supplemented 
with 1 mg/mL uracil (PDB-U) and transformants were regenerated on Czapek 
Solution Agar (CZ; Difco, Leeuwarden, The Netherlands) supplemented with 10 mM 
ammonium sulfate (CZ-AS). Additional knockout mutants of putative cluster 39 
biosynthetic genes (i.e. afvA, afcC-E) were generated using the fusion PCR technique 
as described previously 53. Cluster 39 gene fragments were amplified using Platinum 
Pfx DNA Polymerase (Invitrogen), and A. flavus CA14 genomic DNA and pPG2.8, 
containing the A. parasiticus pyrG selectable marker, as templates. PCR primers used 
in this study are shown in Table 2.11. 
 
Chapter 2 Targeted and Untargeted Analysis of Fungal Secondary Metabolites by Liquid Chromatography-Mass 
Spectrometry 
113 
Table 2.11 Primers used in this study 
Primer Name  Sequence (5’-3’) 
PCRprimers for  
afvB knockout 
 
5’ afvBHindIII AAGCTTCTCTTGAGAGTTGGACAAGCATTGT 
5’ afvBSalI GATGTCGACATAGCCTGACTGCTCAAGAGC 
3’ afvBBamHI GGATCCATTTGTAGATCTTGCAAGCCTTG 
3’ afvBSacI GAGCTCAACCCAGACAGTCTTGGAATCCA 
afvB Up CATTATGAGAGTCGGCCAGATGAGTTCG 
afvB Down GCTAACGTATGCCAATTGCTTTCATCAG 
PCR primers for afvA 
and afvC-E knockouts 
 
afvA-5F CCGGACATGAACTAGGGCTG 
afvA-5R GCAATAAGCCCAACCCTATCGGCATAACTGCGCGAACCTCCTC 
afvA-3F ATTTGTACCGGAGTGTCTGAAGGGGACGGTTGCTCAGTCGATT 
afvA-3R ACTCTACGAGCACCTCACCA 
afvA-nestF TATTGCGGTGGTGGATGCTT 
afvA-nestR CGGAAGCCAAAGGGGAAGTT 
afvC-5F CGCAGTTTCTAGCCTTTGCA 
afvC-5R GCAATAAGCCCAACCCTATCGGCCCTCATCAATCGGGCTGGTT 
afvC-3F ATTTGTACCGGAGTGTCTGAAGGTACCTATCTGAGCGGCCAAC 
afvC-3R CTGTTTCCTGTCGTGGCTGT 
afvC-nestF GTGAGAGTGGTGACGAGTGG 
afvC-nestR TGAGGCTCGCAATAATCCCC 
afvD-5F CCGACCACATTCAACGGGTA 
afvD-5R GCAATAAGCCCAACCCTATCGGCGGCAAAGCGCTTGTCATGAA 
afvD-3F ATTTGTACCGGAGTGTCTGAAGGGGCCGTTCATCGTTACGTTG 
afvD-3R ATATCTTATCCGCCGCTGCC 
afvD-nestF TCTACCACCTCCCCGACATT 
afvD-nestR AATGCAGCCAGAGAAGTCCC 
afvE-5F TCGTGTAGGCGTGAACGAAA 
afvE-5R GCAATAAGCCCAACCCTATCGGCGATGCGAGGATAGCTGGTCC 
afvE-3F ATTTGTACCGGAGTGTCTGAAGGGGAGGAAGGCCCAATGTCT
C afvE-3R ATCTGTAAAGCCGACGCCAA 
afvE-nestF CTCTGGAGATGTGCCACCTG 
afvE-nestR AAGACGTCTTTCTGGCAGGG 
qRT-PCR primers  
afvAF TTGGTCCGGATTAGTGCCAC 
afvA R AATCGACTGAGCAACCGTCC 
afvBF CGACGTATACATATTGCATGGAAACC 
afvBR GTTGAAGGAAGTGCAGTTGAAGGTTC 
afvCF TCATGGACGGAGCCAACATC 
afvC R TTGTTGGCCGCTCAGATAGG 
afvDF GACGGTGAGAGGGATTATTTTAC 
afvD R GAATATTTAGTCCCGGTGAACCA 
afvEF CATCTGGGTCTGCACGCTTA 
afvER ACTTAGCACGGACAGAAGCC 
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2.3.2.3 Identification of the compound associated with A. flavus gene cluster 39 (done 
at Ghent University) 
 
2.3.2.3.1 Sample preparation 
 
The A. flavus CA14 pyrG-1 control and the ΔafvA-E mutant strains were point 
inoculated on Wickerham medium. The cultures were incubated for 8 days at 30 °C in 
the dark. Sclerotia were collected from these cultures and cleaned by rolling them on 
3% agar plates. Sclerotia were lyophilized, placed in a mortar and pestle and ground 
in 5 mL ethyl acetate/acetone (1/1, v/v)/formic acid (0.1%, v/v) with 0.5 g of sterile 
fine sand added to assist with breakage of sclerotia. The ground sclerotia-solvent 
mixture was kept at room temperature for 15 min then briefly ground again and kept 
at room temperature for another 15 min. The solution was collected in a 100 mL glass 
beaker and allowed to dry overnight at room temperature. The dried samples were 
dissolved in 0.5 mL of methanol/acetonitrile/water (30/30/40, v/v/v) and passed 
through a 0.22 μm filter before analysis. 
 
2.3.2.3.2 LC-Oribitrap MS analysis 
 
LC-MS analyses were performed on an Orbitrap Exactive TM mass analyzer (Thermo 
Fisher Scientific) coupled to an ultra-high performance liquid chromatography 
(UHPLC) system (Thermo Fisher Scientific). Chromatographic separation was 
achieved using a Zorbax RRHD Eclipse Plus reverse-phase C18 column (1.8 μm, 100 
mm x 2.1 mm ID) (Agilent) maintained at 30 °C. A gradient elution of solvent A 
(water/methanol, 95/5, v/v) and solvent B (water/methanol, 5/95, v/v), both 
containing 0.1% formic acid and 10 mM ammonium formate was applied as follows: 
0% solvent B from 0 to 0.5 min, 0 to 99% solvent B from 0.5 to 20 min, 99% solvent 
B from 20 to 21 min, 99 to 0% solvent B from 21 to 24 min, and re-equilibration with 
0% solvent B from 24 to 28 min. Five μL of sample was injected into the column. For 
a comprehensive metabolite profiling, both the electrospray ionization and 
atmospheric pressure chemical ionization ion sources were investigated in positive as 
well as in negative mode. ESI positive ion mass spectrometry (ESI+/MS) allowed 
differential detection of peaks in the control compared to the mutant. The ESI 
parameters were: spray voltage 4.5 kV, capillary temperature 250 °C, heater 
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temperature 250 °C, sheath gas flow rate 45 arbitrary units (a.u.), auxiliary gas flow 
rate 10 a.u. The instrument was operated in full scan mode with a resolution of 50,000 
FWHM (Full Width at Half Maximum) and an m/z scan range of 100–1200 was 
selected. The maximum injection time was 250 ms and the number of microscans per 
scan was 1. The automatic gain control target was set at 5 × 105 ions and the number 
of microscans per scan was 1. For atmosphericpressure chemical ionization, the 
parameters were as above except for: spray voltage 5 kV, capillary temperature 
325 °C and heater temperature 350 °C. The data were processed using the Xcalibur 
2.1 and Exactive Tune software (Thermo Fisher Scientific). 
 
2.3.2.3.3 LC-ion trap MS analysis 
 
HPLC-iontrap system (Thermo Fisher Scientific) was used for the fragmental analysis 
of the targeted analytes. The column used was a Symmetry C18 column (5 μm, 2.1 × 
150 mm), supplied by Waters (Milford, MA, USA). The mobile phase was as 
described under Chapter 2.2.2.3.2 LC-orbitrap MS analysis. The linear gradient 
elution program was: 0–10 min B = 0–100%, 10–11 min B = 100%, 11–12 min B = 
100–0%, and hold on for a further 4 min for re-equilibration, giving a total run time of 
16 min. The mass spectrometer was operated both in heated positive electrospray 
ionization mode (HESI+) and in heated negative electrospray ionization mode (HESI-) 
with the following settings: source voltage of 5 kV, capillary temperature of 250 °C; 
heater temperature of 175 °C; sheath gas flow rate of 45 a.u.; auxiliary gas flow rate 
of 10 a.u. The Xcalibur 2.0.7 software (Thermo Scientific) was used for instrument 
control, data acquisition and processing. 
 
2.3.3 Results 
 
Comparison of the metabolome of wild-type with that of ∆pks39 (∆AFLA_108550) 
mutant strain, using HR-orbitrap MS and multiple stage MS, indicated that gene 
cluster 39 in CA14 A. flavus is responsible for producing a series of bicoumarins (1-6) 
(Fig. 2.9 -2.12), which are putatively synthesized by dimerization of the monomeric 
coumarins. The major compound (1) of this series of differentially expressed 
metabolites (more abundant in the wild-type than in the ∆pks39 mutant strain) was 
shown to possess a molecular formula of C24H23O9 ([m+H+]/z = 455.1328; error= 
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-1.843 ppm). This exact mass and the corresponding elemental composition pointed to 
aflavarin, a bicoumarin metabolite previously reported in the sclerotial extracts of A. 
flavus 54. This assignment was further confirmed using an authentic sample of 
aflavarin. Mass spectral analysis demonstrated a perfect match between the metabolite 
1 and the standard solution of aflavarin in terms of exact mass, retention time and 
fragmentation data (Fig. 2.13). As is depicted in Fig. 2.10, aflavarin is eluting in four 
different retention times (12.19; 12.47; 12.74 and 14.14 min) due to the existence of 
many isomers. This isomeric diversity, including stereo- and atropoisomers, is a well 
known feature of dimeric compounds which are formed by a single C-C bridge, as is 
the case of bicoumarins 55.  
 
Figure 2.9 Structures of identified A. flavus gene cluster 39 metabolites 
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Figure 2.10 Extracted ion chromatogram of A. flavus gene cluster 39 metabolites: (A) aflavarin (1, 
m/z 455.1); (B) 2, m/z 453.1; (C) 3, m/z 441.1. 
 
 
 
 
Figure 2.11 Extracted ion chromatogram of A. flavus gene cluster 39 metabolites: (A) 4, m/z 
439.1); (B) 5, m/z 425.1; (C) 6, m/z 411.1. 
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Figure 2.12 Extracted ion chromatogram of A. flavus gene cluster 39 metabolites: (A) 7, m/z 
221.08; (B) 8, m/z 237.07; (C) 9, m/z 207.06; (D) 10, m/z 223.06. 
 
 
 
Figure 2.13 MSn spectra of the A) aflavarin standard, and B) metabolite 1 ([m+H+]/z = 455.1328), 
using LC-ion trap MS. 
 
Compound 2, with a [m+H+]/z of 453.1171 (C24H21O9; error= -2.005 ppm), has 
two hydrogens less as compared with aflavarin implying an extra double bond in its 
structure. Considering the structure of aflavarin, the only possibility for an additional 
double bond is by oxidation of the hydroxy-methyl group (-CH2OH) to an aldehyde 
(-CHO). 
The molecular formula of compound 3 was established as C23H21O9 ([m+H+]/z = 
441.1173; error= -1.516 ppm). The 14 Da difference compared to aflavarin is 
consistent with the lack of a methyl group. The structure of this metabolite was also 
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supported by analysis of the metabolomes of knock-out mutants for the tailoring 
genes AFLA_108570 (methyltransferase) and AFLA_108580 (cytochrome P450 
monooxygenase). 
Compound 4, has a molecular formula of C24H23O8 ([m+H+]/z = 439.1378; error= 
-2.059 ppm), indicating a 16 Da (an oxygen atom) less compared to aflavarin. Based 
on these observations, it became obvious that 4 is a dehydroxylated analogue of 
aflavarin.  
Compound 5 with a [m+H+]/z of 425.1221 (C23H21O8; error= -2.503 ppm) was 
shown to be a demethylated analogue of 4, whereas the metabolite 6 ([m+H+]/z = 
411.1066; C22H19O8, error= -2.053 ppm) proved to be a demethylated analogue of 5. 
In the extracts of CA14 A. flavus wild-type strains, we were able to detect trace 
amounts of coumarin monomers (7-10), which actually represent the biosynthetic 
precursors of the above mentioned bicoumarins. A more clear occurrence and 
accumulation (around 100 times more abundant than in wild-type) of these monomers 
can be seen in the knock-out mutant of cytochrome P450 monooxygenase 
(∆AFLA_108580) (Fig. 2.12). Metabolite 7, with chemical formula C12H13O4 
([m+H+]/z = 221.0807; error= -0.431 ppm) demonstrated to be the monomeric 
coumarin siderin whereas compound 8, with a molecular formula of C12H13O5 
([m+H+]/z = 237.0757; error= -0.090 ppm), proved to be a hydroxylated analogue of 
siderin. Monomer 9, having a molecular formula of C11H11O4 ([m+H+]/z = 207.0649; 
error= -0.305 ppm) was assigned as 7-O-demethyl siderin, whereas metabolite 10, 
with a chemical formula of C11H11O5 ([m+H+]/z = 223.0600; error= -0.070 ppm) 
appears to be the hydroxylated analogue of 9. Monomers 7 and 9 are already 
described in the literature as being important  precursors in the biosynthesis of 
several classes of bicoumarins 56. 
 
2.3.4 Discussion 
 
Cluster 39 is not only present in A. flavus, it is also semi-conserved in A. clavatus, and 
also in A. niger, where it is involved in the synthesis of kotanin 56. In the present study, 
we demonstrated that A. flavus gene cluster 39 is responsible for the production of 
aflavarin, based on HRMS and MSn analysis of extracts of a wild-type strain and its 
deletion mutant for the backbone gene, i.e. pks39 (AFLA_108550). Furthermore,   
we elucidated the biosynthetic pathway that leads to the production of aflavarin by the 
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generation and subsequent HRMS analysis of mutants with deletions of other genes in 
cluster 39 (Fig. 2.14). A large number of natural biaryl compounds have been 
extensively described in plants, fungi and bacteria 57,58. In particular fungi (genera 
Aspergillus and Emericella) have shown to be capable of producing a diverse class of 
bicoumarins, including C8-C8' linked, C6-C8' linked, C6-C6' linked and C3-C3' 
linked bicoumarins 59-61. All these metabolites share the C-C biaryl axis as a 
characteristic structural feature. Aflavarin and its structural derivatives identified in 
this study, as products of CA14 A. flavus gene cluster 39, belong to the C3-C8' linked 
regioisomeric subclass of bicoumarins. Up to the present, there is no evidence for 
existence of any other natural bicoumarin harboring the C3-C6' regioisomeric linkage.   
Previous reports in the biosynthesis of bicoumarins have shown that the main 
biosynthetic step in these dimeric metabolites is the process of dimerization of the 
polyketide monomers via an intermolecular oxidative phenol coupling reaction. All 
these examples of previously described C-C cross-linking bicoumarins have clearly 
demonstrated that the stereo- and regioselectivity during oxidative phenol coupling 
reactions is fundamentally controlled by cytochrome P450 enzymes 56,58.  
Iterative type I PKSs, generally represent a hallmark of fungal polyketide 
biosynthesis compared to bacterial PKSs 62. According to the presence or absence of 
β-keto processing domains, fungal PKSs are subdivided as non-reducing, partially 
reducing and highly reducing PKSs 63. Based on the fact that aflavarin has an 
unsaturated cyclic system, with no reduction step required in its formation, the 
backbone gene, PKS39 (AFLA_108550) can be firmly considered as a non-reducing 
polyketide synthase. 
Disruption of the PKS39 backbone gene led to complete loss in coumarin 
biosynthesis (see ∆pks39 in Fig. 2.10-2.12). HRMS analysis of extracts of mutant 
strains for the tailoring genes in the putative cluster of aflavarin allowed a model of 
biosynthetic pathway to be proposed (Fig. 2.14). Deletion of the O-methyltransferase 
gene (AFLA_108560) totally abolished the biosynthesis of coumarin (see 
∆AFLA_108560 in Fig. 2.10 -2.12). In a previous study 56, it was clearly demonstrated 
that the methoxy group at C4 position of the bicoumarin skeleton is a prerequisite of 
the oxidative phenol coupling reaction. This suggests that also in the case of aflavarin 
the O-methyltransferase is involved in the initial steps of O-methylation of the 
4,7-didesmethyl-siderin (I) which results in the subsequent formation of the 
monomers (9 and 7). 
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The disruption of the cytochrome P450 monooxygenase (AFLA_108580) also led 
to the breakdown of the bicoumarin biosynthesis (1-6) (see ∆AFLA_108580 in Fig. 
2.10, Fig. 2.11). As expected, the monomeric coumarins (7-10) accumulated (see 
∆AFLA_108580 in Fig. 2.12), in line with the concept that cytochrome P450 
monooxygenase is responsible for phenolic coupling reactions. 
On the other hand, the deletion of the methyltransferase gene (AFLA_108570) is 
associated with the accumulation of 3, 5 and 6 (see ∆AFLA_108570 in Fig. 2.11), 
which indicates that AFLA_108570 is responsible for converting these metabolites (3, 
5 and 6) into their corresponding O-methylated products, i.e. compounds 1, 4 and 5, 
respectively. These data suggest that AFLA_108570 (methyltransferase) is mainly 
responsible for the final O-methylation steps after the reactions of oxidative phenolic 
coupling. 
Deletion of the putative NADH oxidase gene (AFLA_108540), in general did not 
affect the total biosynthesis of bicoumarins, although the peak intensity of these 
metabolites was decreased (see ∆AFLA_108540 in Fig. 2.10 and Fig. 2.11). 
Interestingly, in extracts of this intermediate gene deletion mutant an accumulation of 
the monomeric coumarins 7 and 9 could be seen, while the hydroxylated monomers (8 
and 10) were hardly detectable (see ∆AFLA_108540 in Fig. 2.12). Hence, this 
suggests that the putative NADH oxidase is possibly catalyzing the hydroxylation of 
siderin (7) and 7-O-demethyl siderin (9) to their respective hydroxylated analogues, 8 
and 10. 
Regarding metabolite 2, we suggest that this compound is synthesized by further 
oxidation of aflavarin. Since none of the tailoring genes of the gene cluster 39 seems 
to be involved in this process, this biosynthetic step is possibly carried out by an 
oxidase encoded elsewhere in the genome outside gene cluster 39. 
Hence, based on the results we got from knock-out mutants for the backbone genes 
as well as for the tailoring genes, a model for the biosynthetic pathway of aflavarin is 
established as shown in Fig 2.14. Pks 39 catalyzes four repetitive Claisen 
condensations to synthesize the pentaketidic precursor I (4, 7-didesmethyl-siderin), 
which is then O-methylated by the O-methyltransferase AFLA_108560 to give 9. 
Compound 7 is in turn O-methylated by the same enzyme to yield 7. Afterwards, 
these monomers are hydroxylated to produce 8 and 10 (from 7 and 9, respectively), 
possibly by the activity of the putative NADH oxidase. From this point, aflavarin can 
be synthesized through two different paths, by a direct oxidative phenol coupling of 
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the monomers 7 and 8, or indirectly through formation of the metabolite 3 (by 
oxidative phenolic coupling of 7 and 10), which is then O-methylated to give 1. The 
oxidative phenol coupling reactions of this biosynthetic network are catalyzed by 
cytochrome P450 monooxygenase. The other bicoumarins identified in this cluster are 
biosynthesized in the same way as aflavarin.    
 
Figure 2.14 Proposed biosynthetic pathway of aflavarin and its structural analogues; 
AFLA_108540 (putative NADH oxidase); AFLA_108560 (ortho-methyltransferase); 
AFLA_108570 (methyltransferase); AFLA_108580 (cytochrome P450 monooxygenase). 
 
2.3.5 Conclusions 
 
Fungal metabolomics research has recently received much attention mainly for studies 
in A. flavus. The products of many potential metabolite biosynthetic gene clusters are 
still unknown. In the present study, a metabolomics analysis was performed to 
investigate a previously uncharacterized A. flavus gene cluster, namely cluster 39. The 
results showed that this cluster is responsible for the production of aflavarin, a 
compound known for its anti-insectant activity. These findings are an important 
contribution to the elucidation of the regulatory pathways controlling secondary 
metabolism and its role in fungal biology. A better understanding of the conditions 
under which secondary metabolites are formed will assist in the implementation of 
control strategies to reduce the negative effects of fungi as well as to promoting their 
positive impact. 
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3.1 IN VIVO KINETICS AND DISTRIBUTION OF 
CO-OCCURRING AFLATOXIN B1 AND T-2 TOXIN IN RAT 
 
After targeted analysis (Chapter 2.1 and Chapter 2.2) and untargeted analysis (Chapter 
2.3 and Chapter 2.4) of the secondary metabolites of Aspergillus and Fusarium fungi, 
the toxicology of some typical metabolites was further investigated. As discussed in 
Chapter 1.3, AFB1 and T-2 are co-occurring mycotoxins produced by Aspergillus and 
Fusarium fungi frequently found in various food and feed samples. Therefore, the in 
vivo kinetics and distributions of these mycotoxins were investigated in rat. The 
results obtained here are helpful to predict the toxicokinetics and toxicity of 
co-occurring AFB1 and T-2 in animals and humans. 
 
 
Redrafted from: 
Zheng Han, Zhiyong Zhao, Suquan Song, Gang Liu, Jianxin Shi, Jingbo Zhang, Yucai 
Liao, Dabing Zhang, Yongjiang Wu, Sarah De Saeger and Aibo Wu. 
Establishment of an isotope dilution LC-MS/MS method revealing kinetics and 
distribution of co-occurring mycotoxins in rat. Analytical Methods, 2012, 4, 
3708-3717.  
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3.1.1 Introduction 
 
AFB1 and T-2, are produced by Aspergillus and Fusarium species, respectively, 
leading to critical adverse effects to animals and humans (See Chapter 1.1.1 and 
1.1.3). Animals and humans can be co-exposed to AFB1 and T-2. First, the same food 
can be infected or invaded by different mycotoxigenic moulds resulting in the 
co-occurrence of AFB1 and T-2 even at high concentrations in many geographic 
locations under optimum environmental conditions 1-3. Second, co-occurring 
mycotoxins can reach humans through the various diets and also, through milk, meat 
and eggs from livestock and poultry fed with mycotoxin contaminated feedstuffs 4,5. 
The toxic effects might be antagonistic, additive, or synergistic on different occasions. 
Nevertheless, knowledge regarding the influence of co-occurring AFB1 and T-2 on 
kinetics and distribution is still unknown to date, where the main technical obstacle is 
the scarcity of simple, accurate and highly sensitive means capable of quantifying 
target mycotoxins from complicated biological samples.  
Various methods including radioactivity, TLC and HPLC coupled to different 
detectors have been employed to individually analyze single mycotoxin of either 
AFB1 or T-2 in biological fluids and tissues (Chapter 1.3.1). Hitherto, no uniform 
method with sufficient simplicity, relative rapidity and high sensitivity has been 
reported, which could be applicable for simultaneous determination of AFB1 and T-2 
in different biomatrices i.e., plasma, heart, liver, spleen, lung, kidney and brain.  
In the present study, a simple and sensitive LC-MS/MS method based on a 
combination of isotope dilution and fast sample preparation using homemade clean-up 
cartridges was developed and then validated for simultaneous quantification of 
co-occurring AFB1 and T-2 in rat plasma, heart, liver, spleen, lung, kidney and brain. 
The utmost advantage of this proposed analytical method is that identical conditions 
can be utilized for analyzing AFB1 and T-2 in all the above mentioned biomatrices. 
Furthermore, the small amount of sample needed, the low volume of solvents used 
and the fact that IAC are not required for this assay, make it more rapid, economical 
and practical for analyses of AFB1 and T-2. This method was then successfully 
applied to the kinetics and tissue distribution studies after oral administration of 
co-occurring AFB1 and T-2 in the rat, demonstrating its potential for toxicological or 
toxicokinetic studies. 
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3.1.2 Materials and methods 
 
3.1.2.1 Chemicals and reagents 
 
The standards of AFB1 (molecular weight (MW), 312), T-2 (MW, 467) and their 
internal standards (ISs) [13C17]-AFB1 (MW, 329), [13C24]-T-2 (MW, 491) were 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile and methanol, 
purchased from Merck (Darmstadt, Germany), were both HPLC grade. Milli-Q 
quality water (Millipore, Billerica, MA, USA) was used throughout the analysis. All 
other reagents were of analytical grade.  
Silica gel (Product No. 236799), active carbon (Product No. C3345), alumina 
neutral (Product No. 199974), alumina base (Product No. 199443), florisil (Product 
No. 220736) and kieselguhr (Product No. D3877) were all purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Polypropylene SPE empty tubes (3 mL) and 
frits were from Shenzhen Biocomma Biotech CO, LTD (Shenzhen, China). High 
quality poly (9, 9-diethylfluorene) (PDEF) syringe filters (0.22 µm pore size, 13 mm 
diameter) were supplied by Millipore. 
 
3.1.2.2 Apparatus 
 
LC-MS/MS (TSQ QUANTUM ULTRA, Thermo Scientific, Brookfield, USA) using 
selected reaction monitoring (SRM) mode was used for AFB1 and T-2 analyses in 
different biomatrices. Separation was performed on a Thermo Hypersil Gold column 
(100 mm×2.1 mm, 3.0 µm) at 35 °C, with a mobile phase flow rate of 0.35 mL/min. 
Water (containing 0.25 mmol/L ammonium acetate and 0.05% formic acid) (A) and 
methanol (containing 0.25 mmol/L ammonium acetate and 0.05% formic acid) (B) 
were used as the mobile phase. A linear gradient elution program was applied as 
follows: initial 30% B, 3 min 100% B, 3.8 min 100% B, 4 min 30% B, and hold on 
for a further 3 min for re-equilibration, giving a total run time of 7 min. The injection 
volume was 5.0 μL (full loop). The mass spectrometer was operated in ESI+. The 
following settings were used for MS/MS conditions: spray voltage, 4 kV; vaporizer 
temperature, 300 °C; sheath gas pressure, 30 psi; aux valve flow, 30 arb; capillary 
temperature, 350 °C. Data were acquired and processed by Xcalibur software 
(Thermo Scientific, Brookfield, USA). 
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3.1.2.3 Standard solutions 
 
Accurately weighed solid portions (1.0 mg) of AFB1 and T-2 were dissolved in 2 mL 
of pure ethanol, and the solution was diluted with water to prepare a mixture of AFB1 
and T-2 at a concentration of 0.1 mg/mL in 20% of ethanol aqueous solution, which 
was used for the oral administration of rats.  
For LC-MS/MS analysis, solid portions of AFB1 and T-2 were individually 
dissolved in acetonitrile to prepare 0.1 mg/mL of stock solution, and stored at -20 ◦C 
under darkness. The stock solution was diluted step by step with a mixture of 
acetonitrile and water containing 10 mmol/L ammonium acetate (20/80, v/v) to 
prepare work solutions. The stock solutions of the two ISs ([13C17]-AFB1 and 
[13C24]-T-2) were directly used as the purchased product and diluted with the same 
mixed solution to 50 ng/mL. All work solutions were prepared immediately before 
use. 
 
3.1.2.4 Animals 
 
Male Sprague–Dawley (SD) rats, weighing 200±20 g, were purchased from Fudan 
University Laboratory Animal Center (Shanghai, China). The study was approved by 
the Animal Ethics Committee of Shanghai Academy of Agricultural Sciences. 
On the day of arrival, the animals were randomly distributed to polycarbonate 
cages with stainless steel covers for one week to allow acclimatization to the 
environmental conditions: 12 h day/night cycle, temperature 25±2 °C, standard diet 
and water. 
For the kinetics studies in plasma, six rats were fastened and administrated one 
single dose of 0.5 mg/kg b.w. AFB1 and T-2 by gavage with a volume of about 1 mL 
of ethanol aqueous solution (pure ethanol/water, 20/80, v/v, 0.1 mg/mL) depending on 
the weight of the rat itself. Blood samples (300 µL) were collected via the caudal vein 
catheter prior to dosage (0 min) and at 0.083, 0.167, 0.5, 1.0, 1.5, 2.0, 2.5, 5, 7.5, 10.0, 
12.0 and 24.0 h thereafter with minor modifications according to previous protocols 6. 
The blood samples were immediately transferred to heparinized tubes and centrifuged 
at 4000 g for 5 min. All plasma samples were pipetted and stored at -20 °C until 
analysis. 
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For the tissue distribution studies, fifty four rats were randomly divided into nine 
groups (n=6) and administrated an oral dose of 0.5 mg/kg b.w. AFB1 and T-2 by 
gavage. After euthanizing by cervical dislocation prior to dosage (0 h) and at 0.5, 1, 2, 
4, 12, 24, 48 and 72 h thereafter, the tissues of heart, liver, spleen, lung, kidney and 
brain were excised and blot dried. In order to minimize the differences generated from 
various cell types in the organs and to take a representative sample, the whole tissues 
were individually homogenized with normal saline (m/v, 1/3), and the homogenates 
were stored at −20 ◦C until analysis. 
For investigation of tissue accumulation, six rats received a daily administration of 
0.25 mg/kg b.w. AFB1 and T-2 by oral gavages during 20 days, while another six rats 
were administrated with normal saline as control. The animals were euthanized 24 h 
after the last administration, and the tissues were dealt with as described above. 
 
3.1.2.5 Preparation of homemade clean-up cartridges 
 
Silica gel (0.09 g) was accurately weighed into a 3 mL hollow SPE cartridge and was 
shaken to compact the silica gel. Then, 0.01 g of florisil was added. After shaking, 
florisil was then covered by a frit at the end to ensure the upper surface being smooth 
and flat. 
 
3.1.2.6 Sample pretreatment 
 
To the plasma/tissue homogenates (100 μL), 10 μL of IS solution (50 ng/mL) was 
added, followed by the addition of 700 μL of acetone for precipitation of proteins. 
The mixture was vortex-mixed for 1 min and transferred into SPE cartridges. The 
cartridges were eluted with 3 mL of methanol. The collected eluent was evaporated to 
dryness by a gentle stream of nitrogen gas at 40 °C. The residue was reconstituted in 
100 μL mixture of acetonitrile and water containing 10 mmol/L ammonium acetate 
(20/80, v/v), passed through the PDEF syringe filters and was ready for injection. 
Samples with concentrations out of the linear range were appropriately diluted with 
blank plasma/tissue homogenates and 100 μL of the dilution was selected and 
processed as described above. 
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3.1.2.7 Method validation 
 
The method was thoroughly validated on a serial of characteristics of specificity, 
linearity, sensitivity, extraction recovery, accuracy and precision. Matrix effects as 
well as the stability of AFB1 and T-2 in plasma and tissue homogenates were also 
determined. 
Specificity was demonstrated by comparing chromatograms of blank plasma/tissue 
homogenates, plasma/tissue homogenates spiked with AFB1 and T-2, and 
plasma/tissue homogenates collected after the oral administration.  
Calibration curves of seven data points were plotted in the range of 0.05–100 
ng/mL in solvent, plasma, heart, liver, spleen, lung, kidney and brain, respectively, 
and 5 ng/mL of each IS was included in each solvent. The sensitivity was evaluated 
by determining the lower limit of detection (LLOD) and lower limit of quantification 
(LLOQ). The LLOD and LLOQ were defined as the concentrations of AFB1 and T-2 
that yielded S/N =3 and =10, which were both determined by decreasing the spike 
concentrations in various biomatrices, respectively. 
Extraction recovery was assessed using a generic SPE extraction procedure with 
four spiking levels (0.05, 1, 10 and 100 ng/mL). Recovery data were determined by 
comparing the peak areas (n = 6, each concentration) of AFB1 and T-2 obtained from 
plasma/tissue homogenates spiked before extraction with that from plasma/tissue 
homogenates spiked after extraction. Matrix effects were assessed by comparing the 
slope of the standard addition plot with the slope of the standard calibration plot with 
a concentration range of 0.05–100 ng/mL. 
Accuracy was evaluated in the blank plasma and tissue homogenates employing the 
method of standard addition. The homogenized samples were spiked with LLOQ, low, 
intermediate and high levels of AFB1 and T-2 (0.05, 1, 10 and 100 ng/mL) in 
sextuplicate (n=6). The spiked samples were pretreated and analyzed by the 
established LC-MS/MS method. Accuracy was expressed as the percentage of mean 
calculated concentrations vs actual concentrations. Precision was evaluated by 
determining the same spiked samples in one day (intra-day precision) and in four 
consecutive days (inter-day precision) in sextuplicate (n=6).  
The stability of AFB1 and T-2 in plasma and tissue homogenates was investigated 
by analyzing extracted samples at two spiked levels of 1 and 10 ng/mLstored at room 
temperature for 8 h, at –20 °C for two weeks and three successive freeze–thaw cycles. 
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Stability was assessed by comparing the mean concentrations of AFB1 and T-2 in the 
stored samples with those of the freshly prepared ones.  
 
3.1.2.8 Data analysis 
 
All kinetic parameters were processed by Drug and statistics (DAS) software, version 
2.0 (Shanghai, China). The parameters including peak concentration (Cmax), t1/2, time 
of maximum plasma concentration (Tmax), area under the curve (AUC0–t), area under 
the curve from zero to infinity (AUC0–∞), total body clearance (CLz/F), apparent 
volume of distribution (Vz/F), mean residence time (MRT0–t) and mean residence time 
from zero to infinity (MRT0–∞) were calculated. Data for all response variables were 
reported as mean±SD. A significance level (α) of 0.05 was selected. 
 
3.1.3 Results and discussion 
 
3.1.3.1 Optimization of the LC-MS/MS conditions 
 
The MS/MS conditions were firstly optimized for AFB1 or T-2 by individual 
injection of each standard solution (500 ng/mL). Identification of precursor ions was 
performed in the full scan mode by recording m/z from 100 to 800 in both ESI+ and 
ESI-. The results showed that the responses of [M+H]+ ions generated from AFB1 and 
[13C17]-AFB1 under ESI+ were obviously higher than their [M-H]- ions generated 
under ESI-. Then, 313.2 (m/z) and 330.2 (m/z) were selected as the precursor ions for 
AFB1 and [13C17]-AFB1, respectively. For T-2 and [13C24]-T-2, the responses of the 
[M+Na]+ ions generated under ESI+ were significantly higher than those of the other 
ions, i.e., [M+H]+, [M+NH4]+ and [M-H]-, generated under ESI+ or ESI-. As a 
consequence, 489.7 (m/z) and 513.7 (m/z) were selected as the precursors for T-2 and 
[13C24]-T-2, respectively. Based on the confirmation of precursor ions, two product 
ions for each precursor ion were selected according to the optimal selectivity and 
highest sensitivity for the target compounds. Collision energies were selected 
according to the responses of the product ions.The final selection of precursor ions, 
product ions and collision energies is shown in Table 3.1. 
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Table 3.1 Precursor ions, product ions and collision energiesfor the analytes. 
Names 
Precursor 
ion(m/z) 
Primary 
product ion 
(m/z) 
Collision 
energy(eV) 
Secondary 
product ion 
(m/z) 
Collision 
energy(eV) 
AFB1 313.2 (+H+) 285.1 24 241.2 32 
[13C17]-AFB1 330.2 (+H+) 301.0 20 251.9 30 
T-2 489.7 (+Na+) 387.3 23 245.2 26 
[13C24]- T-2 513.7 (+Na+) 406.4 22 344.3 24 
 
A mixture of methanol and water was used as the mobile phase for separation of 
AFB1 and T-2. After optimization, a satisfactory separation for AFB1 and T-2 was 
generated by linear gradient elution. In order to achieve high sensitivity of analysis, 
the ionization efficiency was investigated by further optimization of the composition 
of the mobile phase. Since ESI+ was employed in the present study, acidic conditions 
would be beneficial to the ionization of the analytes. Therefore, water containing 0.05% 
formic acid, water containing 10 mmol/L ammonium acetate, water containing 10 
mmol/L ammonium formate, and water containing 0.25 mmol/L ammonium acetate 
and 0.05% formic acid were compared. Results of multiple injections indicated that 
the responses of AFB1 and T-2 were substantially improved and higher sensitivity 
was subsequently obtained when 0.05% formic acid and 0.25 mmol/L ammonium 
acetate were added compared to other additives. Under such situation, nice peak 
shapes and satisfactory separation efficiency were also achieved. 
 
3.1.3.2 Development of the homemade clean-up cartridges 
 
In general, matrix effects are directly related to an insufficient sample clean-up and 
might be reduced by simply injecting smaller volumes or diluting the sample, which 
seriously influence the sensitivity of the method, and therefore inappropriate in the 
present study. In literature, IAC columns, Multisep multifunctional cartridges and 
Mycosep multifunctional cartridges are frequently used for mycotoxin purification 7,8. 
However, no commercially available cartridges were reported with acceptable 
capability for simultaneous determination of AFB1 and T-2 in plasma and different 
tissue homogenates. 
In the present study, six commercially available normal-phase materials, which 
were commonly used for purification of the analytes in the previous studies, i.e., silica 
gel, active carbon, alumina neutral, alumina base, florisil and kieselguhr, were tested 
for their purification efficiencies. First, the recovery performance of all candidates 
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was evaluated by purifying mixed standard solutions (1.5 ng/mL) with the cartridges 
filled with one single material (0.1 g). The mixed solutions (100 μL) were passed 
through the cartridges and eluted with 3 mL of methanol. The eluent was collected 
and dried by nitrogen gas at 40 °C. The residues were re-dissolved in 100 μL of 
mixed solution of acetonitrile and water containing 10 mmol/L ammonium acetate 
(20/80, v/v). As indicated in Fig. 3.1, silica gel and florisil showed satisfactory 
recoveries (>80%). An orthogonal design L9 (34) was conducted to optimize the ratio 
of silica gel to florisil, quantity of total materials and quantity of the elution solvent. 
The factors and levels were designed as shown in Table 3.2. The mixed solution was 
purified by the homemade clean-up cartridges prepared according to the orthogonal 
table. The combinations of levels and factors were optimized by screening of nine 
treatments and each treatment was done in triplicate. Statistical analysis was 
performed using Student’s t-test and one-way analysis of variance. Multiple 
comparisons of means were separated at P<0.05 by the least significance difference 
(LSD, a=0.05) test. All computations were made by employing the statistical software 
(SAS, version 8.2). As shown in Table 3.2, all of the three factors had significant 
effects on AFB1 and T-2 purification since the F values were all greater than the 
critical F value (19, P=0.05). The total content of AFB1 and T-2 was highest when the 
ratio of silica gel to florisil was selected as 9/1, quantity of total materials was 0.1 g 
and quantity of the elution solvent was 3 mL. Consequently, a simple sample 
purification approach based on the homemade clean-up cartridges was developed. 
Afterwards, spiked plasma and different tissue homogenates were further tested. It 
could be obviously seen from the results that the sensitivities were significantly 
improved for AFB1 and T-2 when the spiked extracts were purified with homemade 
mixed cartridges. On the other hand, some impurities, i.e., pigment and protein, which 
could reduce the lifetime of the analytical columns, were eliminated by the SPE 
cartridges. Satisfactory purification efficiencies evaluated by determining the matrix 
effects and the presence of interference peaks, and high recoveries were generated, 
supporting the strong ability of the homemade clean-up cartridges for the purification 
of co-occurring AFB1 and T-2 in different biomatrices. 
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Table 3.2 Factors, levels and results of the orthogonal experiment L9 (34) for optimization of the 
clean-up procedure. 
Levels 
Factors 
1 
Ratio 
(silica gel/ florisil) 
2 
Quantity of total 
materials 
(mg) 
3 
Quantity of elution 
solvent 
(mL) 
4 
Blank 
 
1 9/1 0.1 1 -a) 
2 7/3 0.3 2 - 
3 5/5 0.5 3 - 
 
Run 1 2 3 4 
Total contents 
(ng/mL) 
1 1 1 1 - 2.269 
2 1 2 2 - 2.077 
3 1 3 3 - 2.466 
4 2 1 2 - 2.262 
5 2 2 3 - 2.066 
6 2 3 1 - 1.267 
7 3 1 3 - 2.518 
8 3 2 1 - 1.318 
9 3 3 2 - 1.822 
1  
(ng/mL) 
2.271 2.350 1.618 2.052 - 
2 
(ng/mL) 
1.865 1.820 2.054 1.954 - 
3 
(ng/mL) 
1.886 1.852 2.350 2.015 - 
Range 0.406 0.530 0.732 0.098 - 
 
Factors Sum of SSE2 
Degree of 
freedom 
F  
Critical Value 
of F  
Significance 
Ratio 0.313 2 20.867 19.000 * 
Quantity of 
total materials 
0.529 2 35.267 19.000 * 
Quantity of 
elution 
solvent 
0.813 2 54.200 19.000 * 
Error 0.01 2    
a) – = not applicable 

X

X

X
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Figure 3.1 Comparison of the recovery performance of all candidate adsorbent materials by 
purifying mixed standard solutions (1.5 ng/mL) with the SPE cartridges filled with one kind of 
material. 
 
3.1.3.3 Method validation 
 
The method was selective for plasma and six different tissue homogenates since no 
interference peaks appeared at the retention time of AFB1 or T-2 in blank samples, 
also indicating that no AFB1 or T-2 was present in the regular rat feed. 
Chromatograms of blank plasma (a) and liver (d), blank plasma (b) and liver (e) 
spiked with AFB1 and T-2 (50 ng/mL), and rat plasma (c) and liver samples (f) at 0.5 
h after oral administration of AFB1 and T-2 in rat are shown in Fig. 3.2.  
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Figure 3.2 SRM chromatograms of blank plasma (a) and liver (d), blank plasma (b) and liver (e) 
spiked with AFB1 and T-2 (50 ng/mL), respectively, and rat plasma (c) and liver samples (f) at 0.5 
h after oral administration of AFB1 and T-2 in rat 
 
 
Table 3.3 Calibration curves of AFB1 and T-2 in liquid solvent and seven different matrices. 
Mycotoxin Matrices Slope Intercept R2              
Lack of fit 
 (p value) 
Range 
(ng/mL) 
Sensitivity 
(ng/mL or 
ng/ga) 
LLOD LLOQ 
AFB1 
Solvent 1.12 0.36 0.9997 0.618 0.05-100 0.01 0.05 
Plasma 1.14 0.07 0.9991 0.312 0.05-100 0.01 0.05 
Heart 1.20 0.09 0.9999 0.175 0.05-100 0.01 0.05 
Liver 1.21 0.40 0.9999 0.081 0.05-100 0.01 0.05 
Spleen 1.10 0.27 0.9997 0.143 0.05-100 0.01 0.05 
Lung 1.22 0.14 0.9995 0.074 0.05-100 0.01 0.05 
Kidney 1.21 1.44 0.9990 0.241 0.05-100 0.01 0.05 
Brain 1.01 0.89 0.9993 0.103 0.05-100 0.01 0.05 
         
T-2 toxin 
Solvent 0.022 0.009 0.9999 0.421 0.05-500 0.01 0.05 
Plasma 0.022 0.034 0.9990 0.257 0.05-500 0.01 0.05 
Heart 0.020 0.007 0.9999 0.539 0.05-500 0.01 0.05 
Liver 0.022 0.002 0.9998 0.102 0.05-500 0.01 0.05 
Spleen 0.020 0.012 0.9998 0.304 0.05-500 0.01 0.05 
Lung 0.021 0.009 0.9996 0.218 0.05-500 0.01 0.05 
Kidney 0.020 0.004 0.9998 0.091 0.05-500 0.01 0.05 
Brain 0.020 0.032 0.9993 0.331 0.05-500 0.01 0.05 
a ng/mL and ng/g refer to the LLOD and LLOQ values of AFB1 and T-2 in plasma and tissues, 
respectively. 
 
The calibration curves for liquid solvent and all biomatrices constructed by isotope 
dilution method showed good linearity (R2> 0.9990) over the concentration range of 
0.05-100 ng/mL (Table 3.3). Since the linear range exceeded 100, a lack of fit test 
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was also performed to assess the adequacy of the linear model. As shown in Table 3.3, 
all p values were higher than 0.05 verifying the reliability of the chosen calibration 
range for the quantification of AFB1 and T-2 in different matrices. For both 
mycotoxins in plasma and tissue homogenates, the LLOD and LLOQ were 0.01and 
0.05 ng/mL, respectively (Table 3.3), which were desirable and obviously lower than 
those obtained in literature via UHPLC-FLD approaches 5.  
The observed matrix effects without ISs correction ranged from 73.0% to 105.8% 
for AFB1 and from 74.9% to 88.6% for T-2, suggesting that matrix effects in 
quantitative analysis could not be ignored. In order to establish an accurate method 
suitable for determination of co-occurring AFB1 and T-2 in different matrices, ISs 
were needed to correct the recovery losses during the ionization process. 
[13C17]-AFB1 and [13C24]-T-2 were selected, and the matrix effects were then 
calculated. The results showed that the extents of SSE were in the range of 90.2-108.9% 
for AFB1 and 90.9-100.0% for T-2, respectively, demonstrating that SSE could be 
reduced by the two ISs (Table 3.4).  
 
Table 3.4 The extents of signal suppression/enhancements (SSEs) calculated using the isotope ISs 
or not (%, n=3). 
Matrices 
With ISs Without ISs 
AFB1 T-2 AFB1 T-2 
Plasma 101.8±5.1 100.0±4.5 85.1±3.2 87.8±3.4 
Heart 107.1±6.7 90.9±3.6 73.0±4.1 75.1±7.2 
Liver 108.0±2.4 100.0±7.8 100.9±10.1 88.6±5.6 
Spleen 98.2±4.3 90.9±4.3 105.8±3.2 80.9±6.4 
Lung 108.9±3.2 95.5±5.6 99.4±2.9 82.7±2.9 
Kidney 108.0±5.6 90.9±6.7 85.2±3.5 81.5±7.1 
Brain 90.2±6.8 90.9±8.4 94.4±6.1 74.9±4.6 
 
The extraction recoveries of AFB1 and T-2 at LLOQ, low, intermediate and high 
concentrations (0.05, 1, 10 and 100 ng/mL) were in the range of 51.6-111.3% for 
AFB1 and 68.9-103.8% for T-2, respectively (Table 3.5). In order to minimize the 
losses of AFB1 and T-2 during the extraction process, the isotope ISs were utilized. 
As a consequence, desirable accuracy of the method ranged from 70.9 % to 107.7% 
for AFB1 and from 72.4% to 108.3% for T-2 (Table 3.5). Values for the precision 
were no more than 12.3% (intra-day) and 13.4% (inter-day) for AFB1, and 11.6% 
(intra-day) and 14.2% (inter-day) for T-2, respectively (Table 3.6). 
The stability of AFB1 and T-2 in rat plasma and tissue homogenates was fully 
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evaluated. As summarized in Table 3.7, the results of short-term, freeze–thaw and 
long-term stabilities showed that all the samples were stable under these conditions, 
indicating there were no stability-related problems during the routine and large-scale 
analysis of samples. 
 
Table 3.5 Recovery tests for AFB1 and T-2 in different matrices (n=6). 
Matrices Spiked level 
AFB1 T-2 
Accuracy 
(Mean±SD %) 
Extraction  
recovery 
(Mean±SD %) 
Accuracy 
(Mean±SD %) 
Extraction  
recovery 
(Mean±SD %) 
Plasma 
High level a 102.3±7.3 56.2±3.4 95.2±4.1 71.7±3.4 
Intermediate level b 107.1±5.1 56.9±4.3 95.6±3.3 69.3±3.2 
Low level c 97.5±3.1 59.1±5.1 94.3±4.0 74.1±4.5 
LLOQd 101.3±6.5 64.9±3.1 96.4±8.3 78.0±3.1 
Heart 
High level 98.2±4.2 79.3±4.8 84.6±4.6 77.5±2.9 
Intermediate level 95.5±6.2 69.2±3.2 83.7±1.9 70.3±5.6 
Low level 82.5±2.0 80.1±3.9 84.1±3.9 68.9±6.7 
LLOQ 90.7±11.2 82.1±5.6 88.7±7.0 73.4±3.6 
Liver 
High level 84.7±3.3 60.0±4.8 89.3±6.3 88.9±3.8 
Intermediate level 93.0±2.0 55.7±4.4 92.5±6.0 83.7±3.4 
Low level 101.9±6.6 59.9±4.1 90.8±6.5 96.8±5.6 
LLOQ 97.1±7.1 56.0±3.9 89.8±8.0 92.2±6.7 
Spleen 
High level 90.1±2.7 60.7±5.7 85.8±6.3 82.0±6.9 
Intermediate level 102.9±2.2 57.4±3.1 91.3±5.1 82.4±4.5 
Low level 100.1±4.1 57.0±1.9 96.8±8.4 93.0±4.8 
LLOQ 93.9±4.3 51.6±2.8 90.3±7.6 80.5±7.4 
Lung 
High level 91.3±6.4 54.4±3.2 92.0±2.9 84.2±6.1 
Intermediate level 98.7±4.7 52.5±3.3 108.3±7.8 91.9±5.5 
Low level 98.6±6.8 55.5±4.9 92.2±8.2 90.3±5.2 
LLOQ 100.9±5.0 54.8±2.0 84.2±3.9 84.9±5.4 
Kidney 
High level 95.9±2.0 61.2±1.1 101.8±8.8 86.7±5.5 
Intermediate level 107.7±7.0 64.1±2.3 83.3±6.2 80.4±6.7 
Low level 94.2±8.2 58.8±4.5 103.8±9.8 98.3±3.4 
LLOQ 86.5±8.8 55.0±3.2 98.2±11.6 98.0±4.3 
Brain 
High level 76.4±3.2 95.2±3.3 72.4±1.9 89.9±2.3 
Intermediate level 70.9±3.6 103.8±4.8 86.7±2.1 98.6±3.4 
Low level 89.9±5.8 111.3±5.4 85.9±3.2 103.8±5.7 
LLOQ 84.9±6.2 108.9±7.8 83.6±5.6 103.7±6.1 
a High level was designed as 100.0 ng/mL;  
b Intermediate level was designed as 10.0 ng/mL; 
c Low level was designed as 1.0 ng/mL; 
d LLOQ was designed as 0.05 ng/mL. 
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Table 3.6 The intra- and inter-day precision tests of AFB1 and T-2 in different matrices (n = 6). 
Matrices Spiked level 
AFB1 T-2 
Inter-day 
(RSDe %) 
Intra-day 
(RSD %) 
Inter-day 
(RSD %) 
Intra-day 
(RSD %) 
Plasma 
High level a 6.6 7.1 2.8 4.3 
Intermediate level b 3.0 4.8 3.9 3.5 
Low level c 7.2 3.2 6.5 4.2 
LLOQ d 8.4 6.4 10.2 8.6 
Heart 
High level 8.1 4.3 6.8 5.4 
Intermediate level 7.3 6.5 8.1 2.3 
Low level 5.1 2.4 7.9 4.6 
LLOQ 6.2 12.3 11.9 7.9 
Liver 
High level 3.2 3.9 2.1 7.1 
Intermediate level 4.9 2.1 7.3 6.5 
Low level 2.3 6.5 6.5 7.2 
LLOQ 5.6 7.3 8.6 8.9 
Spleen 
High level 2.1 3.0 3.1 7.3 
Intermediate level 6.5 2.1 8.7 5.6 
Low level 7.4 4.1 11.6 8.7 
LLOQ 8.6 4.6 14.2 8.4 
Lung 
High level 2.9 7.0 4.6 3.2 
Intermediate level 3.6 4.8 5.6 7.2 
Low level 4.5 6.9 7.2 8.9 
LLOQ 8.2 5.0 7.9 4.6 
Kidney 
High level 8.6 2.1 7.2 8.6 
Intermediate level 13.4 6.5 8.7 7.5 
Low level 10.9 8.7 9.1 9.4 
LLOQ 11.4 10.2 13.9 11.6 
Brain 
High level 4.3 4.2 4.9 1.9 
Intermediate level 6.5 5.1 2.3 2.1 
Low level 7.2 6.4 6.5 3.2 
LLOQ 10.1 7.3 7.8 5.6 
a High level was designed as 100.0 ng/mL; 
b Intermediate level was designed as 10.0 ng/mL; 
c Low level was designed as 1.0 ng/mL;  
d LLOQ was designed as 0.05 ng/mL. 
e RSD meant relative standard deviation. 
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Table 3.7 Stability of AFB1 and T-2 (n = 6). 
Toxins Matrices 
Concentration 
(ng/mL) 
Concentration of stored sample /Concentration of freshly 
prepared sample (mean±SD %) 
Short-term stability  
(at room 
temperautre for 8h) 
Freeze–thaw 
stability 
Long-term stability 
(at -20 oC for 2 weeks) 
AFB1 
Plasma 
1 93.2±3.1 90.1±2.4 84.9±3.4 
100 91.2±4.1 96.8±3.2 76.5±3.8 
Heart 
1 95.1±3.6 78.8±3.4 86.6±5.2 
100 94.2±3.2 83.0±2.4 80.6±4.1 
Liver 
1 95.2±4.5 70.8±4.6 87.9±6.4 
100 91.9±2.1 88.9±6.4 92.5±5.9 
Spleen 
1 93.1±5.6 78.2±2.5 89.5±4.1 
100 91.6±3.4 79.3±3.4 80.3±3.1 
Lung 
1 92.5±2.4 85.0±5.9 84.4±3.2 
100 95.6±3.8 83.0±4.5 82.2±6.7 
Kidney 
1 97.5±4.6 74.3±6.5 80.7±5.1 
100 82.1±4.4 77.6±6.4 79.8±5.7 
Brain 
1 92.8±3.3 79.8±5.6 80.8±6.4 
100 95.5±1.9 83.1±6.2 75.2±4.1 
T-2 
Plasma 
1 82.2±10.6 91.5±2.9 83.8±2.9 
100 83.7±2.9 94.4±3.4 83.6±3.6 
Heart 
1 82.4±8.2 92.5±3.4 90.1±3.6 
100 86.0±4.9 95.6±4.2 92.8±4.1 
Liver 
1 84.7±7.1 96.5±3.4 84.1±2.9 
100 83.5±5.2 94.6±4.7 88.0±3.1 
Spleen 
1 94.8±7.2 84.9±3.2 80.8±3.7 
100 85.3±6.7 82.6±2.7 84.9±5.1 
Lung 
1 83.5±3.1 86.1±4.3 79.3±5.6 
100 95.4±4.9 83.1±2.9 84.4±3.2 
Kidney 
1 88.7±4.6 79.9±4.6 78.9±6.4 
100 86.7±5.8 82.1±3.4 81.3±6.2 
Brain 
1 82.4±4.2 81.6±4.5 77.2±7.2 
100 81.1±2.9 84.7±6.2 76.6±3.1 
 
Comparatively, this proposed simple LC-MS/MS method for simultaneous 
determination of AFB1 and T-2 in different biomatrices showed higher sensitivity and 
faster sample preparation, as well as more accuracy aided by isotope ISs than the 
previously reported methods 9,10. 
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3.1.3.4 In vivo kinetics and distribution studies 
 
The oral dose for administration was ascertained based on the data from pilot 
experiments and previous literature 9,11, and was obviously lower than the reported 
median lethal dose (LD50) of AFB1 (5.5-17.9 mg/kg b.w. by oral) or T-2 (0.9 mg/kg 
b.w. by intravenous) in rat. The developed LC-MS/MS method was employed for 
kinetics investigation of co-occurring AFB1 and T-2 in rat plasma after oral 
administration at a dose of 0.5 mg/kg b.w. The concentration–time profiles are 
presented in Fig. 3.3. The calculated kinetic parameters expressed as mean±SD are 
shown in Table 3.8. After oral administration, the highest concentration of AFB1 
(Cmax= 16.58±1.05 ng/mL) was observed with Tmax being 0.17 min. In previous 
studies, the obtained time-to-peak for AFB1 in rat was in the range of 2-3 h 12,13. 
These differences might be due to the different analytical techniques used. The total 
radioactivity employed in the previous studies might misidentify the target analytes 
with the metabolites and other impurities 11, while LC-MS/MS with high selectivity 
was developed in the present study and could eliminate the false positive results. The 
concentrations of T-2 in rat plasma were lower than that of AFB1, with a Cmax of 
only 0.53±0.08 ng/mL. The t1/2 was 8.12±4.05 h, which was obviously longer than 
that reported in the previous studies (t1/2 =5±2 min by intravenous injection to dogs 
and t1/2 =5±2 min by IA administration to swines) 14-17. This big difference might be 
because of the sensitive methods used for T-2 determination, by which, small amounts 
(around 0.05 ng/mL) of T-2 could be efficiently detected. Additionally, different 
animal species also lead to different t1/2 values. As previously reported, only about 2% 
of the dose appeared in the effluent during the metabolism experiment of tritiated T-2 
(2.3 pg and 230 pg) in vascularly autoperfused jejunal loops of rats 11. Similarly, it 
could be concluded in this study that T-2 was susceptible to liver and intestinal 
first-pass effects, so that its absolute bioavailability might be negligible following oral 
administration.  
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Figure 3.3 Mean plasma concentration–time curves of AFB1 (a) and T-2 (b) following the oral 
administration of co-occurring AFB1 and T-2 (0.5 mg/kg b.w.) in rat (n=6). The error bars 
represent the standard deviation (SD). 
 
Table 3.8 Toxicokinetic parameters of AFB1 and T-2 (0.5 mg/kg b.w.) after oral administration in 
rat (n = 6). 
Toxicokinetic parameters Unit AFB1 T-2 
AUC  a (0-t) μg /L*h 36.24±0.69 0.60±0.03 
AUC (0-∞) μg /L*h 40.84±3.65 0.98±0.24 
MRT b (0-t) h 5.24±0.37 3.43±0.14 
MRT(0-∞) h 8.93±3.33 10.75±5.52 
t1/2 c h 8.44±4.02 8.12±4.05 
Tmax d h 0.17±0.00 0.17±0.00 
CLz /F e  L/h/kg 16.50±1.49 105.70±23.63 
Vz /F f L/kg 195.24±78.59 1149.32±282.52 
Cmaxg μg /L 16.58±1.05 0.53±0.08 
a the area under the curve 
b mean residence time 
c half-life time 
d time to maximal concentration 
e total body clearance 
f apparent volume of distribution   
g maximal concentration 
 
The concentration–time profiles in different tissues analyzed at 0-72 h after oral 
administration are shown in Fig. 3.4. The results indicated that AFB1 underwent a 
rapid distribution in the tissues. Within 1 h after administration, highest 
concentrations of AFB1 were reached in all of the target tissues. Then, AFB1 was 
rapidly eliminated and disappeared within 24 h. Interestingly, AFB1 was also detected 
in brain homogenate, demonstrating that AFB1 could efficiently cross the blood–brain 
barrier. For T-2, very low concentrations were observed in heart, liver, spleen, lung, 
kidney, and disappeared within 4 h in all tissues, also indicating its low absolute 
bioavailability. As to tissue accumulation of AFB1 and T-2 (Fig. 3.5), the highest 
concentration of AFB1 was observed in liver (1.34±0.02 μg/kg), followed by kidney 
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(0.76±0.03 μg/kg), which might be related to its intensively hepatotoxic and 
carcinogenic effects. AFB1 was also detected in heart, brain, spleen and lung, 
indicating that AFB1 could also accumulate in these tissues. Comparatively, only very 
low concentrations of T-2 were observed in spleen (0.70±0.06 μg/kg), possibly 
causing immunosuppressive activity, and then in liver (0.15±0.02 μg/kg), suggesting 
that the accumulation effect of T-2 is weak and spleen is the main accumulation organ 
of T-2. More importantly, the results demonstrated in the kinetic studies in plasma, as 
well as the tissue distribution and tissue accumulation of both toxins could provide 
valuable references for revealing the real mechanism of toxicity in humans. 
 
 
Figure 3.4 The concentration–time profile of AFB1 (a) and T-2 (b) after oral administration of 
AFB1 and T-2 (0.5 mg/kg b.w.) in different tissues of rat (n=6). The error bars represent the 
standard deviation (SD). 
 
Figure 3.5 The tissue accumulation of co-occurring AFB1 and T-2 after 20 days of oral 
administration of AFB1 and T-2 (0.25 mg/kg b.w.) in rat (n=6). The error bars represent the 
standard deviation (SD). 
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3.1.4 Conclusions 
 
A LC-MS/MS approach was developed for simultaneous determination of 
co-occurring mycotoxins exemplified with AFB1 and T-2 in plasma and different 
tissues of heart, liver, spleen, lung, kidney and brain. The homemade clean-up 
cartridges and isotope ISs as combinatorial means were utilized together to eliminate 
the matrix effects, thus ensuring the accuracy and precision of the method. Full 
validation indicated that the method with a total running of 7 min for each sample was 
highly sensitive, selective, fast, economic and proved to be applicable for 
multi-component analysis in different biomatrices. These methodological advances 
guaranteed the successful application for the kinetics study in plasma, and 
investigations on tissue distribution and accumulation after oral administration with 
two co-occurring mycotoxins in rat. The kinetics parameter values, tissue distribution 
and accumulation data obtained in the present study might be helpful to predict the 
toxicokinetics and toxicity of co-occurring AFB1 and T-2 in animals and humans.  
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3.2 IN VITRO METABOLIC STUDY OF OCHRATOXIN A 
 
As discussed in Chapter 1.3, OTA is also an important mycotoxin, produced by 
Aspergillus fungi. Since low elimination and high accumulation effects of OTA are 
observed (Chapter 1.3), the in vitro metabolism was investigated to address the 
remaining uncertainties (glucuronidation) regarding OTA biotransformation. 
 
 
Redrafted from: 
Zheng Han, Emmanuel K. Tangni, José Diana Di Mavungu, Lynn Vanhaecke, Sarah 
De Saeger, Aibo Wu and Alfons Callebaut. 
In vitro glucuronidation of ochratoxin A by rat liver microsomes. Toxins, 2013, 5, 
2671-2685. 
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3.2.1 Introduction 
 
Contamination of food and animal feed with OTA may result in the presence of 
residues in edible offal and blood serum 18. Also, OTA has been found regularly in 
human biofluids showing the exposure of humans to this mycotoxin 19,20. Therefore, 
there is a need for a deeper and more comprehensive understanding of toxicological 
findings concening OTA in animals and extrapolation of the resulting data to human. 
In this regard, in recent years many in vitro and in vivo kinetics and metabolic studies 
have been performed to provide information on its toxicology and food safety 
assessment (Chapter 1.3.4 and 1.3.7). One of the most important metabolisation 
reactions is glucuronidation, mainly in liver microsomes. At the cellular level, 
endogenous glucuronic acid can be conjugated to the phenolic group or carboxylic 
group of OTA under the catalytic reaction by uridine-diphosphate 
glucuronosyltransferase (UGT), which is a membrane bound microsomal enzyme 
adjacent to CYP 21. OTA-conjugates have been detected in liver (8–17%) and 
intestinal tissue (6%) 22. Interestingly, the presence of glucuronide conjugates was 
also reported in bile of pigs upon feeding with OTA contaminated feed 23. However, in 
all these reports, OTA-glucuronides were determined indirectly by using 
β-glucuronidase hydrolysis. No direct or definite evidence for the formation of 
OTA-glucuronides as well as complete chemical configurations are available. For 
example, Gross-Steinmeyer et al. did not observe any OTA glucuronide conjugates in 
in vitro experiments with rat and human hepatocytes 24.   
These data indicate that relevant data on OTA glucuronidation are still missing. 
Therefore, the purpose of this present work was to further clarify the formation of 
OTA metabolites by rat microsomal preparations and to clearly identify the structures 
of these metabolites to propose the major metabolic pathways of OTA in rat liver 
microsomes. 
 
3.2.2 Materials and methods 
 
3.2.2.1 Chemicals and reagents 
 
Methanol and acetonitrile were ultra-high performance liquid chromatography-mass 
spectrometry (UHPLC-MS) grade from Biosolve (Valkenswaard, the Netherlands). 
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Water was purified by a Milli-Q system (Millipore, Brussels, Belgium). Ammonium 
acetate, ammonium formate, formic acid, uridine 5’-diphosphoglucuronic acid 
trisodium salt (UDPGA), uridine 5’-diphospho-N-acetylgalactosamine disodium salt 
(UDPAG), anhydrous magnesium chloride (MgCl2) and 2-amino-2-(hydroxymethyl)- 
1,3-propanediol (Tris) were from Sigma-Aldrich (Saint Louis, MO, USA). 
β-glucuronidase and microsomes (pooled from male rat liver) were from 
Sigma-Aldrich (Saint Louis, MO, USA). 
OTA and OTα were from Coring System Diagnostix GmbH (Gernshein, Germany). 
Accurately weighed solid portions of OTA and OTα standards were dissolved in 
acetonitrile to prepare 0.5 mg/mL of stock solutions. 
The OTA methyl ester was prepared according to a previous report with minor 
modifications 25. The OTA stock solution (0.5 mL) was mixed with 9 mL of methanol 
and 0.5 mL of 12 N HCl, and incubated for 24 h at room temperature. Afterwards, 2.5 
mL of extracts were dried under a nitrogen stream, redissolved with 1.5 mL of 
methanol and ready for analysis. 
 
3.2.2.2 UHPLC-MS/MS analysis 
 
The LC system consisted of an AcquityUPLC® H-class (Waters, Milford, MA, USA). 
The compounds were separated on an Acquity® UPLC HSS T3 column (100 mm × 
2.1 mm, 1.7 μm) at 40 °C, with a mobile phase flow rate of 0.5 mL/min. The mobile 
phase consisted of (A) 10 mmol/L ammonium acetate solution, (B) water and (C) 
methanol. A linear gradient elution program was applied as follows: 0 min 1% A and 
29% C, 10 min 1% A and 59% C, 10.2 min 1% A and 99% C, 11 min 1% A and 99% 
C, 11.8 min 1% A and 29% C, and hold on for a further 2.2 min for re-equilibration, 
giving a total run time of 13 min. The injection volume was 5.0 μL (partial loop with 
needle overfill).  
A XEVO TQ-S® mass spectrometer (Waters, Milford, MA, USA) was used for the 
analysis of the target compounds. Full scan analysis was performed both in ESI+ and 
ESI-. The following settings were used: source temperature, 150 °C; desolvation 
temperature, 500 °C, scan range, m/z 100-1,000, inter-scan delay, 0.01 s. The cone and 
desolvation gas flows were 30 and 1,000 L/h, respectively. Data acquisition and 
processing were performed using MassLynx v4.1 (Waters, Milford, MA, USA). 
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3.2.2.3 UHPLC-orbitrap-HRMS analysis 
 
UHPLC-ExactiveTM Benchtop Orbitrap mass spectrometer (Thermo Fisher Scientific, 
San José, CA, USA) analysis in the full scan mode (m/z, 100-1000) was utilized for 
the metabolic profiling study. Chromatographic separation was achieved on a Zorbax 
Eclipse Plus C18 column (100 mm×2.1 mm, 1.8 μm) at 30 oC, with a mobile phase 
flow rate of 0.4 mL/min. The mobilephase consisted of (A) water/methanol (5/95, v/v) 
containing 0.1% formic acid and 10 mM ammonium formate and (B) water/methanol 
(95/5, v/v) containing 0.1% formic acid and 10 mM ammonium formate. A linear 
gradient elution program was applied as follows: 0 min 0% B, 0.5 min 0% B, 20 min 
99.1% B, 21 min 99.1% B, 24 min 0% B and hold on for a further 4 min for 
re-equilibration, giving a total run time of 28 min. The injection volume was 5.0 μL. 
The mass spectrometer was operated both in HESI+ and in HESI-. The following 
settings were used: spray voltage, 4.5 kV; capillary temperature, 250 oC; heater 
temperature, 250 oC; sheath gas flow, 45 a.u.; auxiliary gas, 10 a.u; sweep gas, 2 a.u., 
resolution 100000 FWHM at 1 Hz (1 scan per second). The automatic gain control 
target was set at high dynamic range (3e6), and the maximum injection time was 20 
ms. Initial instrument calibration was achieved by infusing calibration mixtures 
(Thermo Fisher Scientific) for positive and negative ion modes. The positive 
calibration mixture included caffeine, Met-Arg-Phe-Ala acetate salt (MRFA) and 
Ultramark 1621®, while the negative calibration solution comprised sodium dodecyl 
sulfate, sodium taurocholate and Ultramark 1621®. These compounds were dissolved 
in a mixture of acetonitrile, water and methanol, and both mixtures were infused with 
a Chemyx Fusion 100 syringe pump (Thermo Fischer Scientific). Data were acquired 
and processed by Xcalibur 2.1 and Sieve 2.0 software (Thermo Scientific, Brookfield, 
USA). 
 
3.2.2.4 LC-ion trap analysis 
 
HPLC-ion trap system (Thermo Fisher Scientific) was used for the fragments analysis 
of the targeted analytes. The column used was an X-bridge C18 column (3.5 μm, 
2.1x150 mm), supplied by Waters (Milford, MA, USA). The mobile phase consisted 
of (A) water/methanol (5/95, v/v) containing 0.1% formic acid and 10 mM 
ammonium formate and (B) water/methanol (95/5, v/v) containing 0.1% formic acid 
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and 10 mM ammonium formate. The linear gradient elution program for LC-ion trap 
analysis was: 0-1 min B=50%, 1-13 min B=50-97%, 13-18 min B= 97%, 18-19 min 
B=97-50%, and hold on for a further 6 min for re-equilibration, giving a total run time 
of 25 min. The mass spectrometer was operated both in HESI+ and in HESI- with the 
following settings: source voltage of 5 kV, capillary temperature of 250 oC; heater 
temperature of 175 oC; sheath gas flow of 45 a.u.; aux gas of 10 a.u. The Xcalibur 
2.0.7 software (Thermo Scientific) was used for instrument control, data acquisition 
and processing. 
 
3.2.2.5 Model reactions 
 
The in vitro metabolic study of OTA via glucuronidation biotransformation by rat 
liver microsomes (Sigma-Aldrich, Saint Louis, MO, USA) was performed based on a 
slightly modified procedure adopted from Wu et al. 26 and Welsch et al. 27 for 
synthesis of DON-glucuronides. 
Reaction 1: An aliquot of OTA stock solution (241.8 μL, 0.3 μM) was transferred 
into a 5 mL tube and dried by nitrogen gas under 40 oC. Next, 15 μM of UDPGA, 
0.25 μM of UDPAG and 5 μM of MgCl2 were added and all these reagents were 
dissolved in 400 μL of 50 mM Tris-HCl buffer (pH=7.4). Rat liver microsomes (100 
μL) were firstly mixed with 5 μg of alamethicin and kept on ice for 10 min before 
adding into the tubes. Then, the 500 μL reaction mixture was inverted a few times and 
incubated at 37 oC in a water bath for 1.5 h. The reaction was terminated by addition 
of 1 mL of methanol, vortexed for 30 s and centrifuged at 14,000 rpm for 10 min. The 
supernatant (100 µL) was diluted with 900 μL of methanol/water solution (20/80, v/v) 
and was ready for injection. 
Reaction 2: An aliquot of OTA stock solution (241.8 μL, 0.3 μM) was transferred 
to a 5 mL tube and dried by nitrogen gas under 40 oC. Next, 15 μM of UDPGA, 0.25 
μM of UDPAG and 5 μM of MgCl2 were added and all these reagents were dissolved 
in 400 μL of 50 mM Tris-HCl buffer (pH=7.4). Then 100 μL (2 mg of microsomal 
protein) of rat liver microsomes were added. The reaction mixture (500 μL) was 
subsequently pretreated as reaction 1. 
Reaction 3: A blank reaction was performed using the same procedure and 
ingredients as in reaction 2, except for UDPGA.  
Reaction 4: A control reaction was also performed using the same procedure and 
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ingredients as in reaction 2, except for OTA.  
 
3.2.2.6 Hydrolysis of the glucuronides 
 
Hydrolysis of the reaction solution was performed for further identification of the 
OTA-glucuronides. An aliquot of the reaction solution (10 μL) was incubated with 
β-glucuronidase (1.5 units/reaction) (type IX, from E. coli, Sigma-Aldrich, Saint 
Louis, MO, USA) at 37 oC in 0.25 mL of 0.1 M NaAc buffer (pH=5) for 18 h. The 
reaction was terminated by addition of 1 mL methanol, vortexed for 30 s and 
centrifuged at 14,000 rpm for 10 min. The supernatant was passed through a 0.22 μm 
nylon filter and was ready for injection. 
 
3.2.3 Results and discussion 
 
Metabolic profiling provides important information on in vitro biotransformation 
which is useful in toxicity testing. To identify the metabolites of OTA, LC-MS 
analyses of reaction mixtures 1, 2, 3 and 4 were performed first. The full scan 
chromatogram of the reaction 1 solution under ESI+ is shown in Fig. 3.6 and is similar 
to that of reaction 2. This indicated that alamethicin did not affect the yield of OTA 
glucuronides in the current reaction even though it should be used in the 
glucuronidation of T-2 and HT-2 27. Four new peaks with retention times at 7.751 min 
(compound 1), 8.536 min (compound 2), 8.733 min (compound 3) and 11.012 min 
(compound 4) were evident while they could not be found in control incubations 
(reactions 3 and 4). Special attention should be paid that OTB existed in reactions 1, 2 
and 3 with the same peak area. After direct injection of the standard solution of OTA, 
a similar amount of OTB was also detected, suggesting that OTB was the impurity in 
the standard solution but not formed by dechlorination of OTA. 
 
3.2.3.1 Compound 1 
 
The negative full-scan mass spectrum showed a signal at m/z 578 which corresponds 
to the deprotonated molecule. Exact mass measurement of this signal (Table 3.9) 
provided the ion formula C26H25O12NCl. 
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Figure 3.6 Full scan chromatogram of the reaction 1solution in ESI+ by using UHPLC-MS/MS. 
Compared to the blank reaction (3 and 4) solutions, four new compounds (1-4) were observed in 
reaction 1 solution. 
 
Table 3.9 UHPLC-HRMS data obtained from the four metabolites in HESI+ and HESI-. 
Compounds, polarity, chemical configuration, observed masses, calculated masses and mass error 
of the molecules are reported. 
Compound Polarity Ion formula 
Observed m/z 
(Da) 
Calculated m/z 
(Da) 
Mass error 
(ppm) 
1-3 + C26 H27 O12 N Cl 580.12042 580.12219 -0.59 
1-3 _ C26 H25 O12 N Cl 578.10812 578.10651 2.14 
4 + C21 H21 O6 N Cl 418.10428 418.10574 -0.91 
4 - C21 H19 O6 N Cl 416.09120 416.09009 1.66 
 
Structural elucidation of this compound was accomplished through product ion 
measurements by UHPLC-MS/MS analysis, and MSn experiments by LC ion trap MS. 
The product ion spectrum of [M-H]- (Fig. 3.7a) showed four fragments at m/z 402, 
358, 175 and 113. The fragments at m/z 175 and 113 are known to be diagnostic ions 
of glucuronate moieties 28, so it is reasonable to suppose that compound 1 should 
correspond to a glucuronidated OTA. The fragment with m/z 402 is the negative ion 
[M-H]- of OTA. The fragment ion at m/z 358 results from a neutral loss of CO2, 
revealing the presence of a carboxylic group, which is in agreement with previous 
data for OTA fragmentation 29-32. 
Positive full-scan spectra of compound 1 showed the ion at m/z 580 corresponding 
to [M+H]+, which was confirmed also by UHPLC-HRMS measurements, as shown in 
Table 3.9. 
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The product ion spectrum of [M+H]+ showed different fragments. The protonated 
glucuronide first lost water and formed the fragment with m/z 562. Commonly, the 
product ion scan of glucuronide conjugates by LC-MS/MS provides the neutral loss of 
176 Da (dehydrated glucuronic acid) due to the cleavage of glycosidic bond, with 
charge retention by the aglycone moiety. Therefore, as shown in Fig. 3.8a, the mass 
difference between the ions 580 and 404 (protonated OTA ion), as well as between the 
fragments 562 and 386, corresponded to 176. The protonated ion at m/z 386, through 
losing CO, formed the fragments at m/z 358 (Fig. 3.8a).  
 
 
   Figure 3.7 Product ion spectra of compound 1 (a), compound 2(b), compound 3 (c) and compound 
4 (d) using UPLC-MS/MS. 
 
3.2.3.2 Compounds 2 and 3 
 
The negative full scan showing the deprotonated molecules (m/z 578) of compound 2 
and 3 were isobaric with the [M-H]- of compound 1, and therefore exhibited the same 
ion formula C26H25O12NCl (Table 3.9). The product ion spectrum of [M-H]- also 
showed the same fragments of m/z 402, 358, 175 and 113. Meanwhile, under the ESI+, 
the same data on the full scan and product ions indicated that compounds 1, 2 and 3 
were isomers, which all belonged to the OTA glucuronide conjugates.  
 
Chapter 3 Kinetics and Metabolism Study of Selected Aspergillus and Fusarium Mycotoxins 
161 
3.2.3.3 Acylic, phenolic and amino glucuronides 
 
OTA has three possible glucuronidation sites; in fact, it could form a phenol-, an acyl- 
or an amino-glucuronide. As shown in Fig. 3.6, only small amounts of compounds 1-3 
were found indicating the low transformation rate from OTA to OTA-glucuronides. 
All these three compounds were unknown and to characterize these isomers, different 
paths including retention times, literature references, MS/MS spectra and non-specific 
hydrolysis with β-glucuronidase were exploited in this work. 
 
 
Figure 3.8 MSn spectra of compound 1-3 (a, b, c) and compound 4 (d, e, f). (a) MS2 (+) 580, (b) MS3 
(+) 580→562, (c) MS4 (+) 580→562→404, (d) MS2 (+) 418, (e) MS3 (+) 418→386, (f) MS4 (+) 
418→386→358 using LC iontrap MS. 
 
In the chromatographic separation (Fig. 3.6), compound 1 eluted at a retention time 
of 7.751 min, 0.785 min less than compound 2 and 0.978 min less than compound 3. 
This means that compound 1 is most polar, then compound 2 while compound 3 is the 
least polar. From the structure, OTA amino-glucuronide contained one carboxylic 
group and one phenolic hydroxyl group, so it should be more polar than OTA 
phenol-glucuronide or acyl-glucuronide. Compared to OTA phenol-glucuronide 
containing one carboxylic group, OTA acyl-glucuronide should be less polar due to 
the only one phenolic hydroxyl group. Therefore, compound 1 was proposed to be 
OTA amino-glucuronide, compound 2 was OTA phenol-glucuronide and compound 3 
was OTA acyl-glucuronide. 
The subsequent analyses of ESI- product ions of the three compounds showed that 
besides the characteristic fragments (m/z 175 and 113) of glucuronate moieties, an 
intense peak at m/z 193 corresponding to the glucuronate anion was observed in the 
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spectra of compound 3 (Fig. 3.7c). The proposed fragmentation pathways of the three 
glucuronide conjugates are shown in Fig. 3.9. For compound 1 and compound 2, the 
ions at m/z 193 could not be found; as a consequence, the proposed pathway also 
assigned the structure of acyl-glucuronide to compound 3. Similar results have been 
obtained in previous reports for the other glucuronide conjugates, according to which, 
in the negative MS2 spectrum of acyl-glucuronide conjugates, the base peak fragment 
was the glucuronate anion at m/z 193 28,33-35. To the best of our knowledge, this is the 
first report to provide direct evidence for OTA-glucuronide generation. 
Hydrolysis of the glucuronide conjugates was performed to provide more 
information for definite identification of the three compounds. The enzyme could 
hydrolyze the amino-, phenol- and acyl-glucuronide. The contents of the targeted 
analytes were accurately quantified by the established LC-MS/MS using the standard 
purified in the present study. The parameters and collision energies of precursor ions 
and product ions selected for the analysis are listed in Table 3.10. The results 
demonstrated that after hydrolysis by β-glucuronidase, a significant signal decrease 
was observed for all three compounds with similar extents, indicating their 
glucuronide forms (Fig. 3.10). 
 
Figure 3.9 The proposed fragmentation pathways for compounds 1-3. 
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Figure 3.10 Comparison of the contents of three OTA glucuronide conjugates in the reaction 2 
solution untreated (a, b) and the solution hydrolyzed with β-glucuronidase (c, d). 
 
Table 3.10 The parameters and collision energies of precursor ions and product ions for the targeted 
analytes. 
Names 
Precursor 
Ion (m/z) 
Primary 
product 
Ion (m/z) 
Collision 
energy(eV) 
Secondary 
product ion 
(m/z) 
Collision 
energy(eV) 
Ionization 
mode 
Compound 
1-3 
580 358 20 239 38 ESI+ 
OTA 
methyl 
ester 
418 358 18 239 32 ESI+ 
OTα 257 221 20 102 40 ESI+ 
 
3.2.3.4 Identification of compound 4 
 
The positive and negative full-scan mass spectra analyzed showed the signal at m/z 
580 and 578 that corresponded to the protonated and deprotonated molecules, 
respectively. Exact mass measurement of [M+H]- and [M-H]+ (Table 3.9) provided the 
ion formula C21H21O6NCl and C21H19O6NCl. After analysis by LC-ion trap MS, 
typical fragments at m/z 386, 358, 341 and 239 indicated that this compound was OTA 
methyl ester 32(Fig. 3.8 d, e, f).  
Unambiguous confirmation of this compound was obtained by means of OTA 
methyl ester preparation and from mass spectral comparison. The MRM method was 
established using the obtained standards (Table 3.10).The transformation rate from 
OTA to OTA methyl ester was almost 95% (Fig. 3.11). Then, reaction 1 and reaction 2 
solutions were analyzed by the established method, and OTA methyl ester was clearly 
identified. Although a little amount of OTA methyl ester can be found in reaction 3, 
the quantity was less than 5% of that in reaction 1 or 2, in addition that no OTA 
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methyl was found in reaction 4, indicating that OTA methyl was not an artifact but 
produced by this reaction (Fig. 3.12). The reaction conditions in the present study 
were favorable for the glucuronidation biotransformation resulting in the production 
of OTA-glucuronides, while esterification reaction in principle could not be catalyzed 
by microsomes. However, in the present study, it was clearly demonstrated that OTA 
methyl ester could be produced with relative high content.  
 
Figure 3.11 Comparison of the contents of OTA and OTA methyl ester in the solutions before 
methylation (A, B) and after methylation (a, b). 
 
Figure 3.12 Comparison of the contents of OTA methyl ester in different reaction solutions. 
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3.2.3.5 Identification of OTα 
 
As reported, OTα is a very important metabolite 36,37. However, it was not found in the 
reaction solution in full scan MS mode. A MRM method for detection of OTα was 
established by direct injection of the standard solution (1 μg/mL), with the parameters 
indicated in Table 3.10. The solutions of reaction 1, 2 before and after hydrolysis were 
analyzed by the established MRM method. The results showed that a very low content 
of OTα was present in the solutions of reaction 1, 2 and 3, however, after hydrolysis, 
the concentration of OTα in reaction 1 and 2 significantly increased (Fig. 3.13), 
indicating the existence of OTα-glucuronide formed by the glucuronidation 
transformation. It is not surprising that OTα, a major metabolite in vivo, was hardly 
found in incubations with liver microsomes, since hydrolysis is known to occur in the 
gut. When peptide cleavage occurs by an unspecific hydrolytic activity in the reaction 
mixture, OTα is then apparently further conjugated by microsomal UGTs in reaction 1 
and 2. As hydrolysis but not conjugation could occur in reaction 3, however, a low 
content of OTα was also found in mixture 3. 
 
Figure 3.13 Comparison of the contents of OTα in the reaction 2 solution untreated (a) and in the 
solution hydrolyzed with β-glucuronidase (b) 
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3.2.3.6 Proposed metabolic pathways 
 
Based on the above observations, the in vitro metabolic profile of OTA via 
biotransformation by rat liver microsomes is proposed in Fig. 3.14. First, the 
glucuronidation reaction could occur. There are three possible glucuronidation sites, 
and OTA has been transformed to phenol-, acyl- and amino-glucuronides. Second, the 
phase I methylation reaction could happen on OTA under such conditions, and a 
relatively high amount of OTA methyl ester was formed. Last but not least, hydrolysis 
could occur and OTA was conversed to OTα. The site of hydrolysis was tentatively 
proposed to be N-C9. Then, OTα was glucuronidated to form OTα-glucuronide. On 
the other side, OTA-glucuronides also might be directly hydrolyzed to form 
OTα–glucuronide.  
 
Figure 3.14 The proposed metabolic pathway for OTA via glucuronidation by rat liver microsomes.  
 
3.2.4 Conclusions 
 
To address the remaining uncertainties regarding OTA biotransformation by liver 
microsomes, UHPLC-MS/MS, UHPLC-orbitrap-HRMS and LC-iontrap were applied 
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as combined strategies to investigate the metabolic profile of OTA via glucuronidation 
by rat liver microsomes. Three different OTA glucuronide conjugates, which 
corresponded to OTA amino-glucuronide, OTA phenol-glucuronide and OTA 
acyl-glucuronidewere clearly identified. The suggested structures were supported by 
the fragments observed in the mass spectrometers and by hydrolysis with 
β-glucuronidase. OTA methyl ester, OTα and OTα-glucuronide were formed in the 
same reaction mixture. A possible in vitro biotransformation pathway of OTA in rat 
microsomes was proposed. The obtained results will help to have deeper 
understanding of OTA toxicokinetics. 
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3.3 IN VIVO KINETICS AND METABOLIC STUDY OF 
OCHRATOXIN A IN RAT 
 
The in vitro results obtained in Chapter 3.2 could not reflect the real 
biotransformation of OTA in animals and humans, and therefore, an in vivo kinetics 
and metabolic study was performed in plasma, heart, liver, spleen, lung, kidney and 
brain in rat. 
 
 
Redrafted from: 
Zheng Han, Zhiyong Zhao, Jianxin Shi, Yucai Liao, Zhihui Zhao, Dabing Zhang, 
Yongning Wu, Sarah De Saeger and Aibo Wu. 
A combinatorial approach of LC-MS/MS and LC-TOF-MS for uncovering in vivo 
kinetics and biotransformation of ochratoxin A in rat. Journal of Chromatography B. 
2013, 925: 46-53. 
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3.3.1 Introduction 
 
OTA can be biotransformed into a serious of metabolites in animals. Interpretation of 
toxicological findings in animals and extrapolation of the resulting data to human 
requires knowledge of the kinetics and metabolic fate of OTA and its metabolites in 
plasma and different organs (Chapter 1.3.7). The overall objective of the present work 
was to develop a fast and accurate isotope dilution LC-MS/MS method with the 
capability of determining OTA in plasma, liver, heart, spleen, lung, kidney and brain 
using the same sample preparation, as well as a subsequent LC-TOF-MS approach 
capable of identifying the metabolites of OTA without reference standards or tedious 
purification processes. The developed combinatorial approach was then applied for 
the study of the kinetics and biotransformation of OTA in plasma and different organs 
in rats after oral administration, to elucidate the kinetics and metabolic pathway of 
OTA in rats, which would be significantly helpful for the toxicological evaluation of 
target mycotoxins as a single contaminant source. 
 
3.3.2 Materials and methods 
 
3.3.2.1 Chemicals and reagents 
 
The standards of OTA and [13C20]-OTA (IS) were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Acetonitrile and methanol, purchased from Merck (Darmstadt, 
Germany), were both HPLC grade. Milli-Q quality water (Millipore, Billerica, MA, 
USA) was used throughout the analyses. All other reagents were of HPLC or 
analytical grade.  
 
3.3.2.2 Apparatus 
 
LC-MS/MS (TSQ Quantum Ultra, Thermo Scientific, Austin, TX, USA) was utilized 
for the analysis of OTA. Separation was performed at 35 °C using a Thermo Hypersil 
Gold column (100 mm×2.1 mm, 3.0 µm) with a linear gradient elution using (A) 
water (containing 0.25 mmol/L ammonium acetate and 0.05% formic acid) and (B) 
methanol as the mobile phase. The elution program was as follows: 30% B (initial), 
30–100% B (3 min), 100% B (0.8 min), 100–30% B (0.2 min), and hold on for a 
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further 3 min for re-equilibration, giving a total run time of 7 min. The flow rate was 
0.35 mL/min and the injection volume was 5 μL (full loop). MS/MS detection was 
performed in ESI+. The following settings were used for MS/MS conditions: 
vaporizer temperature, 300 °C; spray voltage, 4 kV; sheath gas pressure, 30 psi; aux 
valve flow, 30 arb; capillary temperature, 350 °C. SRM mode with two transitions 
was developed. The transitions (m/z) used for quantification and qualification were 
404.2   239.1 (collision energy of 22 eV) and 404.2   221.0 (collision energy of 35 
eV) for OTA, and 424.5   250.1 (collision energy of 25 eV) and 424.5   232.1 
(collision energy of 36 eV) for IS, respectively. Data were acquired and processed by 
Xcalibur software (Thermo Scientific, Austin, TX, USA). 
Identification of the metabolites of OTA was performed on an Agilent Technologies 
6224 LC-TOF-MS system (Victoria, US) in ESI+. The analytes were separated on an 
Agilent Poroshell 120 EC-C18 column (50 mm×2.1 mm, 2.7 µm). The same mobile 
phase as for the LC-MS/MS was selected and the elution program was as follows: 60% 
B (initial), 60–95% B (8 min), 95% B (2.8 min), 95–60% (0.2 min), and hold on for a 
further 3 min for re-equilibration, giving a total run time of 14 min. The flow rate was 
0.3 mL/min and the injection volume was 5 μL. The optimized TOF conditions were: 
Gas temperature, 350 °C; Drying gas, 10 L/min; Nebulizer, 40 psig; V Cap, 4 kV; 
Capillary, 0.029 μA; Chamber, 2.2 μA; Fragmentor, 175 V; Skimmer, 65 V. The 
instrument was operated with a resolution of more than 20000, and data were 
collected between m/z 100 and 1000, with an acquisition rate of 2 spectra/s. Purine 
(m/z 121.050873) and HP-0921 (m/z 922.009798) were selected as references for the 
independent reference spray. Calculation of the accurate mass of the analytes was 
performed by Masshunter Workstation software supplied with the instrument. 
 
3.3.2.3 Standard solutions 
 
A stock solution of 0.5 mg/mL of OTA was prepared by dissolving 5.0 mg of OTA in 
10 mL of ethanol and this could be kept stable for one month when it was stored at 
-20 °C in the dark. The stock solution was diluted with water to prepare the solution 
used for the oral administration in rats at a concentration of 0.1 mg/mL in 20% of 
ethanol aqueous solution, while the standard solutions used for LC-MS/MS and 
LC-TOF-MS analyses were prepared by appropriate dilution of the stock solution 
with a mixture of acetonitrile and water containing 10 mmol/L of ammonium acetate 
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(20/80, v/v). The stock solution of the IS ([13C20]-OTA) was directly used as 
purchased and diluted with the same mixture to 50 ng/mL. All work solutions were 
prepared immediately before use. 
 
3.3.2.4 Animals 
 
One hundred thirty two male Sprague–Dawley (SD) rats, weighing 200±20 g, were 
provided by Fudan University Laboratory Animal Center (Shanghai, China). The 
study was approved by the Animal Ethics Committee of Shanghai Academy of 
Agricultural Sciences (Shanghai, China). The animals were randomly divided into 
twenty two groups (n=6), and were kept in an environmentally controlled breeding 
room at a temperature of 25±2 °C and a relative humidity of 50±10%, and free access 
to diet and water until 12 h prior to the experiments. 
Twenty groups of male SD rats were selected and used for the kinetics and 
biotransformation study of OTA in plasma and tissues. Eighteen groups of animals 
were administered a single dose (0.2 mg/kg b.w.) of OTA by oral gavage with a 
volume of about 1 mL of 20% ethanol aqueous solution (0.1 mg/mL) depending on 
the weight of the rat itself, while the other two groups were used as the controls and 
received 1 mL of 20% ethanol aqueous solution by oral gavage. Serial blood samples 
(approximately 0.3 mL) of one group and one control were drawn in heparinized 
polythene tubes from the rats’ caudal veins at the times 0, 0.083, 0.167, 0.5, 1.0, 2.0, 5, 
7.5, 10, 12, 24, 48, 72, 96, 120, 144, 168, 192, 216, 240, 264, 288, 312, 336, 360, 384, 
408, 432 and 456 h with minor modifications according to previous protocols 6. The 
samples were immediately centrifuged at 4000 g for 5 min and the plasma was 
removed and then stored at -20 °C until analysis. In order to obtain the liver, heart, 
spleen, lung, kidney and brain samples, one control group and seventeen groups of 
rats were sacrificed by decapitation at 0, 0.5, 1, 2, 4, 6, 8, 12, 24, 48, 72, 120, 168, 
216, 264, 312, 360 and 408 h. The selected tissues were excised, washed by normal 
saline and blot dried by absorbent paper. In order to minimize the differences 
generated from various cell types in the organs and take a representative sample, the 
whole tissues were individually homogenized with normal saline (m/v, 1/3) by glass 
homogenizer (10 mL) at about 0 °C, and the homogenates were stored at −20 °C until 
analysis. 
For investigation of tissue accumulation, one group of male SD rats received a 
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daily administration of 0.1 mg/kg b.w. OTA by oral gavage during 20 days. For 
control samples, animals were administered by oral gavage with normal saline during 
the same time. The animals were sacrificed for tissues collection 24 h after the last 
administration, and the tissue homogenates were prepared as described above. 
 
3.3.2.5 Sample pretreatment 
 
To the plasma/tissue homogenates (100 μL), 10 μL of IS solution (50 ng/mL) and 300 
μL of methanol were added, the latter for precipitation of proteins. After 1 min vortex 
shaking, the mixture was centrifuged at 15000 g for 5 min. The supernatant was 
transferred into a 1.5 mL centrifuge tube and dried by nitrogen gas at 40 °C. The 
residue was reconstituted in 100 μL acetonitrile/water (20/80, v/v) containing 10 
mmol/L of ammonium acetate by shaking another 1 min, then passed through the 
syringe filters (0.22 μm) and ready for injection. 
 
3.3.2.6 LC-MS/MS method validation 
 
The analytical method was validated according to the following criteria: selectivity, 
linearity, sensitivity, recovery, matrix effects, precision (within- and between-day 
variability) and stability 6. All these were studied individually for each matrix, i.e., 
plasma, heart, liver, spleen, lung, kidney and brain. 
The selectivity of the LC-MS/MS method was evaluated by comparing the blank 
samples (untreated with OTA), with blank samples spiked with OTA and with samples 
collected from OTA-treated rats. Calibration curves in solvent and seven different 
blank matrices (plasma, heart, liver, spleen, lung, kidney and brain) were prepared at 
eight concentration levels in the range of 0.05-100 ng/mL. The sensitivity was 
calculated as the LLOD and LLOQ. LLOD and LLOQ were defined as the 
concentrations of OTA that yielded S/N ≥3 and ≥10, respectively, which were both 
determined by decreasing the spike concentrations in various biomatrices. Extraction 
recovery was determined by comparing the peak areas (n=6, each concentration) of 
OTA obtained from plasma/tissue homogenates spiked before extraction with those 
spiked after extraction without IS added. The present study also compared the slope of 
the standard addition plot with the slope of the standard calibration plot to evaluate 
the SSE using the IS or not. In order to determine the accuracy of the method, 
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fortification of plasma, heart, liver, spleen, lung, kidney and brain samples with 
known concentrations of OTA was performed. Each blank matrix was spiked with 0.1, 
1, 10 and 100 ng/mL of OTA in sextuplicate, and then pretreated as described above 
with 10 μL of IS solution (50 ng/mL) included. Precision was evaluated by 
determining the same spiked samples in one day (intra-day precision, n=6, each 
concentration) and the samples spiked with the same concentrations in four 
consecutive days (inter-day precision, n=6, each concentration). The short-term, 
long-term and freeze–thaw stability of OTA was evaluated by analyzing the OTA 
spiked samples (n=6) just after preparation and stored at room temperature for 8 h, at 
–20 °C for two weeks and subjected to three freeze–thaw cycles. The results were 
expressed as the percentage of calculated concentration vs theoretical concentrations. 
 
3.3.2.7 Identification of the metabolites via LC-TOF-MS 
 
After detection by LC-TOF-MS, the accurate mass of the analyte was calculated not 
only by the precursor ions of [M+H]+, but also by [M+Na] + or by [M+NH4] +, and the 
precursor ions of the isotopical pattern were also confirmed with the peak spacing 
tolerance 0.0025 m/z, plus 7.0 ppm. The possible elemental compositions were 
assumed from the obtained accurate mass, and then, based on previous knowledge, 
such as type and number of atoms, several impossible formulas were further ruled out. 
To ensure accuracy and precision, the references of purine (m/z 121.050873) and 
HP-0921 (m/z 922.009798) were sprayed through the analysis time, thus the software 
could perform ongoing correction of the exact mass of the analytes in the ESI+ 
conditions.  
 
3.3.2.8 Data analysis 
 
Statistical analysis was performed with drug and statistics (DAS) software, version 
2.0 (Shanghai, China). A significance level (a) of 0.05 was used. The parameters 
including Cmax, t1/2, Tmax, AUC0–t, AUC0–∞, CLz/F, Vz/F, MRT0–t and MRT0–∞ were 
calculated. Data for all response variables were reported as mean±SD. A significance 
level (α) of 0.05 was selected. 
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3.3.3 Results and discussion 
 
3.3.3.1 Optimization of LC-MS/MS conditions 
 
The MS/MS conditions were optimized for OTA and IS by identification of precursor 
ions performed in both ESI+ and ESI- by direct injection of standard solutions (500 
ng/mL). The base peak intensity of the positive ion was almost the same as that of the 
negative ion in the different ionization modes. The ESI+ was selected because aqueous 
ammonia, which was the most favorable additive in the mobile phase utilized in ESI -, 
was unstable and consequently caused stability problems to the analysis. As a result, 
m/z 404.2 and 424.5 ([M+H]+) were selected as the precursor ions for OTA and the IS, 
respectively. Two product ions for each compound were selected. For OTA, 221.0 
(m/z) and 239.1 (m/z) were selected as the product ions with collision energies of 35 
eV and 22 eV, respectively, while 232.1 and 250.1 were the product ions for the IS 
with collision energies of 36 eV and 25 eV, respectively. Finally, a SRM mode with 
two transitions was developed for the analysis of OTA. Both transitions (from OTA 
and labeled OTA) are related as the difference is only a water fragmentation. The 
transition with the highest signal intensity was preferred for quantification and the 
other one with less intensity plus the ratio of abundances of the two transitions was 
used for confirmation. 
  Different mobile phases, i.e., (1) methanol-water, (2) methanol-water containing 
0.05% of formic acid, (3) methanol-water containing 10 mmol/L of ammonium 
acetate and (4) methanol-water containing 10 mmol/L of ammonium acetate and 0.05% 
of formic acid, were compared in the pilot test. Results of multiple injections 
indicated that the response of OTA was obviously improved and higher sensitivity 
was obtained when solvent (4) was selected compared to other candidate solvents (Fig. 
3.15). Under such situation, OTA and IS were eluted at 3.36±0.02 min with nice peak 
shapes and no interferences in both transitions.  
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Figure 3.15 Comparison of the separation and ionization efficiencies among four mobile phases: 
(a) methanol-water, (b) methanol-water containing 0.05% of formic acid, (c) methanol-water 
containing 10 mmol/L of ammonium acetate and (d) methanol-water containing 10 mmol/L of 
ammonium acetate and 0.05% of formic acid. The concentrations of OTA and the IS were 30 
ng/mL and 5 ng/mL, respectively. 
 
Figure 3.16 Comparison of the recoveries of ochratoxin A (OTA) from rat plasma extracted with 
methanol, acetonitrile and acetone. Data for all response variables were reported as mean+SD (n=6). 
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3.3.3.2 Optimization of the sample pretreatment method 
 
The extraction profile (extraction solvent and the ratio of extraction solvent to 
sample) was evaluated by determination of the extraction recovery in rat plasma. In 
the present study, three extraction solvents, i.e., methanol, acetonitrile and acetone, 
with different ratios of extraction solvent to sample, i.e., 1:1, 3:1, 5:1; 7:1 and 9:1, 
were compared. To 100 μL of plasma samples, the candidate solvents were added, and 
then pretreated using methanol precipitation described in sample pretreatment. As 
shown in Fig. 3.16, all of the three solvents performed well (recovery >70%) as long 
as the ratio of extraction solvent to sample was higher than 1:1 for methanol and 
acetonitrile, and 3:1 for acetone, respectively. Even though there was no significant 
difference between these candidate solvents, 300 μL of methanol was selected, which 
would constitute a more economic and ecological procedure. Then, the same approach 
was applied to the extraction of OTA from different tissue homogenates, i.e., heart, 
liver, spleen, lung, kidney and brain. Satisfactory extraction recoveries were also 
achieved as indicated in Table 3.11, supporting the suitability of the developed sample 
pretreatment method for extraction and purification of OTA in different biomatrices. 
In addition, since most of small organic molecules can be easily dissolved in methanol, 
methanol was also suitable for the extraction of OTA metabolites from different 
organs.  
 
3.3.3.3 LC-MS/MS method validation 
 
The selectivity was evaluated by comparing the chromatograms of blank matrix, 
blank matrix spiked with OTA, and the samples collected after oral administration of 
OTA. The results showed that in both transitions no interference peaks at the retention 
time of OTA appeared, indicating that the method was selective. 
The calibration curves using the isotope dilution method were created after the 
injection (5 μL) of each standard solution, i.e., solvent, plasma, heart, liver, spleen, 
lung, kidney and brain matrices, respectively. As shown in Table 3.12, linear 
relationships and good coefficients of determination (R2≥0.9990) were obtained. A 
lack-of-fit analysis was also performed. The results clearly showed that all p values 
were higher than 0.05 confirming the reliability of the chosen calibration range for the 
quantification of OTA in different matrices (Table 3.12). The LLOD and LLOQ for 
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OTA in plasma were 0.01 ng/mL and 0.05 ng/mL, respectively, while in heart, liver, 
spleen, lung, kidney and brain they were expressed as 0.01 ng/g and 0.05 ng/g, 
respectively. The obviously lower concentrations compared to the previous reports 
indicated that the sensitivity of the method met the requirements of determination of 
OTA in different biomatrices 38,39. 
 
Table 3.11 Recovery tests of ochratoxin A (OTA) in different matrices. Data for all response 
variables were reported as mean±SD (n=6). 
Matrix Spiked level 
Accuracy  
(%) 
Extraction recovery  
(%) 
Plasma 
LLOQ a 96.4±9.0 81.7±3.2 
Low level b 94.3±7.0 80.3±4.1 
Intermediate level c 95.6±7.5 84.1±3.8 
High level d 95.2±4.3 88.0±5.1 
    
Heart 
LLOQ 88.7±12.7 73.4±6.2 
Low level 84.1±10.0 78.9±6.5 
Intermediate level 83.7±8.6 80.3±5.9 
High level 84.6±10.8 77.5±4.3 
    
Liver 
LLOQ 89.3±6.3 88.5±6.7 
Low level 92.5±7.9 83.7±7.1 
Intermediate level 90.8±6.8 96.8±6.5 
High level 89.8±3.5 92.2±5.2 
    
Spleen 
LLOQ 90.3±12.1 80.5±5.3 
Low level 96.8±8.7 83.0±7.6 
Intermediate level 91.3±6.1 82.4±2.1 
High level 85.8±5.9 82.0±3.4 
    
Lung 
LLOQ 92.0±10.7 85.0±4.6 
Low level 108.3±5.2 90.3±7.5 
Intermediate level 92.3±5.2 91.9±7.7 
High level 84.2±3.8 94.1±6.9 
    
Kidney 
LLOQ 101.8±7.5 86.7±7.2 
Low level 83.3±9.8 80.4±7.4 
Intermediate level 103.8±9.9 98.3±6.5 
High level 98.2±6.0 98.0±5.9 
    
Brain 
LLOQ 103.8±8.2 83.6±7.6 
Low level 103.9±7.1 85.9±3.2 
Intermediate level 98.6±6.3 86.7±3.4 
High level 89.9±8.8 72.4±7.1 
a LLOQ was designed as 0.05 ng/mL or ng/g; 
b Low level was designed as 1.0 ng/mLor ng/g; 
c Intermediate level was designed as 10.0 ng/mL or ng/g; 
d High level was designed as 100.0 ng/mL or ng/g. 
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Table 3.12 Eight calibration curves of ochratoxin A (OTA) in solvent and seven different matrices.  
Matrix Slope Intercept R2 
Lack of fit 
 (p value) 
Range 
(ng/mL) 
Sensitivity 
(ng/mL or ng/ga) 
LLOD LLOQ 
Solvent 0.059 0.025 0.9995 0.329 0.05-500 0.01 0.05 
Plasma 0.061 0.058 0.9991 0.463 0.05-500 0.01 0.05 
Heart 0.063 0.185 0.9990 0.080 0.05-500 0.01 0.05 
Liver 0.067 0.157 0.9991 0.103 0.05-500 0.01 0.05 
Spleen 0.068 0.142 0.9992 0.214 0.05-500 0.01 0.05 
Lung 0.068 0.111 0.9996 0.274 0.05-500 0.01 0.05 
Kidney 0.065 0.156 0.9992 0.339 0.05-500 0.01 0.05 
Brain 0.070 0.143 0.9993 0.198 0.05-500 0.01 0.05 
a ng/mL and ng/g refer to the values of LLOD and LLOQ of OTA in plasma and tissues, 
respectively. 
 
The extraction recoveries were in the range of 72.4-98.3% (Table 3.11), indicating a 
satisfactory sample pretreatment. The matrix effects were also evaluated by 
determination of the SSE. The results showed that negligible matrix effects were 
observed in plasma, heart, liver, lung, kidney and brain with the SSEs ranging from 
96.5% to 117.6%. Compared to other organs, a more pronounced matrix effect of 
spleen caused signal enhancement of 142.1%. The various extents of SSE impelled 
the use of a proper IS. In order to find out whether the IS could be used for correction 
of losses during the ionization process, SSE using [13C20]-OTA as the isotope IS was 
also investigated. The results showed that the SSEs were in an acceptable range of 
103.4–118.6%. 
The method accuracy at different concentrations is presented in Table 3.11 (range 
of 83.3-108.3%). Values for the intra- and inter-day precision determined at 0.05, 1, 
10 and 100 ng/mL are shown in Table 3.13. The RSDs were not above 15.6% in all 
cases.  
All these values indicated that the established method was more sensitive and 
accurate for the determination of OTA compared to the previously established 
methods 5,40, and could be applied in plasma, heart, liver, spleen, lung, kidney and 
brain. 
The short-term stability (at room temperature for 8 h), freeze–thaw stability (three 
circles) and long-term stability (at -20 °C for 2 weeks) were thoroughly investigated 
and results are shown in Table 3.14. The obtained results clearly demonstrated that all 
the samples were stable under these conditions, indicating that there were no 
stability-related problems during the routine and large-scale analysis of samples. 
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Table 3.13 Intra- and inter-day precision tests of ochratoxin A (OTA) in different matrices (n = 6). 
Matrix Spiked level 
Intra-day 
(RSDr %) 
Inter-day 
 (RSDR %) 
Plasma 
LLOQ a 8.7 6.7 
Low level b 6.6 5.4 
Intermediate level c 7.2 6.2 
High level d 4.1 8.9 
    
Heart 
LLOQ 11.3 10.9 
Low level 8.4 3.8 
Intermediate level 7.2 6.7 
High level 9.1 5.2 
    
Liver 
LLOQ 5.6 11.6 
Low level 7.3 10.8 
Intermediate level 6.2 9.1 
High level 3.1 4.3 
    
Spleen 
LLOQ 10.9 13.6 
Low level 8.4 11.2 
Intermediate level 5.6 8.4 
High level 5.1 10.6 
    
Lung 
LLOQ 9.8 15.6 
Low level 5.6 5.9 
Intermediate level 4.8 8.9 
High level 3.2 7.1 
    
Kidney 
LLOQ 7.6 8.2 
Low level 8.2 7.8 
Intermediate level 10.3 6.4 
High level 5.9 3.9 
    
Brain 
LLOQ 8.5 7.8 
Low level 7.4 4.7 
Intermediate level 6.2 6.1 
High level 7.9 8.2 
a LLOQ was designed as 0.05 ng/mL or ng/g ; 
b Low level was designed as 1.0 ng/mL or or ng/g; 
c Intermediate level was designed as 10.0 ng/mL or ng/g ; 
d High level was designed as 100.0 ng/mL or ng/g. 
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Table 3.14 Stability of ochratoxin A (OTA) in different biomatrices. Data for all response 
variables were reported as mean±SD (n=6). 
Matrix 
Concentrations 
(ng/mL or ng/g a) 
Recovery (mean ± S.D. %) 
Short-term stability  
(at room 
temperature for 8h) 
Freeze–thaw 
stability 
(three circles) 
Long-term stability 
(at -20 °C for 20 days) 
Plasma 
1 88.4±3.1 82.5±5.6 90.2±9.1 
100 76.2±4.1 80.6±2.8 88.4±5.3 
Heart 
1 80.2±2.9 82.7±6.9 86.4±8.9 
100 82.2±3.1 91.6±5.7 89.2±3.3 
Liver 
1 82.0±5.4 84.1±10.2 78.4±5.6 
100 85.6±2.9 92.7±8.1 81.3±6.5 
Spleen 
1 82.7±4.1 83.3±6.1 85.9±7.2 
100 80.9±3.1 90.2±5.9 88.4±10.9 
Lung 
1 79.1±3.8 91.5±8.1 79.6±5.8 
100 84.1±5.3 92.2±10.2 81.2±9.5 
Kidney 
1 77.2±6.4 89.2±6.2 83.4±5.2 
100 78.4±6.5 86.3±8.1 81.6±6.9 
Brain 
1 75.0±8.7 83.6±5.4 80.2±3.4 
100 82.6±3.5 84.7±6.9 88.5±4.6 
a ng/mL and ng/g refer to the concentrations of OTA in plasma and tissues, respectively. 
 
3.3.3.4 Kinetics and distribution study in rat plasma and tissues 
 
A plot of the concentration of OTA in plasma vs time after oral administration of 0.2 
mg/kg b.w. is shown in Fig. 3.17. The calculated kinetic parameters are expressed as 
mean±SD (Table 3.15). After oral administration, OTA reached a maximum value of 
1932.4±124.9 ng/mL within 5 h due to its rapid absorption, which has good 
agreement with previous report 41. Then, the concentration of OTA was kept at 
relatively high level in plasma with t1/2 of 75.6±29.0 h. The slow elimination of OTA 
might be due to its high binding affinity to serum proteins such as albumin, as well as 
enterohepatic recirculation of the toxin, substantially contributing to the development 
of its chronic effects 42. In previous studies, the plasma t1/2s were 10 days, 3 days and 
103 h in the Fischer, Dark Agouti and female SD rats, respectively 22,41. Different 
animal species also showed different t1/2s, i.e., t1/2 was 0.68 h for carp, 6.7 h for quail, 
72 h for pig and 510 h for monkey macaca. These markedly different plasma retention 
times of OTA might be due to differences between these species concerning serum 
proteins since most of the circulating OTA is well known to bind to serum albumins 21. 
Interestingly, the t1/2 of experimentally orally ingested OTA was shorter than that of 
intravenously injected OTA as reported in a previous study 43. Indeed, exposure of the 
toxin after oral administration was lower and systemic concentrations fell below the 
LLOQ faster than that after IV administration.  
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Figure 3.17 Mean plasma concentration–time curve of ochratoxin A (OTA) following the oral 
administration of OTA (0.20 mg/kg b.w.) in rat. Data for all response variables were reported as 
mean±SD (n=6). 
 
Table 3.15 Kinetic parameters of ochratoxin A (OTA) (0.20 mg/kg b.w.) after oral administration 
in rat. Data for all response variables were reported as mean±SD (n=6). 
Kinetic parameters Unit OTA 
AUC a (0-t) μg*h /L 121257.2±8383.8 
AUC (0-∞) μg *h /L 121739.8±8497.9 
MRT b (0-t) h 67.8±0.3 
MRT (0-∞) h 69.8±1.6 
t1/2 c h 75.6±29.0 
T max d h 4.8±2.8 
CLz /F e L/h/kg 0.002±0.0 
Vz /F f L/kg 0.178±0.059 
Cmax g μg /L 1932.4±124.9 
a the area under the curve 
b mean residence time 
c half-life time 
d time to maximal concentration 
e total body clearance 
f apparent volume of distribution   
g maximal concentration 
 
After oral administration of OTA, a rapid distribution in different rat tissues was 
observed (Fig. 3.18). With the tested OTA ingestion level (0.2 mg/kg b.w.), the 
concentrations in heart, liver, spleen, lung, kidney and brain were positively related to 
the plasma concentrations with delaying times due to the transfer of the toxin from the 
plasma to the target organs. For example, the highest concentrations of OTA were 
reached in all of the target tissues nearly at 4 h after oral administration. In general, 
kidney received most attention because of OTA’s nephrotoxicity. As shown in Fig. 
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3.18, the highest concentrations of OTA among different tissues were observed in 
kidney, which was similar to the results of the tissue distribution of OTA in pig, 
chicken and goat 21. This might be due to its re-absorption in all kidney segments, 
which may lead to the increase of its toxicity e.g. the disturbance of pH homeostasis 
in the renal papilla 39. Interestingly, OTA was also detected in brain homogenate, 
demonstrating that OTA could efficiently cross the blood–brain barrier. 
Concentrations of OTA in different tissues were declined as the concentrations in 
plasma and were below the LLOD at the last four sampling points (360 h). On the 
other hand, the slow elimination of OTA either from plasma or different tissues 
confirms previous observations on the kinetics of OTA transformation by 
cytochromes P450 and peroxidases in vitro, revealing that OTA biotransformation by 
these enzymes was very inefficient 44,45. 
 
Figure 3.18 The concentration–time profile of ochratoxin A (OTA) in the different rat tissues  
after oral administration of OTA (0.20 mg/kg b.w.). Data for all response variables were reported 
as mean + SD (n=6). 
 
Tissue accumulation was also studied after a daily oral administration of 0.1 mg/kg 
b.w. OTA during 20 days (Fig. 3.19). The highest concentration of OTA was observed 
in lung (95.9 ± 13.7 ng/g), followed by liver (76.0 ± 9.7 ng/g), heart (62.0 ± 4.2 ng/g) 
and kidney (55.7 ± 4.7 ng/g), which might be related to its toxic effects, i.e., renal 
carcinogenic and hepatotoxic effects, as well as urinary tract tumors. The results of 
the lower accumulation of OTA in kidney compared to that in lung, liver and heart, 
where similar results were reported in previous studies 46,47, apparently inconsistent to 
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the case that kidney was commonly recognized as the targeted toxic organ of OTA. 
Indeed, Toxicity is not only driven by tissue distribution and toxicokinetics,  but also 
by organ-specific toxicodynamic effects. Furthermore, since the vascular part of the 
tissue is quite extensive, organs also contain blood and the concentration of 
mycotoxin is often related to the amount of blood present in the tissues 48. The results 
shown in tissues might be related to the amount of vascular tissue in the organs. The 
higher concentrations of OTA in lung, heart and liver might be due to the relatively 
high distributions of the vessels, and thus could not infer that these organs are also the 
specific targets of OTA.  
 
Figure 3.19 The tissue accumulation of ochratoxin A (OTA) after a daily oral administration of 
0.1 mg/kg b.w. OTA during 20 days. Data for all response variables were reported as mean+SD 
(n=6). 
 
3.3.3.5 Biotransformation study of OTA 
 
The experimental mass of the parent (OTA) ions given by the LC-TOF-MS was m/z 
=404.0880 ([M+H]+) and m/z =426.0705 ([M+Na]+), which was less than a 5 ppm 
difference compared to the theoretical mass, 404.089 ([M+H]+) and 426.0715 
([M+Na]+), and the molecular formula proposed, C20H18ClNO6, was the same as the 
theoretical molecular formula (Fig. 3.20a). OTA was identified in all biomatrices of 
heart, liver, spleen, lung, kidney and brain with the retention time of 6.26 min. 
According to the same principle, phenylalanine was identified in heart and kidney 
with the retention time of 0.93 min (Fig. 3.20c). Although phenylalanine might also 
be present in rat even without administration of OTA, no phenylalanine was detected 
by the established LC-TOF-MS in blank matrices of heart and kidney. Therefore, OTA 
could be transformed to phenylalanine in heart and kidney. In kidney, ochratoxin β 
(OTβ) with precursor ion of m/z=223.0634 and retention time of 7.25 min was also 
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detected (Fig. 3.20b). In addition, after direct injection of the standard solution of 
OTA, no OTβ and phenylalanine were observed, indicating that phenylalanine and 
OTβ were not pre-existing impurities. Based on the identification of OTβ and 
phenylalanine, a possible metabolic pathway of OTA in kidney was proposed (Fig. 
3.21). First, OTA might be dechlorinated in vivo to transform to ochratoxin B (OTB), 
as reported in previous studies though not found in the present study 31,49. Then, a 
hydrolysis reaction could occur and OTB was conversed to OTβ and phenylalanine. 
The site of hydrolysis was tentatively supposed to be N-C9. This pathway was in 
accordance to the literature, which reported that OTB can be transformed into OTβ by 
the liver microsomes of rats in the presence of NADPH in vitro, and OTβ was also the 
major metabolite excreted in the urine when male F344 rats were administered with 
OTB 49. On the other side, OTA also might be directly metabolized to OTβ and 
phenylalanine in kidney. OTα, the direct hydroxyl metabolite of OTA, was not 
detected in any biomatrices, which was also in agreement with the findings from 
previous metabolism studies in rat, in which OTα was excreted mainly in faeces and 
was detected as the only metabolite recovered from the caecum and large intestine of 
rat 50-52. Another metabolisation product named OTB methyl ester, which was 
reported in plants, was found in spleen with m/z 384.1456 ([M+H]+) and 406.1275 
([M+Na]+) and retention time of 9.8 min. Compared to the molecular structure of 
OTA, OTβ, phenylalanine and OTB methyl ester can lead to a significant reduction in 
toxicity 52. The OTA-glucuronides identified in Chapter 3.2 were not detected here, 
which might be attributed to the unstability of these metabolites and their low transfer 
rate (less than 5%). 
 
Figure 3.20 Identification of ochratoxin A (OTA) and its metabolites by liquid chromatography 
coupled with time of flight mass spectrometry (LC-TOF-MS). (a) = OTA, (b) = ochratoxin β 
(OTβ), (c) = phenylalanine, (d) = ochratoxin B (OTB) methyl ester.  
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Figure 3.21 The proposed metabolic pathway of ochratoxin A (OTA) in rat. 
 
3.3.4 Conclusions 
 
A combinatorial approach of LC-MS/MS and LC-TOF-MS were developed for 
quantitative and qualitative analysis of OTA and its metabolites in plasma, heart, liver, 
spleen, lung, kidney and brain in rat. Full validation of LC-MS/MS indicated that the 
method with a total run time of 7 min for each sample showed higher sensitivity and 
faster sample preparation, as well as more accuracy aided by isotope IS than the 
previously reported ones. The firstly developed LC-TOF-MS method for 
identification of metabolites of OTA in different biomatrices showed obvious 
advantages in terms of easy automatization and unambiguous analyte identification 
without any further time-consuming and error-prone confirmation steps with a total 
run time of 14 min. The combinatorial platform has been successfully applied to 
uncover the in vivo kinetics and biotransformation of OTA in rat.  
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4.1 QUANTITATIVE ASSESSMENT OF THE RISKS 
ASSOCIATED WITH DIETARY INTAKE OF OCHRATOXIN 
A ON THE ADULT INHABITANTS IN SHANGHAI CITY OF 
P.R. CHINA 
 
After investigating the toxicokinetics of mycotoxins produced by Aspergillus and 
Fusarium fungi (Chapter 3), the harmful effects on humans associated with dietary 
intake of these mycotoxins were studied in this Chapter. The risk assessment results of 
OTA obtained here could clearly identify the risks of OTA in the human diet in China. 
 
 
Redrafted from: 
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4.1.1 Introduction 
 
Due to the high toxicity and widespread occurrence of OTA, the assessment of risk 
associated with dietary intake of OTA is in need of obligatory studies. 
In general, risk assessment is the systematic characterization of the potential 
adverse effects resulting from exposure to hazardous agents, which has been clearly 
described in Chapter 1.4. Many researches on the risk assessment of OTA in different 
food commodities have been performed in Canada 1-4, Spain 5,6, European SCF, 
JECFA, the Codex Committee on Food Additives and Contaminants, and different 
countries 1,7. Whilst in contrast to other countries, evidence from human studies to 
evaluate the risk of OTA at current dietary exposures in China is still inadequate. Up 
to now, no studies have been reported to identify the risk of OTA from the diet to 
human health in China. Since the dietary habits in China are completely different 
from those in most other countries, in addition of the large geographic area and 
different environmental conditions, it is essential to perform a risk assessment to 
reveal the realistic probabilities of adverse effects associated with OTA to humans in 
China. 
The main purpose of this work is to assess possible health risks of a representative 
group of adult inhabitants in Shanghai city to OTA, by means of its occurrence in 
frequently consumed food based on the inhabitants consumption habits surveyed in 
the present study, and by comparison of the daily intake (DI) of OTA from the 
analysis of the food consumption data provided by the invited participants to the 
doses of OTA anticipated to be without appreciable risk. 
 
4.1.2 Materials and methods 
 
4.1.2.1 Standard and reagents 
 
The standards of OTA and [13C20]-OTA (IS) were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). Acetonitrile and methanol, purchased from Merck (Darmstadt, 
Germany), were both HPLC grade. Milli-Q quality water (Millipore, Billerica, MA, 
USA) was used throughout the analyses. All other reagents were of HPLC or 
analytical grade.  
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4.1.2.2 Samples 
 
A total of 400 samples randomly collected from different areas of Shanghai were 
included in four types: (a) grapes and derived products: grapes (60), red wine (20) and 
grape juice (20); (b) cereals and derived products: rice (25), maize (25), wheat (25) 
and flour (25); (c) beans and derived products: dried beans (50) and fresh beans (50); 
(d) dried fruits and derived products: peanut (50), walnut (25) and almond (25). The 
samples were collected from September, 2011 to February, 2012. Information about 
the geographic origin of the samples was registered. Each sample was milled into 
powders using a Romer analytical sampling mill (Romer Laboratories, Tulln, Austria) 
and maintained in zipper-top paper bags at −20 °C until analysis. 
 
4.1.2.3 Determination of OTA in different samples 
 
OTA concentrations were accurately quantified in different samples by the isotope 
dilution LC-MS/MS approach according to the method developed by Han et al. 8. 
 
4.1.2.4 Food consumption data 
 
A total of 265 participants (70 males and 195 females) were invited to fill in a 
questionnaire about the quantity and frequency of foods in which OTA was known or 
suspected to occur from September, 2011 to February, 2012. The questionnaire 
included 12 food items, classified in four groups: (a) grapes and derived products: 
grapes, red wine and grape juice; (b) cereals and derived products: rice, maize, wheat 
and flour; (c) beans and derived products: dried beans and fresh beans; (d) dried fruits 
and derived products: peanut, walnut and almond. Food consumption was calculated, 
from data of the food consumption questionnaires, as grams of food per person and 
day. Standard portions of each food were defined and showed to the participants by a 
photographic album. The body weight, gender and age for each participant were also 
registered. 
 
4.1.2.5 Risk assessment 
 
For the risk assessment of OTA, three TDI values, i.e., 17 ng/kg b.w./day proposed by 
Chapter 4 Risk Assessment of Selected Aspergillus and Fusarium Mycotoxins 
198 
EFSA 9, 14 ng/kg b.w./day proposed by JECFA 10 and 5 ng/kg b.w./day proposed by 
the SCF 11, were selected as the reference values.  
The point evaluation (deterministic approach) and the Monte Carlo assessment 
model (probabilistic approach) were used for the computation of the risks of OTA 
according to the equation 4-1: 
y=x·c/w                                     4-1                                                                                                 
where y is the DI values of OTA (ng/kg b.w./day), x is the food consumption 
(g/day), c is the concentration level of OTA in different food (ng/g), w is the body 
weight (kg).  
The point evaluation multiplied the distributions of “all persons” 
food-consumption data by the mean OTA-exposure data. The latter one combined 
distributions of food-consumption data with distributions of OTA in food, which 
involves a scenario in which both the levels of OTA and the intake of foods are 
modeled as distributions. The @RISK software package, version 6.0 (Microsoft, 
USA), in combination with Microsoft Excel 2002 was applied to run the simulation. 
The simulation was run for 10,000 iterations and reflects the inherent uncertainty in 
the OTA contents of different foodstuff, in food consumption and in the uncertainty of 
the mathematical process. Then, the values of DI under different percentile intakes, 
i.e., 50th, 75th, 90th, 95th, 97.5th, and 99th, were consecutively obtained, and 
compared to the TDI values to evaluate the margin of safety (MOS) according to 
equation 4-2. Significantly adverse effects of OTA could be speculated if MOS≥1. 
Otherwise, no potential adverse effects could be observed.  
MOS = DI/TDI                         4-2 
 
4.1.3 Results and discussion 
 
4.1.3.1 Evaluation of OTA contamination in different food samples 
 
Since the method established by Han et al. was originally applied to traditional 
Chinese medicines 8, a certified reference material (OTA in food, satisfactory range of 
0.5-1.3 μg/kg), supported by FAPAS, was analyzed to prove the trueness of the 
analytical method. OTA concentrations were 0.93±0.08 μg/kg, indicating that the 
isotope LC-MS/MS method was selective, robust and accurate for the determination 
of OTA not only in the traditional Chinese medicines, but also in the other food 
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matrices. The limit of quantification (LOQ) of the established LC-MS/MS method 
was 0.01 μg/kg for determination of OTA in different food matrices, and 
concentration of OTA in the analyte-free foods was recorded as 0.005 μg/kg (half of 
the LOQ), which was used for the risk assessment. 
After analysis by the established method, the foods demonstrated great variability 
in types and levels of OTA contamination. The grapes and derived products were the 
most contaminated food samples where 35 out of 100 samples contained OTA (Table 
4.1). The incidence (35%) was similar to the results (30%) reported by Lucchetta et al. 
12, but obviously lower than that reported by Solfrizzo et al. 13. In contrast to the high 
levels detected in the previous reports, the relatively low concentrations, ranging in 
levels up to 0.94 µg/kg, obtained in the present study might be attributed to the high 
selectivity of the LC-MS/MS method eliminating false positive results, or due to the 
infavourable conditions in China for the related fungi. The incidence of OTA in 
cereals and derived products (21%) was a little higher than that in dried fruits and 
derived products (16%) and in beans and derived products (14%). Among the 400 
samples, only one sample contained OTA with a concentration (7.22 µg/kg) higher 
than the maximum level established by the European Commission (5 µg/kg). All these 
values were similar to the data (the incidence of 11.8% and the concentrations of 
OTA in positive samples lower than 5 µg/kg) reported by Wu et al. using HPLC with 
fluorescence detector for the detection of OTA in grain and manufactured food 
products in China 14, and also to the results found in the United States 15, but 
significantly lower than the levels in Hungary 16.  
 
Table 4.1 Occurrence of OTA in different foods in Shanghai, China. 
Food Varieties 
Number 
(n) 
Positive 
samples 
Mean ± SD 
(µg/kg) 
Median 
(µg/kg) 
95th 
Percentile 
(µg/kg) 
Range 
(µg/kg) 
Highly contaminated 
samples 
(>5 µg/kg) 
        
Cereals and 
derived products 
100 21 0.94 ± 1.48 0.6 3.41 0-7.22 1 
        
Beans and 
derived products 
100 14 0.59 ± 0.47 0.4 1.36 0-1.59 0 
        
Dried fruits and 
derived products 
100 16 0.56 ± 0.37 0.5 1.17 0-1.22 0 
        
Grapes and 
derived products 
100 35 0.21 ± 0.22 0.2 0.57 0-0.94 0 
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4.1.3.2 Consumption of possibly contaminated food 
 
After collection of the questionnaire, the average weights of the male and female were 
calculated as 60.6 and 51.3 kg, respectively. The ages of the participants registered 
were in the range of 16-35 years old. Significant differences were found among food 
consumption of the different food varieties. Cereals and derived products were the 
highest consumed food, with a consumption of 303.5±187.3 g/d, which were in 
accordance with the values surveyed by Su et al. in China from 1989-2006 17, 
followed by beans and derived products (18.8±28.3 g/d), dried fruits and derived 
products (11.5±23.7 g/d) and grapes and derived products (2.8±5.8 g/d) (Table 4.2). 
All food varieties showed non-consumption cases (minimal value of 0 g/d).  
 
Table 4.2 Dietary consumption of different foods in Shanghai, China (g/d). 
Food Varieties Mean ± SD 90th percentile Range 
    
Cereals and derived products 303.5±187.3 544.6 0-1292 
    
Beans and derived products 18.8±28.3 42.3 0-359 
    
Dried fruits and derived products 11.5±23.7 48.2 0-300 
    
Grapes and derived products 2.8±5.8 38.8 0-50 
 
4.1.3.3 Risk assessment 
 
4.1.3.3.1 Point evaluation 
 
The results of the risk assessment of OTA performed by point evaluation are shown in 
Table 4.3. Mean DI estimated from food data was 1.147 ng/kg b.w./day, which was 
lower than all the reference values, however, DI values (8.566 ng/kg b.w./day) in the 
97.5th percentiles were above the TDI (5 ng/kg b.w./day) proposed by the SCF. This 
was similar to the results of the risk assessment performed based on OTA plasma 
levels in the province of Lleida, Spain 5.   
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Table 4.3 The results of the risk assessment of OTA performed by the point evaluation (ng/kg 
b.w./day). 
Food Varieties Mean 50th Percentile 
97.5th 
Percentile 
Cereals and derived products 1.093 0.027 7.962 
    
Beans and derived products 0.029 0.002 0.354 
    
Dried fruits and derived products 0.019 0.001 0.210 
    
Grapes and derived products 0.005 0.000 0.040 
    
Total 1.147 0.030 8.566 
 
Among the four different groups of foods, OTA in cereals and derived products 
made the largest contribution to the health risk. The mean DI value and 97.5th 
percentile were 1.093 ng/kg b.w./day and 7.962 ng/kg b.w./day, respectively, 
indicating that more than 90% of the risk was due to the contamination of OTA in 
cereals and derived products, which was the major food for the inhabitants in 
Shanghai. The mean DI values and 97.5th percentiles of OTA in beans and derived 
products and dried fruits and derived products were 0.029 ng/kg b.w./day and 0.354 
ng/kg b.w./day, and 0.019 ng/kg b.w./day and 0.210 ng/kg b.w./day, respectively. 
Although high incidence of OTA was found in grapes and derived products, relatively 
low risks were observed with the mean DI value and 97.5th percentile of 0.005 ng/kg 
b.w./day and 0.040 ng/kg b.w./day, respectively.   
Differences of health risks of OTA between male and female were also investigated. 
The mean DI value of male (1.227 ng/kg b.w./day) was a little higher than that of 
female (1.118 ng/kg b.w./day) (Fig. 4.1). The values found in China were similar to 
the result of Thuvander et al, in which the risks of OTA from food consumption and 
food contamination data (1.3-1.4 ng/kg b.w./day) were estimated in Scandinavia 18. 
The DI values of male and female in 97.5th percentile were 9.121 ng/kg b.w./day and 
8.367 ng/kg b.w./day, respectively, which are both above the reference value set by 
the SCF. Similar as described above, the contamination of OTA in cereals and derived 
products made the largest contribution, more than 90%, to the health risk for both 
male and female (Fig. 4.1). 
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Figure 4.1 Risk assessments of OTA in different foodstuffs for male and female. 
 
4.1.3.3.2 Monte Carlo assessment model 
 
When the point evaluation was utilized for the risk assessment, the variability and 
uncertainty of the food consumption and contamination levels were not considered, 
resulting in over-evaluation of the exposure. In an effort to account for the highly 
variable occurrence data and to provide more realistic estimates of exposure, a full 
probabilistic method (Monte-Carlo model) was used for further investigation. The 
mean DI values (confidence intervals) and the 50th, 75th, 90th, 95th, 97.5th, and 99th 
percentiles are shown in Table 4.4. The mean DI values for male, female and total 
person were 1.149, 1.047 and 1.074 ng/kg b.w./day, respectively. All the DIs were 
below the three reference values. Some of the DI values in the 95th, 97.5th and 99th 
were still below the latest TDI sproposed by EFSA and JECFA, but above the limit (5 
ng/kg b.w./day) proposed by the SCF, which also supported the results from the point 
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evaluation. 
 
Table 4.4 Results of the risk assessment of OTAperformed by the Monte Carlo assessment model 
(ng/kg b.w./day). 
Percentiles Man Woman Average 
Mean 1.149(0.543, 2.261) 1.047(0.495, 2.057) 1.074(0.508, 2.111) 
50.0th 0.032(0.032, 0.032) 0.029(0.029, 0.029) 0.030(0.030, 0.030) 
75.00th 0.036(0.033, 1.387) 0.034(0.030, 1.251) 0.035(0.031, 1.287) 
90.00th 3.734(1.387, 4.744) 3.402(1.251, 4.365) 3.490(1.287, 4.465) 
95.00th 4.744(3.734, 9.151) 4.365(3.402, 8.401) 4.465(3.490, 8.599) 
97.50th 9.121(4.654, 42.106) 8.367(4.268, 38.108) 8.566(4.370, 39.164) 
99.00th 9.151(4.888, 42.106) 8.401(4.544, 38.108) 8.599(4.635, 39.164) 
 
The DI values of OTA in mean, 50th, 75th, 90th, 95th, 97.5th and 99th percentiles 
from cereals and derived products (a and b), beans and derived products (c and d), 
dried fruit and derived products (e and f) and grapes and derived products (g and h) by 
male and female are shown in Fig. 4.2. Similar to the results of the point evaluation, 
the DI values of OTA from cereals and derived products were the highest, while those 
of grapes and derived products were the lowest. Similar health risks of OTA from 
beans and derived products were observed between male and female (Fig. 4.2). 
However, compared to female, higher risks in cereals and derived products, and lower 
risks in beans and derived products and grapes and derived products were found for 
male, which might be due to different consumption habits.  
Overall, it appeared to be a low risk of OTA to consumers in Shanghai city, P. R. 
China. However, in some special cases when a single diet is used for a long time, 
potential health risks do exist. Moreover, it should be noted that the study population 
consisting of only adults was not representative of the whole population, as children 
and elderly people were not included in the present study. 
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Figure 4.2 The DI values of OTA from cereals and derived products (a for male and b for female), 
beans and derived products (c for male and d for female), dried fruits and derived products (e for 
male and f for female), and grapes and derived products (g for male and h for female), 
respectively. 
 
4.1.4 Conclusions 
 
As a natural and unavoidable contaminant of important agricultural commodities and 
derived products, OTA has continued to impact on human health. The risk is well 
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recognized, but at present it has not been accurately quantified. In the present study, 
the point evaluation and the Monte-Carlo model were combined and applied to 
perform a quantitative risk assessment of OTA based on the consumption habits of 
inhabitants in Shanghai city. The obtained results indicated that the mean DI values in 
the studied locations were lower than the TDIs. However, high percentiles (≥97.5%) 
showed higher values of DI. In addition, the investigated population consisting of 
only adult inhabitants is not representative of the whole population as elderly people 
and children did not participate in the study, and the diet simplification phenomenon 
still exists in some areas of Shanghai.  
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4.2 CUMULATIVE HEALTH RISK ASSESSMENT OF THE 
CO-OCCURRING MYCOTOXINS DEOXYNIVALENOL 
AND ITS ACETYL DERIVATIVES IN WHEAT AND MAIZE 
 
The risk assessment strategies proposed in Chapter 4.1 only focused on one 
mycotoxin. Actually, different mycotoxins could co-occur in maize and wheat 
worldwide, posing synergistic or additive adverse health effects. Therefore, the health 
risks related to a group of frequently co-occurring mycotoxins including DON, 
3-ADON and 15-ADON, produced by Fusarium fungi, were simultaneously 
investigated by using the concentration addition concept. This strategy can accurately 
estimate the total risk of different mycotoxins, and thus is more valuable than single 
mycotoxin risk assessment.   
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4.2.1 Introduction 
 
DON, 3-ADON and 15-ADON, mainly produced by F. graminearum and F. 
culmorum, are co-occurring mycotoxins in maize and wheat worldwide. Various 
toxicological effects have been reported and a large amount of regulations have been 
set for these mycotoxins in different countries (Chapter 1.4.1 and Chapter 1.4.2). Due 
to the high toxicity and co-occurrence of the targeted mycotoxins, assessments of 
cumulative health risks associated with DI of multiple mycotoxins are required. 
A number of methods for the hazard and risk assessment of chemical mixtures of 
environmental contaminants have been developed to predict the combined toxicity of 
mixtures and their risks 19 (Chapter 1.4.3.3). Among them, the approach based on CA 
concept seems to be the most suitable one for the cumulative risk assessment of DON, 
3-ADON and 15-ADON because of their similar actions and toxicity. 
The objectives of the present study were (i) to determine the occurrence of DON 
and its derivatives in maize and wheat originating from Shanghai, China; (ii) to make 
the first attempt using CA concepts to quantitatively assess the potential risks to 
Shanghai residents associated with the intake of co-occurring mycotoxins, 
individually and in combination; (iii) to clarify the mechanism of the interaction and 
cumulative effects of different mycotoxins; (iv) to investigate the relationship 
between the mycotoxins exposure and the dietary habits of Shanghai residents as well 
as the other elements, i.e., age and gender, in order to better understand the causal 
factors of the health risks to Shanghai populations and to be able to set-up effective 
prevention and control actions.  
 
4.2.2 Materials and methods 
 
4.2.2.1 Reagents and materials 
 
The chemical standards of DON, 3-ADON and 15-ADON were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Acetonitrile and methanol, purchased from 
Merck (Darmstadt, Germany), were both HPLC grade. Milli-Q quality water 
(Millipore, Billerica, MA, USA) was used throughout the analyses. All other reagents 
were of HPLC or analytical grade.  
 
Chapter 4 Risk Assessment of Selected Aspergillus and Fusarium Mycotoxins 
208 
4.2.2.2 Apparatus 
 
The quantification of DON, 3-ADON and 15-ADON was performed by LC-MS/MS 
(SHIMADZU, Kyoto, Japan). Inertsil ODS column (100 mm×2.1 mm, 3 µm) (GL 
Sciences B.V., Eindhoven, Netherlands) at 35 °C was utilized for separation with a 
linear gradient elution using (A) water and (B) methanol as the mobile phase under 
ESI-. The elution program was set as follows: 20% B (initial), 20–80% B (0-6 min), 
80–20% B (6-6.1 min) and hold on for a further 5.9 min for re-equilibration, giving a 
total run time of 12 min. The flow rate was 0.3 mL/min and the injection volume was 
5 μL (partial loop with needle overfill). MS/MS detection was performed with the 
following parameters: nebulizing gas flow of 3 L/min, drying gas flow of 15 L/min, 
interface voltage of 4.5 kV, DL temperature of 250 °C, heat block temperature of 
400 °C. Quantification was performed in multiple reaction monitoring (MRM) mode 
and the parameters were optimized for each mycotoxin during infusion (Table 4.5).  
 
Table 4.5 The MS/MS parameters for deoxynivalenol (DON), 3-acetyldeoxynivalenol (3-ADON) 
and 15-acetyldeoxynivalenol (15-ADON). 
Mycotoxins 
Precursor 
ions 
(m/z) 
Primary 
product ions 
(m/z) 
Collision 
energies 
(eV) 
Secondary 
product ions 
(m/z) 
Collision 
energies 
(eV) 
DON 295 265 15 247 16 
3-ADON 337 307 15 173 16 
15-ADON 337 219 18 277 15 
 
4.2.2.3 Dietary consumption data 
 
Three different zones were targeted according to the population distribution and 
comprised of the city center, countryside and island. The four districts representing 
the central part of Shanghai included Xuhui, Hongkou, Changning and Yangpu, while 
Pudong and Fengxian districts represented the suburbs. Congming district was the 
only island in Shanghai. A schematic view of the map of Shanghai showing the 
geographical location of the studied areas is represented in Fig. 4.3. 
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Figure 4.3 Map of Shanghai showing the locations of different studied regions for sample 
collection and dietary consumption data investigation. 
 
Representative food consumption data were obtained from the Shanghai Food 
Consumption Survey of 2012-2013. The recruitment of participants took gender into 
consideration and comprised of a total of 1269 participants, including 608 males and 
661 females, with the age older than 7, using a balanced design as recommended by 
Schiebinger 20. A 24-hour dietary recall questionnaire was administrated, in which the 
wheat and maize products used in preparing home meals were clearly listed. A 
carefully structured questionnaire was designed and administered by trained 
interviewers and included all basic information such as demographic factors (age, sex 
and education), socioeconomic and general health status. 
 
4.2.2.4 Samples for analysis 
 
From 2009-2012, a total of 330 samples including wheat (n=198) and maize (n=132) 
were randomly collected from supermarkets located in the same three studied zones of 
Shanghai. The distributions of the samples across the different years were as follows: 
18 wheat and 30 maize samples were collected in 2012, 20 wheat and 20 maize 
samples in 2011, 40 wheat and 37 maize samples in 2010, 120 wheat and 45 maize 
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samples in 2009. All samples were ground into powders, maintained in zipper top 
paper bags to prevent humidity changes and stored at -20 oC prior to analysis. The 
concentrations of DON were determined by LC-MS/MS in all samples collected 
during the 4-year period, while 3-ADON and 15-ADON were only analyzed in the 
samples collected in 2011 and 2012 after the regulations for these toxins were issued 
by JECFA 21.  
 
4.2.2.5 Sample preparation 
 
The wheat and maize samples were pretreated according to the standard operating 
procedures regulated in China 22. Portions of 5 g of tested samples were accurately 
weighed and put into 50 mL polypropylene centrifuge tubes. Then, 10 mL of water, 5 
g of sodium chloride and 16 mL of acetonitrile were added. The mixture was shaken 
for 30 minutes, and then centrifuged at 5000 g for 5 minutes. An aliquot of 8 mL of 
the supernatant was collected and mixed with 4 mL of n-hexane saturated with 
acetonitrile. After mixing for 3 minutes and centrifugation at 5000 g for 2 min, the 
acetonitrile layer was selected and dried by nitrogen gas at 45 oC. The residues were 
dissolved in 5 mL of water and passed through preconditioned Oasis HLB SPE 
cartridges at a rate of about 2 mL/min, and then 5 mL of water was passed through the 
cartridges at a rate of about 2 mL/min. All targets were eluted with 5 mL methanol 
and then dried by nitrogen gas at 40 oC. The residues were reconstituted in 1 mL 
methanol/water (20/80, v/v) solution, passed through a 0.22 μm nylon filter (Millipore, 
Billerica, MA, USA) and ready for injection.  
 
4.2.2.6 Risk assessment 
 
The health risks of DON were first assessed using all samples collected in the period 
2009-2012. In order to compare the health risks related to single and multiple 
mycotoxins, the risks related to DON, 3-ADON, 15-ADON and the combinations of 
these mycotoxins (DON+3-ADON, DON+15-ADON, 3-ADON+15-ADON and 
DON+3-ADON+15-ADON) were further evaluated using only the samples collected 
in the period 2011-2012.  
Two mathematical approaches, point evaluation (deterministic approach) and 
Monte Carlo simulation (probabilistic analysis) were used for the computation of the 
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risk assessments for DON, 3-ADON and 15-ADON. The point evaluation multiplied 
the mean/highest mycotoxin concentration data by the mean/highest 
food-consumption data. The Monte Carlo approach simulated both the 
food-consumption data and the concentration levels of mycotoxins as distributions. 
Best fit distributions were formed for DON and its derivatives individually and in 
combination in maize and wheat and also to the respective consumption data. First 
order Monte Carlo simulations were performed considering 5,000 iterations. By 
means of Monte Carlo simulation, the inherent uncertainty and variability associated 
with the mycotoxin contents of different foodstuffs, the food consumption pattern and 
in the mathematical process were considered. The exposure results for DON were 
calculated over the 4-year (2009-2012) and 2-year (2011-2012) period and expressed 
as a ratio (DON exposure from samples collected in the period 2009-2012/DON 
exposure from samples collected in 2011-2012; expressed as DON4-year/DON2-year). 
The whole population was grouped into subgroups by gender (male and female) and 
age (≥18, 15-17, 11-14, 7-10), and were investigated respectively, in order to better 
understand the causal factors of the health risks to Shanghai residents. 
For evaluation of the cumulative effects of multiple mycotoxins, the concentration 
addition (CA) concept was utilized. The resulting daily intake values (DIs) were 
compared with the PMTDI of 1000 ng/kg b.w./day proposed by JECFA 21 to evaluate 
the margin of safety (MOS) calculated as DI/PMTDI. 
 
4.2.2.7 Statistical analysis 
 
According to the criteria indicated in SCOOP (2003), non-detects were assigned a 
value of half the LOD (LOD/2) for the mycotoxin dietary exposure assessment. Point 
evaluation and other calculations, i.e., food consumption and mycotoxins 
contamination, were performed by using Microsoft Office Excel 2003. Probabilistic 
analysis was simulated by using @RISK software package, version 6.0 (Microsoft, 
USA). 
 
4.2.3 Results and discussion 
 
4.2.3.1 Validation of the LC-MS/MS method 
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Matrix matched calibration curves were constructed for DON, 3-ADON and 
15-ADON, respectively, to minimize the matrix effects so as to ensure the accuracy of 
the method. The results showed that linear relationships (R2≥0.999) were obtained for 
DON, 3-ADON and 15-ADON in both maize and wheat matrices with a 
concentration range of 5-500 μg/L. The recoveries for DON, 3-ADON and 15-ADON 
were in the range of 70-120%, and the intra- and inter- day precision were less than 
20%. The LOD and LOQ were designed as the concentrations of a compound at 
which its signal-to-noise (S/N) ratios were detected as 3:1 and 10:1, respectively. The 
results showed that the values for LOD and LOQ were 0.1 µg/kg and 0.5 µg/kg for 
DON, 3-ADON and 15-ADON in maize and wheat, respectively. 
All these details supported that the utilized method was reliable, sensitive and 
accurate, and could be used for the determination of the contamination levels of the 
three targeted analytes. 
 
4.2.3.2 Contamination levels of DON, 3-ADON and 15-ADON in maize and wheat 
 
From the pool of 330 samples, 237 (incidence of 71.8%) were contaminated with 
DON. The incidence of DON in wheat samples (80.8%) collected in the period of 
2009-2012 was higher than that in maize (58.3%) from the same period (Table 4.6). 
This is similar to the results (88%) earlier reported by Li et al 23. Worth noting is the 
fact that the concentrations of DON in all samples analyzed were within the limits 
(1000 μg/kg) set by the Chinese government. The relatively low concentration levels 
reported here compared to previous data from China 23,24, South Africa 25, Africa 26 
and Lebanon 27 may be due to the implementation of the strict regulations in Shanghai, 
which prevents highly contaminated samples from entering the food supply, alongside 
differences in the geographical and environmental conditions in other countries when 
compared to China. 
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Table 4.6 Occurrence of deoxynivalenol (DON), 3-acetyldeoxynivalenol (3-ADON) and 
15-acetyldeoxynivalenol (15-ADON) in maize and wheat in Shanghai, China. 
 Mycotoxins 
Total 
samples  
(n) 
Positive 
samples 
(n) 
Median 
(µg/kg) 
Mean 
(µg/kg) 
SD 
(µg/kg) 
Range 
(µg/kg) 
Maize 
DONa) 132 77 32.5 78.9 113.5 0.5-584.0 
DONb) 50 50 54.4 116.0 126.4 0.5-584.0 
3-ADONc) 50 50 1.5 2.0 1.5 0.7-8.4 
15-ADONd) 50 50 11.2 23.9 41.2 0.5-242 
Totale) 50 50 72.3 141.9 152.0 3.3-834.4 
        
Wheat 
DONa) 198 160 50 64.7 72.8 0.5-604.0 
DONb) 38 38 62.9 106.5 141.1 0.5-604.0 
3-ADONc) 38 38 6.5 10.3 8.3 0.7-35.2 
15-ADONd) 38 38 0.7 1.4 1.5 0.5-6.2 
Totale) 38 38 71.1 118.2 146.7 3.0-628.9 
a) The contamination levels of DON in wheat and maize samples collected from 2009 to 2012. 
b) The contamination levels of DON in wheat and maize samples collected from 2011 and 2012.  
c) The contamination levels of 3-DON in wheat and maize samples collected from 2011 and 2012.  
d) The contamination levels of 15-ADON in wheat and maize samples collected from 2011 and 
2012. 
e) Total was designed as the sum of the concentrations of DON, 3-ADON and 15-ADON in the 
samples collected from 2011 and 2012. 
 
Co-occurrence of DON, 3-ADON and 15-ADON was observed in maize and wheat. 
For the 2-year period, 2011-2012, all the samples were simultaneously contaminated 
by DON, 3-ADON and 15-ADON, with an incidence of 100% (Table 4.6), indicating 
that co-exposure to several different mycotoxins resulting in possible additive or/and 
synergistic toxic effects is really an important issue in maize and wheat for the 
residents in Shanghai. Differences in the contamination levels for DON, 3-ADON and 
15-ADON in maize and wheat for the 4-year period, 2009-2012 are shown in Fig. 4.4. 
The concentrations of DON were higher than that of 3-ADON or 15-ADON. 
Although there was an apparent increase in the DON levels in maize during this 
period in Shanghai, these data could not be simply interpreted as an increasing trend 
since mycotoxin contaminations highly depend on many intrinsic and extrinsic factors 
such as humidity and temperature conditions and could vary widely between and 
within regions. However, all these values clearly underlined the importance of DON 
and its derivatives, 3-ADON and 15-ADON as important contaminants in wheat and 
maize in this region.  
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Figure 4.4 Differences in the occurrence and contamination levels for deoxynivalenol (DON), 
3-acetyldeoxynivalenol (3-ADON) and 15-acetyldeoxynivalenol (15-ADON) in wheat (A) and 
maize (B) collected in the period 2009-2012. 
 
4.2.3.3 Consumption data of maize and wheat 
 
The bottle-neck in risk assessment is the availability of dietary consumption data 
regarding mycotoxins contaminated foods. The food categories investigated in the 
present study were wheat and maize. Rice, being one of the staples in Shanghai, was 
not included in this study because rice is known not to be a good substrate for 
Fusarium growth. The presence of DON, 3-ADON and 15-ADON has rarely been 
reported in rice samples. Considering other foodstuffs such as oats and nuts, 
consumption is very minimal in the region, and hence the contribution of such dietary 
sources to the total DON intake can be considered as negligible. Several approaches 
generally known as market basket, 24-hour dietary recall and food record, 
food-frequency or dietary history have been established to assess food consumption 
28-30. Given that wheat/maize-based products are considered as the major sources of 
mycotoxin exposure in the Shanghai region, the 24-hour dietary recall approach was 
chosen to determine the amounts of wheat and maize used for the family meal. 
Significant differences in the consumption of maize and wheat were observed in 
Shanghai. As shown in Table 4.7, with regards to wheat consumption, 816/1269 
(64.3%) of the consumers indicated wheat as the most popular ingredient in family 
meals. Compared to wheat, the consumption rate for maize was only 1.7%. The 
average value of wheat consumption was 1.43 g/kg b.w./day (83.2 g/d), which was in 
agreement with previously reported results of 71.2 g/d in Shanghai city 31, showing 
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the reliability of the questionnaire and suitability of the approach. 
For both wheat and maize, the average consumption values for males were higher 
than for females, which might not only be due to differences in the portion sizes, but 
also due to the differences in their specific food choices. 
With respect to age, no significant differences were observed across the different 
age groups (Fig. 4.5). Nearly all the data followed the general rules that males 
consumed more than females and that wheat was the preferred source of daily 
nutrients. It should be noted that none of the respondents within the age group of 
11-14 reported consuming a maize-based diet, but they were the highest wheat 
consumption group with average values of 2.55±2.68 g/kg b.w./day for males and 
1.80±2.42 g/kg b.w./day for females. These unbalanced dietary choices coupled with 
higher consumption of wheat might lead to higher potential health risks caused by the 
contamination of mycotoxins in wheat. 
 
Table 4.7 Consumption of wheat and maize by different populations in Shanghai, China (g/kg 
b.w./day). 
 
Male 
(average body weight of 
62.7 kg) 
Female 
(average body weight of 
54.0 kg) 
Total 
(average body weight of 
58.2 kg) 
 Maize Wheat Maize Wheat Maize Wheat 
Average 0.03 1.52 0.01 1.34 0.02 1.43 
SD 0.23 1.78 0.08 1.82 0.18 1.81 
Minimum 0.00 0.00 0.00 0.00 0.00 0.00 
Maximum 3.19 11.2 1.85 14.8 3.44 13.8 
P50 0.00 1.07 0.00 0.74 0.00 0.86 
P90 0.00 3.99 0.00 3.70 0.00 3.78 
P95 0.00 5.00 0.00 4.76 0.00 5.15 
P97.5 0.00 6.41 0.00 6.08 0.00 6.19 
P99 0.80 7.79 0.16 7.91 0.43 8.25 
Number of 
Participants 
608 608 661 661 1269 1269 
Number of 
Consumers 
12 420 9 396 21 816 
Incidence of 
consumption 
1.9% 69.1% 1.3% 59.9% 1.7% 64.3% 
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Figure 4.5 The consumption proportions of cereal grains for males (A) and females (B), and their 
average consumptions of maize (C) and wheat (D). 
 
4.2.3.4 Risk assessment 
 
Risk assessment is the process of evaluating the probable incidence of an adverse 
health effect to humans under various conditions of exposure with a description of the 
uncertainties involved. The method based on the CA concept is one of the most 
frequently applied approaches for cumulative health risk assessment of mixed 
compounds, in which, all components in the mixture are considered to have an 
equivalent mode or mechanism of action and only differ in the concentrations needed 
to elicit a toxic effect. In this case, each substance can be replaced by equivalent 
concentrations of another component without changing the overall toxicity of the 
mixture. Although, recently, the toxicity of 15-ADON was reported to be higher than 
DON and 3-ADON on the intestine 32, no other evidence has been provided for the 
toxicities of these mycotoxins on other organs, neither for the overall toxicity. The in 
vivo actions and toxicities in human bodies of DON, 3-ADON and 15-ADON were 
still considered to be similar 21. The method based on CA was suitable for quantitative 
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assessment of cumulative risks in the current study. 
 
4.2.3.4.1 Point (deterministic) evaluation 
 
The health risks associated with exposure to DON, 3-ADON and 15-ADON were first 
assessed by point evaluation. The results of the point evaluation showed that mean DI 
values (94.0 ng/kg b.w./day) of DON for the whole population from the samples 
collected in the period 2009-2012 were lower than the health-based guidance limit 
(1000 ng/kg b.w./day), which was similar to the values (104 ng/kg b.w./day) reported 
from Belgium when only cereal-based foods were considered 29. Among the three 
mycotoxins from the samples collected in the period 2011-2012, the mean DI values 
of DON were higher than that of 3-ADON and 15-ADON (Table 4.8), indicating that 
DON was the most important contributor to human health risks, although 3-ADON 
and 15-ADON also played an important role. The maximum DI values of the three 
mycotoxins calculated by point evaluation was up to 11,512 ng/kg b.w./day implying 
the potential for adverse health effects. Although the maximum data were not reliable 
enough, in which the highest consumed foods were contaminated with the highest 
mycotoxin concentrations (worst case scenario), possibilities of the adverse effects to 
humans could be speculated only when the maximum DI values﹥ PMTDI. 
Differences of health risks of DON, 3-ADON and 15-ADON between maize and 
wheat were also investigated in the present study. The average DI values for the three 
mycotoxins were 169.4 and 2.32 ng/kg b.w./day for wheat and maize, respectively, 
indicating that more than 90% of the risks were due to the contamination of wheat 
with mycotoxins. 
The health risks were also investigated for the populations in different age groups 
(Table 4.9). Although mean DI values were still within the PMTDI in all cases, a 
clearly decreasing trend could be seen with increasing age. For all age groups, the 
potential health risks of males were higher than that of females, confirming the 
hypothesis that unbalanced dietary habits combined with higher consumption could 
lead to higher risks.  
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Table 4.8 Results of the risk assessments of deoxynivalenol (DON), 3-acetyldeoxynivalenol 
(3-ADON) and 15-acetyldeoxynivalenol (15-ADON), individually and in combination, performed 
by point evaluation (ng/kg b.w./day). 
 
Mycotoxins 
Male Female Total 
 Average Maximum Average Maximum Average Maximum 
Maize 
DON4-year/DON2-year a) 2.04/3.00 1863/1863 0.48/0.71 1081/1081 1.29/1.89 2007/2007 
3-ADONb) 0.05 26.8 0.01 15.6 0.03 28.9 
15-ADONc) 0.62 771.9 0.15 448.1 0.39 831.6 
Totald) 3.67 2662 0.87 1545 2.32 2867 
 
Wheat 
DON4-year/DON2-year 98.5/162.2 6743/6743 86.5/142.4 8948/8948 92.7/152.6 8302/8302 
3-ADON 15.7 393.0 13.8 521.5 14.8 483.8 
15-ADON 2.13 69.2 1.87 91.9 2.01 85.2 
Total 180.0 7021 158.0 9317 169.4 8645 
 
Maize 
and 
Wheat 
DON4-year/DON2-year 100.5/165.2 8606/8606 87.0/143.1 10029/10029 94.0/154.5 
10309/1030
9 
3-ADON 15.8 419.8 13.8 537.1 14.8 512.7 
15-ADON 2.75 841.1 2.02 540.0 2.40 916.8 
Total 183.7 9683 158.9 10862 171.7 11512 
a) DON4-year/DON2-year means the DI values of DON from samples collected in the period 
2009-2012/ DI values of DON from samples collected in 2011-2012.  
b) The DI values of individual 3-ADON from samples collected in the period 2011-2012.  
c) The DI values of individual 15-ADON from samples collected in the period 2011-2012. 
d) The DI values of combined DON, 3-ADON and 15-ADON from samples collected in the period 
2011-2012. 
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Table 4.9 Results of the risk assessments of deoxynivalenol (DON), 3-acetyldeoxynivalenol (3-ADON) and 15-acetyldeoxynivalenol (15-ADON), individually and in 
combination, performed by point evaluation for the residents in different age groups (ng/kg b.w./day). 
 Mycotoxins 
Male 
(7-10) 
Female 
(7-10) 
Male 
(11-14) 
Female 
(11-14) 
Male 
(15-17) 
Female 
(15-17) 
Male 
(≥18) 
Female 
(≥18) 
Maize 
DON4-year/DON2-year a) 3.34/4.91 0.40/0.59 0/0 0/0 1.75/2.58 0.73/1.08 2.39/3.51 0.57/0.83 
3-ADONb) 0.08 0.01 0/0 0/0 0.04 0.02 0.06 0.01 
15-ADONc) 1.01 0.12 0/0 0/0 0.53 0.22 0.72 0.17 
Totald) 6.00 0.72 0/0 0/0 3.15 1.32 4.30 1.02 
          
Wheat 
DON4-year/DON2-year 166.7/274.5 145.5/239.5 164.9/271.4 116.3/191.4 105.4/173.5 97.0/159.6 78.7/129.5 76.9/126.5 
3-ADON 26.5 23.2 26.3 18.5 16.8 15.4 12.5 12.2 
15-ADON 3.61 3.15 3.57 2.52 2.28 2.10 1.70 1.66 
Total 304.6 265.8 301.2 212.4 192.5 177.1 143.8 140.4 
          
Maize 
and 
Wheat 
DON4-year/DON2-year 170.1/279.4 145.9/240.1 164.9/271.4 116.3/191.4 107.1/176.1 97.7/160.7 81.1/133.1 77.4/127.4 
3-ADON 26.6 23.2 26.3 18.5 16.8 15.5 12.6 12.3 
15-ADON 4.62 3.27 3.57 2.52 2.81 2.32 2.42 1.83 
Total 310.6 266.5 301.2 212.4 195.7 178.4 148.1 141.5 
a) DON4-year/DON2-year means the DI values of DON from samples collected in the period 2009-2012/ DI values of DON from samples collected in 2011-2012.  
b) The DI values of individual 3-ADON from samples collected in the period 2011-2012.  
c) The DI values of individual 15-ADON from samples collected in the period 2011-2012. 
d) The DI values of combined DON, 3-ADON and 15-ADON from samples collected in the period 2011-2012. 
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4.2.3.4.2 Probabilistic analysis 
 
When the point estimate approach is used for risk assessment, the variability and 
uncertainty of the food consumption and the contamination levels are not considered, 
resulting in over-estimation of the real exposure 4. To account for the above 
mentioned shortcomings, a full probabilistic model (Monte Carlo simulation) is 
recommended 33 as was the case in this study.  
As shown in Table 4.10, the DI values in mean and 95th percentile indicated that 
considering the individual mycotoxins, there was not any health risk to Shanghai 
residents since the computed DI values did not exceed the PMTDI. The mean 
probabilistic exposure assessment results of individual mycotoxins were similar to the 
deterministic values, and also comparable to that reported from northern Nigeria 34, 
Cameroon 35, Belgium 36 and Japan 33. When the cumulative health risks of a pair or a 
combination of the three mycotoxins were assessed, the mean DI values for 
DON+3-ADON, DON+15-ADON, 3-ADON+15-ADON and three mycotoxins were 
171.6, 164.8, 17.0 and 174.7 ng/kg b.w./day, respectively, which were still below the 
PMTDI (Table 4.10). However, exposures exceeding the PMTDI occurred at high 
(95th) percentiles (1082 ng/kg b.w./day for DON+3-ADON, 1046 ng/kg b.w./day for 
DON+15-ADON and 1087 ng/kg b.w./day for the three mycotoxins), emphasizing the 
necessity of performing the risk evaluation of not only the parent forms but also in 
combination with the mycotoxin derivatives. As shown in Fig. 4.6, the MOS values of 
combined DON, 3-ADON, 15-ADON calculated in the present study were not equal 
to the sum of the individual MOS values due to their different distribution types used 
in Monte Carlo simulation, which clearly meant that the interaction mechanism of 
DON, 3-ADON, and 15-ADON were not additive but most probably synergistic. This 
implies the approach based on the CA concept can account for the interactions and 
cumulative effects of DON, 3-ADON and 15-ADON, and can be further extended to 
other contaminants such as the AFs. We believe this is the first report carried out to 
estimate the cumulative health risks related to co-occurrence of multiple mycotoxins. 
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Table 4.10 Results of the risk assessment of deoxynivalenol (DON), 3-acetyldeoxynivalenol 
(3-ADON) and 15-acetyldeoxynivalenol (15-ADON), individually and in combination, performed 
by probabilistic analysis (ng/kg b.w./day). 
  Aa) Bb) Cc) A+Bd) A+Ce) B+Cf) A+B+Cg) 
 Mean 0.87/1.77 0.03 0.47 1.84 2.14 0.47 2.16 
 5th 0.01/0.02 0.00 0.01 0.03 0.04 0.01 0.04 
Maize 
50th 0.18/0.71 0.02 0.11 0.73 0.86 0.14 0.87 
90th 1.39/4.46 0.07 0.83 4.63 5.52 0.87 5.59 
95th 2.48/7.03 0.10 1.53 7.33 8.35 1.55 8.79 
         
 Mean 76.1/159.6 14.4 2.06 169.8 162.7 16.5 172.5 
Wheat 
5th 7.84/2.19 0.51 0.13 3.47 3.22 1.10 4.24 
50th 56.1/54.7 7.07 1.03 66.2 55.0 9.30 67.6 
90th 254.5/582.4 55.5 5.60 636.0 616.1 59.9 655.6 
95th 328.1/963.9 82.3 8.80 1075 1038 89.4 1078 
         
Wheat 
and 
Maize 
Mean 77.0/161.4 14.4 2.53 171.6 164.8 17.0 174.7 
5th 7.85/2.21 0.51 0.14 3.5 3.26 1.11 4.28 
50th 56.3/55.4 7.09 1.14 66.9 55.9 9.44 68.5 
90th 255.9/586.9 55.6 6.43 640.6 621.6 60.8 661.2 
95th 330.6/970.9 82.4 10.3 1082 1046 91.0 1087 
a) A means the DI values of DON from samples collected in the period 2009-2012/ DI values of 
DON from samples collected in 2011-2012; expressed as DON4-year/DON2-year.  
b) B means DI values of individual 3-ADON from samples collected in the period 2009-2012. 
c) C means DI values of individual 15-ADON from samples collected in the period 2009-2012.  
d) A+B means DI values of concomitant mycotoxins of DON and 3-ADON from samples collected 
in the period 2011-2012.  
e) A+C means DI values of concomitant mycotoxins of DON and 15-ADON from samples 
collected in the period 2011-2012. 
f) B+C means DI values of concomitant mycotoxins of 15-ADON and 3-ADON from samples 
collected in the period 2011-2012. 
g) A+B+C means DI values of concomitant mycotoxins of DON, 3-ADON and 15-ADON from 
samples collected in the period 2011-2012. 
 
With regards to the health risks associated with the consumption of mycotoxins 
contaminated maize and wheat, the results obtained using the Monte Carlo simulation 
were similar to that of point estimates. Contamination of DON, 3-ADON and 
15-ADON in wheat made a very large contribution (≥90%) to the total health risks 
with the DI values higher than 1000 ng/kg b.w./day in 95th percentiles (Fig. 4.6). 
Overall, the health risks of DON, 3-ADON and 15-ADON to the consumers in 
Shanghai city, China appeared to be relatively low. However, exclusive consumption 
of highly contaminated foods over a long period may pose potential health risks, 
especially when considering the cumulative effects of concomitant mycotoxins. 
Moreover, current trends show a possible shift in dietary habits among the youth from 
the traditional rice dominated diet to a more wheat and/or maize dominated diet, 
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which will also increase their exposure to mycotoxins.  
 
 
Figure 4.6 Boxplots showing the distributions of margin of safety (MOS) in different percentiles 
for males (A) and females (B) for maize consumption, males (C) and females (D) considering 
wheat consumption, males (E) and females (F) for both of the cereal grains computed by Monte 
Carlo simulation. Lower Bound: MOS value in 5th; Midline: MOS value in 50th; Upper Bound: 
MOS value in 95th. “a’” means MOS values of individual deoxynivalenol (DON) from the 
samples collected in the period 2009-2012; “a” means MOS values of individual DON from the 
samples collected in the period 2011-2012; “b” means MOS values of individual 
3-acetyldeoxynivalenol (3-ADON) from the samples collected in the period 2011-2012; “c” means 
MOS values of individual 15-acetyldeoxynivalenol (15-ADON) from the samples collected in the 
period 2011-2012; “a+b” means MOS values of concomitant mycotoxins of DON and 3-ADON 
from the samples collected in the period 2011-2012; “a+c” means MOS values of concomitant 
mycotoxins of DON and 15-ADON from the samples collected in the period 2011-2012; “b+c” 
means MOS values of concomitant mycotoxins of 3-ADON and 15-ADON from the samples 
collected in the period 2011-2012; “a+b+c” means MOS values of concomitant mycotoxins of 
DON, 3-ADON and 15-ADON from the samples collected in the period 2011-2012. 
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4.2.3.5 Uncertainty 
 
In this assessment, there were several data gaps and uncertainties. The major one is 
the relatively small sample size (n=330), which may influence the statistical 
prediction power of the study. For the collection of the consumption data, 24-hour 
dietary recall was selected. By this way, the risks were surely likely to vary daily, 
weekly, monthly and/or even yearly, thus the present study was therefore a snapshot 
of exposure that could be more or less over time. 
 
4.2.4 Conclusions 
 
To the best of our knowledge, this is the first time that a cumulative health risk 
assessment was performed on multiple mycotoxins with cereal grains as model food 
matrices. Considering the contamination levels of DON and its derivatives in wheat 
and maize, the toxic effects associated with DON, 15-ADON and 3-ADON should be 
of less concern to the population of Shanghai. After performing further quantitative 
risk assessment by Monte Carlo simulation using the CA concept, the results indicated 
that the DI values of individual mycotoxins were lower than the PMTDI. However, 
integration of the risks from DON together with one or two derivatives as concomitant 
mycotoxins gave DI values exceeding the PMTDI proposed by JECFA at 95 
percentile. Since the MOS values of the total mycotoxins were not equal to the sum of 
the individual MOS values, the interaction mechanism of DON, 3-ADON, and 
15-ADON were considered to be synergistic but not additive. In view of the 
cumulative health risks related to the DON derivatives, a call for an overhaul of 
legislation focusing not only on the parent forms of mycotoxins but also their 
derivatives is indeed indispensable. Furthermore, as recommended, the derivatives of 
DON should be included in routine monitoring and control programs of agricultural 
practices, crop management and food production, as well as food safety 
administration on environmental contaminants. 
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Mycotoxins, a series of toxic secondary metabolites, are produced by various mould 
species growing on plant-based products, e.g., wheat and maize, either in the field or 
during storage. Various toxicological effects including weight loss, carcinogenicity, 
renal intumescences and hepatotoxicity have been reported. Due to their high toxicity 
along with the widespread occurrence, it is necessary to thoroughly investigate the 
risks related to mycotoxins from the source (fungi) to the in vitro- and in vivo- 
metabolites to gain insight in food safety, protect human health and prevent economy 
losses. 
First, the toxigenic fungi and their secondary metabolites were thoroughly 
investigated. On one hand, a targeted and reliable LC-MS/MS method was developed 
for simultaneous quantification of 33 mycotoxins, i.e., AFs (AFB1, AFB2, AFG1, 
AFG2, AFM1 and AFM2), OTA, type B-trichothecenes including DON, 3-ADON, 
15-ADON, DOM-1, Fus X and NIV, type A-trichothecenes such as T-2, HT-2, NEO 
and DAS, ZEN and its derivatives, FB1, FB2, STC, GT, CIT and CPA.The validation 
details, including linearity, sensitivity, recovery, and precision, proved that the 
developed method was sensitive, accurate and repeatable, and thus, was the 
foundation of the Ph.D research for targeted analysis of important mycotoxins. Then, 
a total of twelve isolates including F. graminearum (III T010, II F030, III S002 and 
III R048), F. venenatum (III A048, IV A034, II Q002 and IV B035) and F. 
verticillioides (IV B133, II R078, III K048 and III B011) obtained in Belgium were 
investigated for their production of different Fusarium toxins under different 
environmental conditions. F. verticillioides was identified as the major strain, which is 
able to produce high concentration levels of mycotoxins in maize-based products in 
Belgium. On the other hand, an untargeted analytical strategy combining different 
techniques, i.e., LC-orbitrap, LC-ion trap, LC-MS/MS and NMR, was established to 
identify and quantify the secondary metabolites of A. flavus, not only focusing on 
known mycotoxins, but also investigating new compounds. The functions of the 
previously uncharacterized gene cluster 39 were clarified by determining the 
secondary metabolites they produce. It was found to be responsible for synthesis of 
the polyketide-derived compound, aflavarin, known for its antiinsectant activity. 
AFB1, T-2 and OTA, selected as the most frequently occurring Aspergillus and 
Fusarium mycotoxins, were further studied regarding their in vivo kinetics and 
distributions. As revealed, both AFB1 and T-2 were rapidly eliminated in rat, and they 
could not be detected either in plasma or in any tissue within less than 24 h. In 
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contrast to AFB1 and T-2, the kinetics and distribution studies of OTA in rat revealed 
that OTA could reach a maximum value within 5 h due to its fast absorption, and was 
then slowly eliminated in plasma with a t1/2 of about 75.6 h. The highest accumulation 
level was observed in lung, followed by liver, heart and kidney. Due to its slow 
degradation and high accumulation, the metabolism was further investigated to 
address remaining uncertainties regarding OTA biotransformation (glucuronidation 
and targeted tissues) by in vitro and in vivo metabolic studies. Three different 
analytical approaches including UHPLC-MS/MS, UHPLC-orbitrap-HRMS and 
LC-iontrap were applied as combined strategies to investigate the metabolic profile. 
The in vitro tests (glucuronidation reaction) indicated that via glucuronidation by rat 
liver microsomes, three different OTA glucuronide conjugates, which corresponded to 
OTA amino-glucuronide, OTA phenol-glucuronide and OTA acyl-glucuronide, were 
identified. The suggested structures were supported by the fragments observed in the 
mass spectrometers and by hydrolysis with β-glucuronidase. Meanwhile, OTA methyl 
ester, OTα and OTα-glucuronide were also formed in the same reaction mixture. The 
in vivo metabolic study was performed by oral administration of OTA in rats. Three 
less toxic metabolites of OTA including phenylalanine, ochratoxin β (OTβ) and OTβ 
methyl ester were identified and two possible metabolic pathways in kidney were 
proposed: first, OTA might be dechlorinated to form ochratoxin B, and then, a 
hydrolysis reaction could occur producing OTβ and phenylalanine. The site of the 
hydrolysis was tentatively supposed to be N-C9. On the other side, OTA also might be 
directly metabolized to OTβ and phenylalanine. 
Finally, quantitative risk assessments for typical Aspergillus and Fusarium 
mycotoxins (OTA, DON, 3-ADON and 15-ADON) were performed to reveal their 
real hazardous effects on humans. The health risks related to the dietary intake of OTA 
were assessed by combined use of point evaluation and Monte-Carlo model 
simulation based on the inhabitants’ consumption habits in Shanghai city of P. R. 
China. The obtained results indicated that the mean DI values in the studied locations 
was lower than the TDIs. However, high percentiles (≥97.5%) showed higher values 
of DI, leading to potential health risks for consumers. With regard to DON and its 
derivatives, a cumulative health risk assessment was performed on multiple 
mycotoxins with cereal grains as model food matrices. Considering the contamination 
levels of DON and its derivatives in wheat and maize, the toxic effects associated with 
DON, 15-ADON and 3-ADON should be of less concern to the population of 
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Shanghai. Further quantitative risk assessments by Monte Carlo simulation using the 
CA concept indicated that the DI values of individual mycotoxins were lower than the 
PMTDI. However, integration of the risks from DON together with one or two 
derivatives as concomitant mycotoxins gave DI values exceeding the PMTDI 
proposed by JECFA at 95 percentile. Since the MOS values of the total mycotoxins 
were not equal to the sum of the individual MOS values, the interaction mechanism of 
DON, 3-ADON and 15-ADON was considered to be synergistic but not additive. 
Based on the consideration of cumulative health risks related to DON and its 
derivatives, it is recommended to include not only the parent form of DON but also its 
derivatives in routine monitoring and control programs of agricultural practices, crop 
management and food production, as well as in food safety administration. 
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Mycotoxins, as one of the most important natural contaminants in food and feedstuffs, 
cause high economic losses (billions of dollars per year) and serious environmental 
contamination, and thus are a serious threat not only in China or Belgium, but also in 
the whole world making it a universal problem. 
To protect human and animal health, various regulations and analytical methods 
have been established for the management and control of mycotoxin contamination in 
food and feed. Since samples are frequently contaminated by different mycotoxins, 
within the field of mycotoxin analysis, a clear trend toward the use of multi-analyte 
methods can be seen in recent literature 1-3. Based on the established targeted 
LC-MS/MS method (Chapter 2.1), international or local standardized analytical 
methods, not only for screening of the six major groups of frequently found 
mycotoxins including AFs, ochratoxins, type-A trichothecenes, type-B trichothecenes, 
FBs, ZEN, and its derivatives, but also covering some other mycotoxins such as 
fusaric acid, MPA, SMC, PAT and CIT, could be established in order to ensure the 
safety of food and feed. Although a reliable targeted LC-MS/MS method was 
developed for determination of multiple mycotoxins, the sample pretreatment 
procedure is still limited. Matrix interferences could not be efficiently eliminated and 
the results were corrected by using expensive internal standards or/and matrix 
matched calibration curves. Therefore, the development of an effective clean-up 
procedure is still the bottleneck for a rapid, sensitive and reliable analytical method 
for simultaneous determination of multiple mycotoxins. Recently, nano-materials 
have attracted more and more attention because of their unique thermal, mechanical, 
electronic and chemical properties. Carbon nanotubes (CNTs), as one of the most 
important nano-materials, can be classified into two groups including single-walled 
carbon nanotubes and multi-walled carbon nanotubes (MWCNTs) based on the 
principle of carbon atom layers in the wall of nanotubes. MWCNTs, composed of 
several rolled-up graphite sheets, have been reported to display a high adsorption 
capacity primarily due to their unique structure with internal tube cavity and 
dramatically hydrophobic surface 4,5. Previous studies have demonstrated that 
MWCNTs possess a unique feature of notable purification and enrichment efficiency 
as sorbents to polycyclic aromatic hydrocarbons, amantadine, sulfonamide antibiotics, 
resorcylic acid lactones, chloramphenicol and various pesticides 6-10. In the future, it is 
possible to develop some new sample pretreatment procedures based on these novel 
nano-materials to efficiently eliminate the matrix interferences and ensure accurate 
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quantification results, not only in food and feed samples, but also in biomatrices, i.e., 
plasma, liver, heart, spleen, lung, kidney and brain. On the other hand, although 
mycotoxin contaminations in food and feed have been extensively investigated, few 
fundamental data can be found to correctly evaluate the potential risks of various 
mycotoxins in other products, such as mushrooms. Mushrooms, growing on a wide 
range of organic substrates, are well known to be rich in protein, minerals, vitamins, 
essential amino acids and fiber 11,12. The high-quality mushrooms taste delicious and 
provide high levels of macronutrients, tocopherols and poly-unsaturated fatty acids, 
and low contents of saturated fatty acids. Important bioactive compounds in 
mushrooms also possess anti-tumor and anti-cancer properties and can help lower 
blood pressure 13-15. Since an increasing number of people use these products as 
functional food and as sources for the development of drugs 14,16,17, the safety of 
mushrooms has attracted more and more attention around the world. Research on the 
mycotoxins contamination in mushroom is scarcely performed due to the 
consideration of the mushroom as the definitely dominant fungi, in addition that the 
various metabolites of the mushroom might act as antitoxicant inhibiting mycotoxins 
production. The analytical results of L. edodes samples clearly proved that edible 
macro-fungi could be infected by mycotoxigenic fungi leading to mycotoxins related 
health risks. As a consequence, the established method could also be used for 
developing analytical methods for screening mycotoxin contaminations in other 
mushrooms, i.e., Agaricus campestris, Tremella fuciformis or Auricularia auricular, 
which are widely consumed around the world, to provide scientific evidences for 
evaluating health risks and setting regulations. 
Infection of agricultural products by toxigenic fungi leading to mycotoxins 
production remains a challenging problem despite decades of research progress. 
Cultural practices were investigated to reduce mycotoxins contamination by altering 
the conditions, such as crop rotation, tillage, planting date and fertilization, under 
which the crop is grown so that infection by the offending fungi can be avoided. Crop 
rotation or tillage has limited effects on infection and subsequent mycotoxin 
accumulation 18. Because of the importance of timing in the events leading to 
infection, mycotoxin accumulation could be affected by a change in planting date. For 
example, in maize, earlier planting dates in temperate areas normally result in lower 
risks, but annual fluctuations in weather can jeopardize this advantage 19. A higher rate 
of nitrogen fertilization can reduce AFs production 20. Mold development can arise in 
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storage procedure, and thus reducing grain moisture by artificial drying has been 
proved to be a valuable tool for preventing fungal infection and mycotoxins 
production 21. After harvest, grains should be dried as quickly as possible to reduce 
the risks of mycotoxin development. The lower the moisture contents of grains in 
storage, the lower the risks of mycotoxins development. Temperature is the most 
critical factor effecting mycotoxins production during storage for dried grains. Ideally, 
grain should be cooled after drying and stored at 1 °C to 4 °C, at which, fungal 
metabolism is minimal 22. Since aeration is essential for maintaining grain quality in 
storage, temperature, moisture and aeration should all be satisfied during storage. 
Current infrastructure and grain storage practices in developed countries can 
effectively prevent mycotoxins production in a certain part, but this aspect still 
remains a threat in developing countries, especially in tropical areas.  
Strategies based on genetic resistance (native resistance and transgenic resistance) 
pose greatest potential for managing the mycotoxins problem, either directly or 
indirectly 23. For native resistance, high levels of genetic resistance to toxigenic fungi 
in agricultural products are difficult to achieve because of the inconsistent, 
labor-intensive inoculation techniques, lack of major single genes, the expense of 
evaluating results and the lack of resistant control genotypes, but progress has been 
made. First, the ear and kernel characteristics of some agricultural products can 
contribute to mycotoxin management. The ones with tight husk coverage tend to be 
highly susceptible to fungal infection, apparently due to that tight husks can hinder the 
rate of grain drying, maintaining higher moisture contents favorable to fungi growing. 
Second, plants under stress are generally more susceptible to toxigenic fungi and 
mycotoxins contamination 24. In a previous study, fumonisin concentrations in a group 
of hybrids planted in 17 locations ranging from Georgia to Nebraska and Wisconsin 
were determined. The results clearly indicated that hybrids grown outside their 
adapted range showed higher fumonisin concentrations 25. Tolerance to specific 
environmental stresses, such as drought, has been proposed to be a way to evaluate 
the abilities of the agricultural products for reducing fungal infection and mycotoxins 
production 26. Third, inheritance of resistance has been studied for reducing fungal 
infection and mycotoxins production. Till now, several sources have been 
well-characterized for resistance to A. flavus infection or aflatoxin production, which 
has been related to one or more kernel proteins 27-29. However, this approach has not 
been sufficiently exploited due to the difficulties in incorporating polygenic resistance 
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into elite germplasm, and currently available commercial hybrids generally lack 
adequate resistance levels. 
For transgenic resistance, three basic strategies have been proposed: (1) using 
pathogen to reduce fungal infection, (2) inserting genes capable of degrading 
mycotoxins and (3) interfering with the biosynthetic pathways of mycotoxins to 
reduce their production 23. The first strategy is to enhance the expression of relative 
genes or introduce novel genes to express antifungal proteins or secondary 
metabolites, i.e., hydroxamic acids, stilbenes and phenolics. Meanwhile, inducing 
existing plant defense pathways might also be effective in preventing infection. This 
strategy has been successfully explored by altering ribosomal proteins to engineer for 
resistance to trichothecene-producing fungi. A gene from rice has been modified to 
produce a trichothecene-resistant ribosomal protein and can protect transgenic cell 
cultures from trichothecenes 30. The second strategy has been realized for preventing 
fumonisins. Genes for fumonisin esterase and an amine oxidase from a yeast 
(Exophiala spinifera) capable of metabolizing fumonisins in vitro 31, have been 
identified and cloned, and now have been expressed in maize 32. By this strategy, 
degradation of mycotoxins could not be expected to reduce the infection of related 
fungi. The third strategy is to engineer plants to produce proteins or compounds 
interfering with the biosynthesis of mycotoxins. This strategy has been successfully 
applied to AFs 33. An α-amylase inhibitor from the legume Lablab purpureus has been 
found capable of inhibition of aflatoxin production, spore germination, and hyphal 
growth by A. flavus 34, and is a candidate for expression in genetically altered plants. 
Therefore, a very active area of research is to reveal the functions of the gene clusters 
and the biosynthesis of mycotoxins with the goal of identifying targets for developing 
transgenic resistance strategies. In the present thesis (Chapter 2.3), A. flavus was 
investigated and the functions of the previously uncharacterized A. flavus gene cluster 
39 were unveiled. The results greatly contributed to the elucidation of new regulatory 
pathways controlling secondary metabolism and their roles in fungal biology. 
Additionally, these findings could be applied to develop transgenic resistance 
strategies. As previously reported, the genome of A. flavus, has been shown to harbor 
as many as 56 putative secondary metabolic gene clusters including the one 
responsible for production of the toxic and carcinogenic, PKS-derived AFs 35,36. 
Except for the production of AFs, CPA and few other metabolites 37, the capability for 
metabolite production of most of these putative clusters is still unknown. Furthermore, 
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there are also large amounts of uncharacterized gene clusters in other fungal species. 
Therefore, the functions of a lot of other gene clusters are in need to be investigated 
by the established untargeted analytical system. 
  Due to the widespread and high toxicity, toxicokinetics and metabolic studies have 
been performed for different mycotoxins all over the world. The current research 
(Chapters 3.1 and 3.2) has investigated the toxicokinetics and metabolisms of AFB1, 
T-2 and OTA to reveal their toxicological mechanisms, so as to provide scientific 
basis for setting accurate and scientific limits for these mycotoxins and keeping 
humans and animals health. The toxicokinetics data described in the present study was 
obtained from experiments on male rats. Since gender-related differences in 
toxicokinetics have been reported for OTA, it would be useful to investigate the 
toxicokinetics parameters for the males and females, separately, in the future. 
Furthermore, there is still large room for further investigations in this aspect 
especially considering the recently found modified mycotoxins. The term “modified 
mycotoxins” was introduced in 2014 by Rychlik et al. describing all types of 
mycotoxins modifications either by chemical or biological approaches on four levels 
38. Here mentioned modified mycotoxins are referred to the ones, whose structures are 
changed in the plant, and thus are frequently detected in cereal-based food and feed 
samples, i.e., D3G, ZEN-14-glucoside, ZEN-14-sulfate, α-ZEL-14-glucoside, 
β-ZEL-14-glucoside, T-2-3-glucoside and HT-3-glucoside. Modified mycotoxins 
might be cleaved during digestion posing potential health risks to humans and animals 
39. Recently, although more and more attention has been paid to modified mycotoxins 
research, toxicological data regarding these mycotoxins are still rare due to the limited 
amounts of reference standards available. In a recent report, the standard of D3G 
could be synthesized in a simple and rapid way by using recombinant 
UDP-glucosyltransferase from rice 40. The great advantage by this approach is that the 
enzyme could be functionally expressed with E. coli, and thus possiblly provide 
sufficient amounts of D3G for toxicokinetics and metabolism study. Similar strategies 
may be of interest to produce β-glucosides of other mycotoxins.  
Since modified mycotoxins are known to be detoxification products in plants, they 
are generally considered to exhibit a lower toxicity compared to their free compounds 
41. In a previous study, D3G was put under the conditions simulating early stages of 
the mammalian digestion. The results showed that D3G was resistant to HCl for at 
least 24 h at 37 °C (pH 1.7), suggesting that D3G could not be hydrolyzed in the 
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stomach of mammals 42. Besides DON, the in vitro metabolisms of modified forms of 
ZEN (ZEN-14-glucoside, ZEN-14-sulfate) were also investigated. These modified 
mycotoxins were reported to be cleaved by human colonic microbiota releasing their 
toxic aglucones 43. In an in vitro fecal fermentation assay, ZEN-14-glucoside, 
ZEN-14-sulfate were found to be completely cleaved after 24 h 44. Several 
toxicokinetic and toxicodynamic investigations in mammals have also been performed 
to further assess the risks related to modified mycotoxins. In rat, after administration 
of D3G, only 3.7±0.7% of the given dose were found in urine and only 0.3±0.1% 
were detected in the form of urinary D3G. The majority of administered D3G was 
recovered as DON and DOM-1 in feces 45. These results clearly suggested that D3G 
was little bioavailable, and was hydrolyzed to DON during digestion, and partially 
converted to DOM-1 and DON-glucuronides prior to excretion, indicating that D3G is 
of considerably lower toxicological relevance than DON in rats 45. In pigs, the 
bioavailability of D3G was also lower than DON and therefore of lower toxicological 
relevance 46,47. The metabolism of modified ZEN (ZEN-14-glucoside) has also been 
investigated in rat. After administration of ZEN-14-glucoside, ZEN was found in the 
stomach (16–19%) proving the possibility of hydrolysis, while small amounts of 
ZEN-14-glucoside were also detected in the small and large intestines suggesting that 
the modified mycotoxins could not be fully hydrolyzed 48. Data regarding in vivo 
experiments on other modified mycotoxins are non-existent. Due to a lack of in vitro 
and in vivo data, there are still no regulatory limits on modified mycotoxins in 
different countries around the world.  
  Ensuring of safe and healthy foods free from mycotoxins is an important challenge 
all over the world. Currently, it is really important to adopt some measures aimed at 
guaranteeing food safety and protecting human health. Risk assessment is 
undoubtedly an obligatory tool for characterization and identification of the adverse 
effects related to the exposure to mycotoxins. In the present research (Chapters 4.1 
and 4.2), quantitative risk assessments of OTA, DON and its derivatives have been 
performed. The results proved that these mycotoxins should be included in monitoring 
and control programs of agricultural practices, crop management and food production, 
as well as in food safety administration. Of great concern in risk assessment and a 
possible hazard for humans are modified mycotoxins, which frequently co-occur with 
free mycotoxins in different agricultural products as well as that they could be 
hydrolyzed into their toxic free forms during mammalian digestion. It has become 
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clear that modified mycotoxins could represent a potential additional risk for both 
animals and humans. There are two challenges for risk assessments of modified 
mycotoxins: (1) the modified mycotoxins cannot be detected or are underestimated by 
the conventional analytical methods except D3G for which reference standards are 
commercially available. The need of identification of new modified forms via 
untargeted screening of samples is an emerging research topic. Having in mind this 
circumstance it can be speculated that the levels of target mycotoxins in 
foods/feedstuffs are often actually higher. (2) There are currently no sufficient 
toxicokinetic and toxicodynamic data available to quantitatively evaluate the true 
risks related to modified mycotoxins. The risk assessments of some modified 
mycotoxins have been performed in some recent reports and by EFSA 39,49. In the 
absence of specific toxicity data, toxicity equal to the free compounds was assumed 
for modified mycotoxins. The modified mycotoxins have been proved to increase the 
risks of free forms and a reduction of (modified) mycotoxin concentrations is a 
prerequisite to keep within their safety boundaries. The recognition of the 
toxicological relevance and the evaluation of the occurrence of modified mycotoxins 
in food commodities currently become new big challenges for risk assessments. 
Extra attention should also be paid to the real situations where more than one 
mycotoxin is present resulting in an additive or synergistic toxic effect. Three methods 
have been proposed for exposure assessments of chemical mixtures of environmental 
contaminants to predict their cumulative risks (Chapter 1.4.3). The cumulative risks 
related to DON, 3-ADON and 15-ADON were evaluated (Chapter 4.2). In view of the 
cumulative health risks related to the DON derivatives, the work has supported 
reliable evidences for setting legislation that should not only focus on the free forms 
of mycotoxins but also should indispensably consider their derivatives. Apparently, it 
is not enough since DON, 3-ADON and 15-ADON belong to the same type of 
mycotoxins, the toxicity of which was considered the same, and the DI values for the 
sum of the three mycotoxins have been regulated by JECFA, making a special case 
for CA application. In most of the real situations, different types of mycotoxins could 
co-enter the body of consumers simultaneously, through the same food or by a diverse 
human diet. In this case, the established CA model was not feasible for quantitative 
assessment of the total risks. For example, a potent synergistic effect was observed 
between ochratoxin A and penicillic acid that may be produced by the same 
ochratoxinogenic fungi, when the two mycotoxins were simultaneously given to pigs 
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or chickens 50,51. It is almost certain that co-exposure to different mycotoxins even in 
low contamination levels (not exceed the regulations) might also lead to chronic renal 
diseases in animals and humans, especially after long-term exposure. The presence of 
multiple toxins in various foods and food products presents a new challenge since 
toxicological information of simultaneous exposure is still very scarce and limited. 
One or several new statistical models need to be established in future work, to reveal 
the real health risks related to different mycotoxins, so as to introduce new regulations 
and limits in regard to combined contamination of food by several mycotoxins having 
in mind their possible interaction and increased hazard for humans. 
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The current Ph D-dissertation entitled “Aspergillus and Fusarium toxins: analysis, 
metabolic profiling, in vivo kinetics and metabolism, and risk assessment” contributes 
to mycotoxin research by providing reliable LC-MS/MS methods for accurate 
quantification of multiple mycotoxins, investigating the untargeted secondary 
metabolites of toxigenic Aspergillus and Fusarium fungi, revealing the in vivo kinetics 
and metabolic mechanism of selected mycotoxins, and assessing the health risks to 
human beings.  
In Chapter 1, an extensive introduction on mycotoxins was provided. An overview 
of the frequently occurring mycotoxins, including AFs, ochratoxins, FBs, 
trichothecenes, ZEN and its derivatives was given to provide general information 
including chemical structure, toxicity and regulations. Since most important 
mycotoxins are produced by Aspergillus and Fusarium fungi, these fungi and their 
metabolites were then thoroughly investigated to fully understand their harmful 
effects. The second part of this chapter describes the absorption, distribution, 
metabolism and excretion of the selected Aspergillus and Fusarium mycotoxins, and 
presents their related health risks to humans and animals.  
   Due to the widespread and high toxicity of mycotoxins, development and 
validation of a reliable LC-MS/MS method for multiple mycotoxins determination is a 
prerequisite. In Chapter 2, a rapid LC-MS/MS method was developed for 
simultaneous determination of 33 frequently occurring mycotoxins. Targeted 
mycotoxins were extracted using a QuEChERS procedure without any further 
clean-up step, andanalyzed by LC–MS/MS on an Agilent Poroshell 120 EC-C18 
column (100 mm×3 mm, 2.7 µm) with a linear gradient elution program using water 
containing 5 mM ammonium acetate and methanol as the mobile phase. Validation 
details including linearity (R2>0.99), sensitivity (LOQ≤20 ng/kg), recovery 
(73.6-117.9%) and precision (0.8-19.5%), indicated that the established method was 
rapid, sensitive and reliable. Among the different mycotoxins, AFs and ochratoxins 
were related to Aspergillus species, while trichothecenes, fumonisins and ZEN were 
mainly produced by Fusarium fungi, emphasizing the importance of these two fungal 
genera. Therefore, metabolic profiling of Aspergillus and Fusarium fungi was 
performed by combined use of LC-MS/MS, LC-TOF, LC-orbitrap, LC-ion trap and 
NMR. Finally, the functions of the previously uncharacterized gene cluster 39 in 
Aspergillus fungi were clarified and the biosynthetic pathway of aflavarin was clearly 
identified. Meanwhile, the toxin-producing ability of a total of 12 Fusarium species 
Summary 
254 
obtained in Belgium was investigated. F. verticillioides was identified as the major 
strain able to produce the highest concentration levels of mycotoxins in maize based 
products in Belgium.  
Among the different secondary metabolites produced by Aspergillus and Fusarium 
fungi, AFB1, T-2 and OTA were further investigated for in vivo kinetics and 
metabolism. In Chapter 3, isotope dilution LC-MS/MS methods were developed for 
the determination of AFB1 and T-2, and OTA, respectively. The established methods 
were validated by determination of specificity, linearity, sensitivity, accuracy, 
precision and stability, and all results indicated that the established LC-MS/MS 
methods were rapid, sensitive and reliable for AFB1, T-2 and OTA detection in vivo. 
Based on this methodological advance, kinetics and tissue distribution after oral 
administration of both AFB1 and T-2 in rats were thoroughly studied. As revealed, 
both AFB1 and T-2 were rapidly eliminated in vivo. In contrast to AFB1 and T-2, the 
degradation of OTA was very slow, and accumulation in different tissues was 
observed in vivo. Due to its slow degradation and high accumulation, the metabolism 
was further investigated to address the remaining uncertainties regarding OTA 
biotransformation (glucuronidation and targeted tissues) by in vitro and in vivo 
metabolic studies, so as to provide a better insight into its toxicological mechanisms. 
The metabolites of OTA were identified by using UHPLC-MS/MS, 
UHPLC-orbitrap-HRMS and LC-iontrap, and the in vivo and in vitro pathways 
(glucuronidation and targeted tissues) for OTA were proposed for the first time. 
Health risks related to dietary intake of the studied mycotoxins (OTA, DON and its 
derivatives) were quantitatively assessed in Chapter 4. For OTA, a total of 400 food 
samples randomly collected from different locations of Shanghai were analyzed by 
the previously established LC-MS/MS method. Then, 265 participants (70 males and 
195 females) as representative inhabitants were invited to answer the designed 
questionnaire about the quantity and frequency of foods including four major varieties 
of grapes, cereals, beans and dried fruits as well as their derived products. Finally, all 
data were simulated by point evaluation and probabilistic analysis (Monte Carlo 
model) for the risk assessment of OTA contamination. Results showed that mean DI 
values of OTA were lower than all the health-based guidance values. However, the DI 
values in the high percentile (97.5th) were higher than the TDI (5 ng/kg b.w./day) 
proposed by the SCF. Among the different groups of foods, OTA in cereals and 
derived products made the largest contribution to the potential health risk. In the 
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second part of Chapter 4, we quantitatively assessed for the first time the cumulative 
health risks of concomitant exposure via dietary intake to DON and its derivatives, 
based on the CA concept. A cross-sectional study was conducted in seven districts in 
Shanghai, China with 1269 participants and 330 wheat and maize samples analyzed. 
After probabilistic analysis using Monte Carlo simulation, the results showed no 
health risks to the population in Shanghai considering individual mycotoxins. 
However, if the cumulative health risks were calculated based on the combined 
consideration of DON with either 3-ADON or 15-ADON or both, the DI values in the 
95th percentile were up to 1087 ng/kg b.w./day, exceeding the PMTDI of 1000 ng/kg 
b.w./day and hence representing potential health risks to the population in Shanghai. 
The integrated study proposed here could be a model strategy for cumulative health 
risk assessment on co-occurring hazards in the fields of food safety combined with 
environmental contaminants. 
All the essential information of the research work gathered from the different 
chapters was used to form the general conclusions in Chapter 5.  
Finally, Chapter 6 clarified the broader international perspective of the conducted 
research, paying particular attention to the future developments to be expected, and 
also to the potential contribution of the research conducted to these developments. 
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Dit doctoraatsonderzoek getiteld “Aspergillus and Fusarium toxins: analysis, 
metabolic profiling, in vivo kinetics andmetabolism, and risk assessment” levert een 
bijdrage tot de ontwikkeling van betrouwbare methodologieën voor 
mycotoxinenanalyse, de studie van de kinetiek van geselecteerde mycotoxinen en de 
risico-inschatting van deze mycotoxinen op de volkgezondheid. 
In hoofdstuk 1 werd een uitgebreide inleiding gegeven over mycotoxinen. Een 
overzicht van de meest voorkomende mycotoxinen, waaronder aflatoxinen, 
ochratoxinen, fumonisinen, trichothecenen, zearalenone en zijn derivaten werd 
gegeven met algemene informatie zoals chemische structuur, toxiciteit en de wetgeving 
inzake mycotoxinen. Daar de meest relevante mycotoxinen door Aspergillus en 
Fusarium schimmels worden geproduceerd, werden deze schimmelsoorten en hun 
metabolieten grondig bestudeerd om hun schadelijke gevolgen beter te begrijpen. Het 
tweede deel van dit hoofdstuk beschrijft de absorptie, distributie, metabolisme en 
excretie van de geselecteerde Aspergillus en Fusarium mycotoxinen, en de 
bijbehorende gezondheidsrisico's voor mens en dier worden daarbij aangetoond. 
Als gevolg van het wereldwijde voorkomen en de hoge toxiciteit van mycotoxinen is 
de ontwikkeling en validatie van een betrouwbare LC-MS/MS methode voor 
multi-mycotoxinenanalyse noodzakkelijk. In hoofdstuk 2 werd een snelle LC-MS/MS 
methode ontwikkeld voor de simultane bepaling van 33 vaak voorkomende 
mycotoxinen. De beoogde mycotoxinen werden geëxtraheerd gebruik makend van een 
QuEChERS procedure zonder verdere opzuiveringsstap, en werden geanalyseerd d.m.v. 
LC-MS/MS. Er wordt gebruik gemaakt van een Agilent Poroshell 120 EC-C18-kolom 
(100 mm x 3 mm, 2,7 urn) met een lineaire gradiënt elutie programma van mobiele 
fasen bestaande uit 5 mM ammoniumacetaat in water en methanol. De validatie data, 
namelijk delineariteit (R2> 0,99), gevoeligheid (LOQ≤20 ng/kg), recovery 
(73,6-117,9%) en precisie (0,8-19,5%) toonden aan dat de methode snel, gevoelig en 
betrouwbaar was. Van de verschillende mycotoxinen worden aflatoxinen en 
ochratoxinen gerelateerd aan Aspergillus species, terwijl detrichothecenen, 
fumonisinen en zearalenone (ZEN) voornamelijk door Fusarium worden geproduceerd, 
wat het belang van deze twee schimmelsoorten benadrukt. Als gevolg werd een 
metabole profilering van Aspergillus en Fusarium uitgevoerd door middel van van 
LC-MS/MS, LC-TOF, LC-orbitrap, LC-ion trap en NMR. Tenslotte werden de 
metabolieten geproduceerd door de Aspergillus flavus genecluster 39 geïdentificeerd 
en de enzymen van de biosynthese ontrafeld. Ondertussen werden ook 12 Fusarium 
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species, verkregen in België, onderzocht voor mycotoxinenproductie. F. verticillioides 
werd geïdentificeerd als de belangrijkste Fusarium schimmel die in staat is om de 
hoogste mycotoxinegehalten te produceren in maïsproducten in België. 
Van de verschillende secundaire metabolieten geproduceerd door Aspergillus en 
Fusarium schimmels, werden aflatoxin B1 (AFB1), T-2 toxine (T-2) en ochratoxin A 
(OTA) verder onderzocht op het vlak in vivo kinetiek en metabolisme. In hoofdstuk 3 
werden isotopendilutie LC-MS/MS methoden ontwikkeld en gevalideerd voor de 
bepaling van AFB1 en T-2, en OTA. Bij de validatie van die verschillende LC-MS/MS 
methoden werd er voldaan aan de prestatiecriteria (specificiteit, lineariteit, 
gevoeligheid, nauwkeurigheid, precisie en stabiliteit), met als gevolg dat deze 
methoden geschikt waren voor de in vivo detectie van AFB1, T-2 en OTA. Na deze 
methodologische vooruitgang werden de kinetiek en weefseldistributie na orale 
toediening van zowel AFB1 als T-2 in ratten grondig bestudeerd. Deze twee toxinen 
werden snel geëlimineerd in vivo. In tegenstelling tot AFB1 en T-2, was de afbraak van 
OTA zeer traag, en een accumulatie in verschillende weefsels werd waargenomen in 
vivo. Gezien de langzame afbraak en de hoge accumulatie, werd verder onderzoek 
gedaan om de onduidelijke OTA biotransformatie (glucuronidatie en doelweefsel) via 
in vitro en in vivo metabolische studies te kunnen ophelderen, teneinde een beter 
inzicht in de toxicologische mechanismen te leveren. De metabolieten van OTA 
werden geïdentificeerd d.m.v. UHPLC-MS/MS, UHPLC-orbitrap-HRMS en LC-ion 
trap, en de in vivo en in vitro pathways (glucuronidatie en doelweefsel) voor OTA 
werden voor de eerste keervoorgesteld. 
De gezondheidsrisico’s geassocieerd met de inname via voedsel van de bestudeerde 
mycotoxines (OTA, DON en zijn derivaten) werden kwantitatief onderzocht in 
hoofdstuk 4. Voor OTA werden in totaal 400 voedingsstalen ad random verzameld uit 
verschillende locaties in Shanghai en geanalyseerd door middel van de eerder 
ontwikkelde LC-MS/MS methode. Daarna werden 265 deelnemers (70 mannen en 195 
vrouwen), als een representatieve groep van bewoners, verzocht een vragenlijst in te 
vullen over hun voedselconsumptie, waaronder vier belangrijke voedselsoorten 
namelijk druiven, granen, bonen en gedroogde vruchten als ook hun afgeleide 
producten. Tenslotte werd een probabilistische risico-evaluatie uitgevoerd met behulp 
van Monte Carlo simulaties voor OTA. De resultaten toonden aan dat de gemiddelde 
dagelijkse inname (DI) waarden voor OTA lager waren dan de toegestane limieten. 
Echter, de DI waarden waren in het hoge percentiel (P97.5) hoger dan de tolereerbare 
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dagelijkse inname (TDI) (5 ng/kg lichaamsgewicht (l.g.)/dag) voorgesteld door de 
“Scientific Committee on Food” (SCF). Onder de verschillende groepen van 
voedingsmiddelen was het mogelijk gezondheidsrisico het hoogst voor OTA in granen 
en afgeleide producten. In het tweede deel van hoofdstuk 4 werden de cumulatieve 
gezondheidsrisico's door gelijktijdige blootstelling via inname van voeding aan DON 
en zijn derivaten voor de eerste keer kwantitatief geëvalueerd, op basis van het 
“concentration addition” (CA) concept. Een cross-sectionele studie werd uitgevoerd in 
zeven districten in Shanghai, China met 1269 deelnemers en in totaal werden 330 tarwe 
en maïs stalen geanalyseerd. Probabilistische risico-evaluatie met behulp van Monte 
Carlo simulatie toonden geen gezondheidsrisico's voor de bevolking van Shanghai 
indien  afzonderlijke mycotoxinen werden beschouwd. Als echter de cumulatieve 
gezondheidsrisico's werden berekend op basis van de gecombineerde bijdragen van 
DON met hetzij 3-ADON of 15-ADON of beide, waren de DI waarden in de 95ste 
percentiel zo hoog als 1087 ng/kg l.b./ dag, wat hoger is dan de TDI van 1000 ng/kg 
l.g./dag, en dus neerkomt op mogelijke gezondheidsrisico's voor de bevolking in 
Shanghai. De hier voorgestelde geïntegreerde studie zou een model strategie kunnen 
zijn om de cumulatieve gezondheidsrisico in te schatten van gelijktijdige aanwezigheid 
van meerdere contaminanten in voeding eventueel gecombineerd met 
milieucontaminanten. 
In hoofdstuk 5 werden  de algemene conclusies geformuleerd vanuit alle relevante 
onderzoeksresultaten. 
Tot slot gaf hoofdstuk 6 een breder internationaal perspectief van het uitgevoerde 
onderzoek, met bijzondere aandacht voor toekomstige ontwikkelingen en de potentiële 
bijdrage van het onderzoek met betrekking tot deze ontwikkelingen. 
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